UNIVERSALCORPORATION 2 0 1 5
Annual Report
ABOUT THE COMPANY
Universal Corporation, headquartered in Richmond, Virginia, is the leading global leaf tobacco supplier.
Tobacco has been its principal focus since its founding in 1918. The largest portion of the company’s
business involves procuring and processing flue-cured and burley leaf tobacco for manufacturers of
consumer tobacco products. Universal conducts its business in more than 30 countries on 5 continents
and employs over 27,000 permanent and seasonal workers.
$ 4.06
$ 5.25
$ 4.66
2.06
2.08
47.16
2.02
2.04
55.89
1.98
2.00
56.04
$ 1,363,697
$ 1,218,270
$ 1,123,376
1,362,725
1,378,230
1,258,571
Net Income per Diluted Share *
Dividends Declared
Operating Income
in dollars
in dollars
in millions of dollars
6
0
.
2
2
0
.
2
8
9
.
1
4
9
.
1
0
9
.
1
5
2
.
5
6
6
.
4
6
0
.
4
2
4
.
5
5
2
.
3
6
5
4
3
2
1
0
2.0
1.5
1.0
0.5
0.0
2
.
6
4
2
0
.
3
2
2
6
.
4
5
2
3
.
0
8
1
9
.
7
6
1
300
240
180
120
60
0
15
14
13
12
11
15
14
13
12
11
15
14
13
12
11
* Attributable to Universal Corporation common shareholders after deducting amounts attributable to noncontrolling interests in
consolidated subsidiaries.
ANNUAL REPORT
1
FINANCIAL HIGHLIGHTSOPERATIONSSales and other operating revenues Segment operating incomeOperating income Net income Net income attributable to Universal CorporationPER COMMON SHARENet income attributable to Universal Corporation common shareholders—dilutedDividends declaredIndicated 12-month dividend rateMarket price at year endAT YEAR ENDWorking capitalTotal Universal Corporation shareholders’ equityin thousands, except per share dataFiscal Year EndedMarch 31, 2013Fiscal Year EndedMarch 31, 2014$ 2,271,801 167,225 167,874120,461 114,608 Fiscal Year EndedMarch 31, 2015$ 2,461,699 232,757223,009140,919132,750$ 2,542,115 175,175 246,151155,155 149,009 Lennart R. Freeman 1 4 5
Retired Executive Vice President
Swedish Match AB
Thomas H. Johnson 1 5
Chief Executive Officer
The Taffrail Group, LLC
Eddie N. Moore, Jr. 2 3 4 *
President and
Chief Executive Officer
Norfolk State University
Robert C. Sledd 2 * 3 4
Managing Partner
Pinnacle Ventures, LLC
1 Executive Committee
2 Pension Investment Committee
3 Finance Committee
4 Audit Committee
5
Executive Compensation, Nominating,
and Corporate Governance Committee
* Committee Chairman
Chairmen Emeritus
Henry H. Harrell
Allen B. King
BOARD OF DIRECTORS
Universal Corporation
George C. Freeman, III 1 * 3
Chairman, President, and
Chief Executive Officer
Universal Corporation
John B. Adams, Jr. 2 3 4
President and
Chief Executive Officer
Bowman Companies
Diana F. Cantor 2 3 *
Partner
Alternative Investment
Management, LLC
Chester A. Crocker 2 3
Professor
Georgetown University
Charles H. Foster, Jr. 1 5 *
Retired Chairman
LandAmerica Financial
Group, Inc.
1
2
Retired March 31, 2015
As of April 1, 2015
2
UNIVERSAL C ORP OR ATION
OFFICERS
Universal Corporation
George C. Freeman, III
Chairman, President, and
Chief Executive Officer
David C. Moore
Senior Vice President and
Chief Financial Officer
Preston D. Wigner
Vice President, General
Counsel, and Secretary
Pamela J. Kepple
Corporate Director,
Taxes
1
W. Keith Brewer
Executive Vice President
and Chief Operating
Officer
2
Airton L. Hentschke
Senior Vice President and
Chief Operating Officer
Candace C. Formacek
Vice President and
Treasurer
Robert M. Peebles
Vice President and
Controller
DIRECTORS
Universal Leaf Tobacco Company, Inc.
George C. Freeman, III
Chairman, President and
Chief Executive Officer
2
1
W. Keith Brewer
President and
Chief Operating Officer
David C. Moore
Executive Vice President
and Chief Financial Officer
Theodore G. Broome
Executive Vice President
and Sales Director
2
Airton L. Hentschke
Executive Vice President
and Chief Operating
Officer
James A. Huffman
Senior Vice President,
Information and Planning
Preston D. Wigner
Senior Vice President,
General Counsel, and
Assistant Secretary
Paul G. Beevor
Managing Director,
Asia Region
Jennifer S. Rowe
Assistant Vice President,
Capital Markets
Catherine H. Claiborne
Assistant Secretary
H. Michael Ligon
Vice President,
Corporate Affairs
Harvard B. Smith
Vice President and Chief
Compliance Officer
Joseph W. Hearington, Jr.
Vice President,
Internal Auditing
Friedrich G. Bossert
Managing Director,
Dark Air-Cured Region
Clayton G. Frazier
Managing Director,
North America Region
Cesar A. Bünecker
Managing Director,
South America Region
Gary S. Taylor
Managing Director,
Africa Region
Domenico Cardinali
Managing Director,
Europe Region
Jonathan R. Wertheimer
President,
Socotab, LLC
ANNUAL REPORT
3
TO OUR SHAREHOLDERS
Market conditions created a challenging operating environment for
your Company in fiscal year 2015. We faced oversupplied markets that
we believe were driven not only by global leaf tobacco overproduction,
but also by lower customer demand, caused in part by weak economic
conditions in some of their retail markets, particularly Europe. Despite
delivering results below expectations in the first half of the fiscal year,
we were able to end the year with strong second half results and
achieved segment operating income for the fiscal year which was only
modestly lower than the prior year. At the same time, we maintained
our strong balance sheet and saw an increase in operating cash flows.
Most importantly, we demonstrated once again our ability, even in
demanding markets, to deliver a compliant product in an efficient
manner to our customers and to produce solid fiscal results.
Net income for fiscal year 2015, was $115 million, or $4.06 per diluted share, compared with last year’s
net income of $149 million, or $5.25 per diluted share. Fiscal year 2014’s results included a gain in the first
fiscal quarter of $82 million before tax ($1.87 per diluted share) from the favorable outcome of an excise
tax-related legal proceeding in Brazil. This year’s results included a further gain related to those tax credits
($0.29 per diluted share) as well as a non-recurring income tax benefit ($0.28 per diluted share). Pretax
restructuring costs of $5 million ($0.11 per diluted share) and $7 million ($0.15 per diluted share) were also
incurred for fiscal years 2015 and 2014, respectively. Segment operating income, which excludes those
items, was $167 million for fiscal year 2015, a decrease of $8 million from the prior year. The lower earnings
were primarily due to this year’s lower sales volumes, partially offset by a reduction in our selling, general,
and administrative costs.
4
UNIVERSAL C ORP OR ATION
We completed a major refinancing of our credit facilities in fiscal year 2015. This refinancing provides us
with continued flexible and efficient funding mechanisms for our business and extended our long-term
debt maturities by five to seven years. In addition, our operations generated $230 million more in operating
cash flows in fiscal year 2015, as compared to the prior year, primarily due to lower green leaf prices and
crop purchase volumes. We also increased our cash balances by $85 million, spent $58 million on capital
projects, and returned $95 million to shareholders in the form of dividends and repurchases of our common
and preferred stock. We are well-positioned as we enter fiscal year 2016 with substantial cash balances and
manageable uncommitted inventory levels to support.
We have also continued to work hard this year to ensure that we are prepared to capitalize on opportunities
to enhance our business. While we operate in a mature industry, we believe there are prospects to both
strengthen and expand our business. As the leading global leaf tobacco supplier, we have a long history in
bringing both supply chain efficiencies and agricultural sustainability programs to the leaf tobacco industry.
As I like to say, we did sustainability before sustainability became the popular buzzword that it is today.
Recently, we have seen an increase in the level of demand for supply chain services, which include direct
purchasing, that we provide our customers. We are expanding the supply chain services that we provide in
the United States, Mexico, Brazil, and Dominican Republic. Many of these changes are already underway
or will begin to be fully implemented in fiscal year 2016. We believe that this trend acknowledges both
the efficiencies that we as a global leaf supplier bring to the tobacco leaf industry and the strength of our
sustainability programs, including our ability to meet strict customer criteria. I also firmly believe that further
opportunities exist for us to increase our market share and to offer expanded services to our customers.
We operate in a unique position in the leaf tobacco industry that allows us to be a catalyst for improved
efficiencies throughout the supply chain. We find buyers for all leaf grades and styles of tobacco produced in
a farmer’s crop. This role helps to eliminate inefficient allocation of tobacco production, which improves leaf
utilization, benefitting all parties involved. In addition to leaf utilization, we bring operational efficiencies to the
industry, which in turn helps to reduce costs. These efficiencies include economical utilization of processing
ANNUAL REPORT
5
capacity in our facilities, an established and scalable global network of agronomists and technicians helping
to maintain a stable, productive, and sustainable farmer base, and agronomic and production improvements
to optimize leaf yields and qualities. As a result, we are able to offer manufacturers a complete range
of services from the field to the delivery of the packed product when they need it, that benefit from
our efficiencies. These services include such things as buying station optimization, processing to specific
customer specifications or needs, storage of green or packed leaf tobacco, and logistical services. Our
global footprint and extensive operations in all major leaf production origins allows us to provide this critical
broad range of services and to support our customers’ desires to achieve security of supply while reducing
sourcing complexity.
In addition to efficiencies, we also bring established, top quality sustainability programs to the industry.
A key aspect to sustainability is the production of compliant leaf tobacco. To be considered compliant,
leaf tobacco must be grown using Good Agricultural Practices (GAP). One of our key GAP programs is
the Agricultural Labor Practices program, which is featured in this annual report. We have long invested
significant resources in programs and infrastructure needed to work with growers to produce compliant
leaf and continue to enhance our ability to monitor and demonstrate this compliance to our customers. We
believe that compliant leaf requirements and reduction in sourcing complexity will continue to be important
to our customers and should favor stable global leaf suppliers who are able to meet these requirements.
Strategically I believe your Company is poised for continued success and that we are in this strong position
due to the work of our many outstanding employees around the world. Today I’d like to thank one of them
who was not only my partner and sounding board for many years, but also my dear friend, W. Keith Brewer.
Keith retired on March 31, 2015 after 38 years of service in the leaf tobacco industry. He brought extensive
6
UNIVERSAL C ORP OR ATION
knowledge to the table that included expertise in processing and experience leading one of our large
regions. As Chief Operating Officer, his job took him around the world, and he wanted to spend more time
with his family and less on airplanes. I cannot fault him for that. His leadership, insight, and gentlemanly
demeanor will be greatly missed by the entire Universal family. Luckily, Keith did not leave us without a
great succession plan. Airton Luis Hentschke succeeded Keith as Chief Operating Officer on April 1st.
Airton has been working for Universal since 1991, mainly in South America, and has had as broad an
exposure to our business as anyone in our Company. He has served in industrial, financial, and commercial
capacities and successfully led one of our largest regions. Airton moved to the United States in January
2013 and until the end of March, worked closely with Keith and also with me.
As we move into fiscal year 2016, we remain focused on continuing to be a leader in bringing both market
efficiencies and excellence in our sustainability programs to our customers and returning value to our
shareholders. We are in a good position both financially and operationally to capitalize on prospects to
strengthen and expand our business. I would like to thank our customers for our long-standing relationships
and ongoing business opportunities. I also appreciate the hard work and dedication of my talented
colleagues around the globe during this past year and look forward to bringing you continued achievements
and rewards in fiscal year 2016.
George C. Freeman, III
Chairman, President, and Chief Executive Officer
ANNUAL REPORT
7
8
UNIVERSAL C ORP OR ATION
FOCUS ON AGRICULTURAL LABOR PRACTICES (ALP) PROGRAM
At Universal Corporation, we endeavor to be a proactive and constructive supply chain partner and address
key aspects and concerns of all of our stakeholders. As one of our Key Operating Principles, we focus on
sourcing a compliant product that meets customer requirements in a competitive, yet sustainable, manner.
Through our Good Agricultural Practices (GAP) program, we are committed to continuous improvement by
employing and promoting crop quality, environmental stewardship, and agricultural labor practices.
A critical component of our GAP program is the Agricultural Labor Practices (ALP) program. ALP is designed
to further our corporate goals and the goals of our customers of progressively addressing and eliminating
concerns found in agriculture with child and other labor issues, and achieving safe and fair working conditions
on all farms from which we source tobacco. We actively promote the rights of workers who not only are
employed by us, but who are part of our supply chain.
Primary ALP tenets for growers with whom we do business include:
• Prohibition of child labor and forced labor;
• Assurance of sufficient income to meet workers’ basic needs and to generate discretionary income,
without excessive or illegal work hours;
• Provision of a safe work environment to minimize injury and health risks, including, where provided,
accommodations that are clean and safe;
• Assurance of fair treatment of workers and prohibition of harassment, discrimination, and all forms
of abuse;
• Recognition and respect of workers’ rights to freedom of association and collective bargaining; and
• Compliance with all employment laws of their country.
The ALP program incorporates labor standards proposed by the International Labour Organization (ILO)
and relevant ILO conventions. We engage with numerous organizations in a collaborative process to
support our mutual objectives. For example, we are a member of the Farm Labor Practices Group, a multi-
stakeholder initiative in the United States which fosters improved farm labor practices that educate and
shape a worker’s experience on the farm and help growers understand and comply with applicable labor
laws and regulations. We are also a founding member of the Eliminating Child Labor in Tobacco Growing
Foundation (ECLT), a multi-stakeholder initiative dedicated specifically to addressing the issue of child labor
in tobacco-growing areas around the world.
Elimination of child labor is of paramount concern. We work with grower communities around the world to
increase awareness and further understanding of the importance of this issue. Universal is a global leader
in promoting the prevention of child labor in tobacco production, and protecting and improving the lives of
children in tobacco-growing areas. Our active participation in the ECLT and our adoption of and adherence
to the ECLT Pledge of Commitment in 2014 exemplifies our dedication at the highest levels.
ALP program implementation incorporates ongoing training and measurable standards to monitor results
and support continuous improvement. We commit significant time and resources to training our employees
on our program and providing them the tools they need to implement the program. For example, we utilize
ANNUAL REPORT
ANNUAL REPORT
9
9
MobileafTM, our proprietary tablet-based grower management solution, in many countries to help our leaf
technicians efficiently monitor and implement ALP along with other agricultural, sustainability and social
responsibility elements of our GAP program. Universal also commits significant time and resources to
working closely with external stakeholders. We believe strongly in engaging with customers, investors,
NGO’s, political leaders, and regulatory bodies in concert with the implementation of the ALP and social
responsibility programs. Our robust corporate affairs, agronomy and operations departments, to name a
few, provide continual engagement with stakeholders regarding initiatives to address social, labor, and
environmental considerations in the tobacco industry.
The strength, efficiency, and security of the tobacco supply chain is vital to our success and to the success
of our customers. We work diligently to preserve the quality and integrity of our tobacco from the time it
is planted through the time it is processed and delivered to our customers. To this end, we will continue to
employ the high standards of our GAP program and to promote the ALP program with growers, customers
and other stakeholders.
10
UNIVERSAL C ORP ORAT ION
PERFORMANCE GRAPH
Comparison of 5 Year Cumulative Total Return*
$250
$200
$150
$100
$50
$0
3/10
3/11
3/12
3/13
3/14
3/15
Universal Corporation
S&P Smallcap 600
S&P Midcap 400
Peer Group
*$100 invested on 3/31/10 in stock or index, including reinvestment of dividends. Fiscal year ending March 31.
Copyright© 2015 S&P, a division of McGraw Hill Financial. All rights reserved.
The performance graph compares the cumulative total shareholder return on Universal Corporation
common stock for the last five fiscal years with the cumulative total return for the same period of the
Standard & Poor’s MidCap 400 Stock Index and the peer group index. The peer group represents Alliance
One International, Inc. The graph assumes that $100 was invested in Universal Corporation common stock
at the end of the Company’s 2010 fiscal year, and in each of the comparative indices, in each case with
dividends reinvested.
CUMULATIVE TOTAL RETURN ON UNIVERSAL CORPORATION COMMON STOCK
2010
2011
2012
2013
2014
2015
At March 31
Universal Corporation
$ 100.00
$
86.34
$
96.80
$ 121.15
$ 125.39
$ 110.55
S & P MidCap 400
S&P Smallcap 600
Peer Group
100.00
100.00
100.00
126.95
125.26
78.98
129.47
131.56
74.07
152.55
152.80
76.42
184.96
195.29
57.37
207.52
212.32
21.61
ANNUAL REPORT
ANNUAL REPORT
11
9
UNIVERSALCORPORATION 2 0 1 5
10-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED MARCH 31, 2015
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______________TO_______________
Commission File Number: 001-00652
UNIVERSAL CORPORATION
(Exact name of registrant as specified in its charter)
Virginia
(State or other jurisdiction of
incorporation or organization)
9201 Forest Hill Avenue,
Richmond, Virginia
(Address of principal executive offices)
54-0414210
(I.R.S. Employer
Identification Number)
23235
(Zip Code)
Registrant's telephone number, including area code: 804-359-9311
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, no par value
Name of each exchange on
which registered
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes
No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act.
Yes
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes
No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). Yes
No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III
of this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of
the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
No
The aggregate market value of the registrant's voting and non-voting common equity held by non-affiliates, based upon the closing
sales price on the New York Stock Exchange of the registrant's common stock on September 30, 2014, the last day of the registrant's
most recently completed second fiscal quarter, was approximately $1.0 billion.
As of May 20, 2015, the total number of shares of common stock outstanding was 22,593,266.
DOCUMENTS INCORPORATED BY REFERENCE
Certain information contained in the 2015 Proxy Statement for the Annual Meeting of Shareholders of the registrant is incorporated
by reference into Part III hereof.
[THIS PAGE INTENTIONALLY LEFT BLANK]
UNIVERSAL CORPORATION
FORM 10-K
TABLE OF CONTENTS
Item No.
Page
PART I
1.
1A.
1B.
2.
3.
4.
5.
6.
7.
Business ....................................................................................................................................................
Risk Factors...............................................................................................................................................
Unresolved Staff Comments .....................................................................................................................
Properties ..................................................................................................................................................
Legal Proceedings .....................................................................................................................................
Mine Safety Disclosures ...........................................................................................................................
PART II
Market for Registrant's Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities.................................................................................................
Selected Financial Data.............................................................................................................................
Management's Discussion and Analysis of Financial Condition and Results of Operations....................
7A.
Quantitative and Qualitative Disclosures About Market Risk ..................................................................
8.
9.
9A.
9B.
10.
11.
12.
13.
14.
Financial Statements and Supplementary Data.........................................................................................
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure...................
Controls and Procedures ...........................................................................................................................
Other Information .....................................................................................................................................
PART III
Directors, Executive Officers, and Corporate Governance.......................................................................
Executive Compensation...........................................................................................................................
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Certain Relationships and Related Transactions, and Director Independence..........................................
Principal Accounting Fees and Services ...................................................................................................
PART IV
15.
Exhibits, Financial Statement Schedules ..................................................................................................
Signatures..................................................................................................................................................
3
9
12
13
14
14
15
16
18
33
34
82
82
82
83
84
84
84
84
85
87
2
[THIS PAGE INTENTIONALLY LEFT BLANK]
General
This Annual Report on Form 10-K, which we refer to herein as our Annual Report, contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). Among other things, these statements relate to Universal Corporation’s financial condition, results of operations
and future business plans, operations, opportunities, and prospects. In addition, Universal Corporation and its representatives may
make written or oral forward-looking statements from time to time, including statements contained in other filings with the Securities
and Exchange Commission (the “SEC”) and in reports to shareholders. These forward-looking statements are generally identified
by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,”
and similar expressions or words of similar import. These forward-looking statements are based upon management’s current
knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or
achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied
by such forward-looking statements. Such risks and uncertainties include, but are not limited to: anticipated levels of demand for
and supply of our products and services; costs incurred in providing these products and services; timing of shipments to customers;
changes in market structure; government regulation; product taxation; industry consolidation and evolution; changes in exchange
rates; and general economic, political, market, and weather conditions. For a description of factors that may cause actual results to
differ materially from such forward-looking statements, see Item 1A, “Risk Factors.” We caution investors not to place undue reliance
on any forward-looking statements as these statements speak only as of the date when made, and we undertake no obligation to
update any forward-looking statements made in this report. In addition, the discussion of the impact of current trends on our business
in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Other Information Regarding Trends
and Management’s Actions” in Item 7 should be read carefully in connection with evaluating our business and the forward-looking
statements contained in this Annual Report.
This Annual Report uses the terms “Universal,” “the Company,” “we,” “us,” and “our” to refer to Universal Corporation
and its subsidiaries when it is not necessary to distinguish among Universal Corporation and its various operating subsidiaries or
when any distinction is clear from the context in which it is used.
PART I
Item 1. Business
A.
The Company
Overview
We are the leading global leaf tobacco supplier. We operate in over 30 countries on five continents. Tobacco has been
our principal focus since our founding in 1918. The largest portion of our business involves procuring and processing flue-cured
and burley leaf tobacco for manufacturers of consumer tobacco products. Our reportable segments for our flue-cured and burley
tobacco operations are North America and Other Regions. We also have a third reportable segment, Other Tobacco Operations,
which comprises our dark tobacco business, our oriental tobacco joint venture, and certain tobacco- and non-tobacco-related services.
We generated approximately $2.3 billion in consolidated revenues and earned $167.2 million in total segment operating income in
fiscal year 2015. Universal Corporation is a holding company that operates through numerous directly and indirectly owned
subsidiaries. Universal Corporation’s primary subsidiary is Universal Leaf Tobacco Company, Incorporated. See Exhibit 21,
“Subsidiaries of the Registrant,” for additional subsidiary information.
3
Key Operating Principles
We believe that by following several key operating principles we can continue to produce good financial returns from our
business and enhance shareholder value. These key operating principles are:
•
•
Strategic market position. We work closely with both our customers and suppliers to ensure that we deliver a product
that meets our customers' needs and promotes a strong sustainable supplier base. We believe that developing and
maintaining these relationships is particularly valuable in the leaf tobacco industry where delivering quality, compliant
tobacco at an appropriate price is a key factor in long-term profitability. Balancing these relationships, we target our
tobacco production contracts against customer purchase indications and maintain global procurement and production
supply chain operations that allow us to maximize efficiencies. We continually work to adapt our business model to
meet our customers' evolving needs while providing the compliant products, stability of supply, and the high level of
service that distinguishes our company.
Strong local management. We operate with strong local management. We believe that having strong local
management in each leaf tobacco origin helps us better identify and adjust to constantly changing market conditions
and provides us with specific market knowledge quickly. We believe that this, coupled with effective global
coordination, is a key factor in our ability to continue to deliver the high quality, competitively-priced products and
services that our customers expect.
• Compliant products. We focus on sourcing a compliant product that meets customer requirements in a competitive,
yet sustainable, manner. We are committed to continuous improvement by employing and promoting good agricultural
practices which encompass crop quality, environmental stewardship, and agricultural labor practices (“Good
Agricultural Practices”). Our Good Agricultural Practices programs educate farmers in such matters as the reduction
of non-tobacco related materials, product traceability, environmental sustainability, and social responsibility.
• Diversified sources. We strive to maintain efficient diversified sources of leaf tobacco to minimize reliance on any
one sourcing area. We operate in over 30 countries on five continents, maintain a presence in all major flue-cured,
burley, oriental, and dark air-cured tobacco growing regions in the world, and hold a prominent position in all key
tobacco areas. Our global reach allows us to meet our customers' diverse and dynamic leaf requirements and helps
minimize the impact of crop failures or other localized supply interruptions.
• Financial strength. We believe that sustaining our financial strength is important, because it enables us to fund our
business efficiently and make investments in our business when appropriate opportunities are identified. We believe
that lower interest and capital costs give us a competitive advantage. Our financial strength also affords us financial
flexibility in dealing with customer requirements and market changes. We continually work to improve our financial
condition and creditworthiness.
Additional Information
Our website address is www.universalcorp.com. We post regulatory filings on this website as soon as reasonably practicable
after they are electronically filed with or furnished to the SEC. These filings include annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, Section 16 reports on Forms 3, 4, and 5, and any amendments to those reports filed
with or furnished to the SEC. Access to these filings on our website is available free of charge. Copies are also available, without
charge, from Universal Corporation Investor Relations, 9201 Forest Hill Avenue, Richmond, VA 23235. Reports filed with the SEC
may be viewed at www.sec.gov or obtained at the SEC Public Reference Room at 100 F Street, NE, Washington, D.C. 20549.
Information regarding the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. We
also post our press releases on our website. Information on our website is not deemed to be incorporated by reference into this
Annual Report.
In addition, our Corporate Governance Guidelines, Code of Conduct, and charters for the Audit Committee, the Executive
Committee, the Executive Compensation, Nominating and Corporate Governance Committee, the Pension Investment Committee,
and the Finance Committee are available free of charge to shareholders and the public through the “Corporate Governance” section
of our website. Printed copies of the foregoing are available to any shareholder upon written request to our Treasurer at the address
set forth on the cover of this Annual Report or may be requested through our website, www.universalcorp.com.
4
B.
Description of Business
General
Our primary business is procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to, or for the
account of, manufacturers of consumer tobacco products throughout the world. Procuring leaf tobacco involves contracting with,
providing agronomy support to, and financing farmers in many origins. We do not manufacture cigarettes or other consumer tobacco
products. Through various operating subsidiaries and unconsolidated affiliates located in tobacco-growing countries around the
world, we contract, purchase, process, and sell flue-cured and burley tobaccos, as well as dark air-cured and oriental tobaccos. Flue-
cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used
mainly in the manufacture of cigars, smokeless, and pipe tobacco products. We also provide value-added services to our customers,
including blending, chemical and physical testing of tobacco, service cutting for select manufacturers, manufacturing reconstituted
leaf tobacco, and managing just-in-time inventory.
In addition to our primary business, we are involved in tobacco and other agribusiness opportunities where we believe we
can earn an adequate return, leverage our assets and expertise, and enhance our farmer base. We participate in a joint venture that
supplies traceable liquid nicotine to the vapor products industry. During fiscal year 2015, we entered a new business to produce
high-quality dehydrated and juiced fruit and vegetable products.
With respect to our primary business, we generate our revenues from product sales of processed, packed tobacco that we
source, from processing fees for tobacco owned by third parties, and from fees for other services. Sales to our five largest customers,
with whom we have longstanding relationships, have accounted for more than 60% of our consolidated revenues for each of the
past three fiscal years. Our sales consist primarily of flue-cured and burley tobaccos. For the fiscal year ended March 31, 2015,
our flue-cured and burley operations accounted for 90% of our revenues and 94% of our segment operating income.
We conduct our business in varying degrees in a number of countries, including Bangladesh, Brazil, the Dominican
Republic, Germany, Guatemala, Hungary, India, Indonesia, Italy, Malawi, Mexico, Mozambique, the Netherlands, Nicaragua,
Paraguay, the People’s Republic of China, the Philippines, Poland, Russia, Singapore, South Africa, Spain, Switzerland, Tanzania,
the United States, Zambia, and Zimbabwe. In addition, our oriental tobacco joint venture, Socotab, L.L.C. has operations in Bulgaria,
Greece, Macedonia, and Turkey.
Because unprocessed, or “green,” leaf tobacco is a perishable product, timely processing is an essential service to our
customers. Our processing of leaf tobacco includes grading in the factories, blending, removal of non-tobacco material, separation
of leaf from the stems, drying, packing to precise moisture targets for proper aging, as well as temporary storage. Accomplishing
these tasks generally requires investments in factories and machinery in areas where the tobacco is grown. Processed tobacco that
has been properly packed can be stored by customers for a number of years prior to use, but most processed tobacco is used within
two to three years.
We are a major purchaser and processor in the chief exporting regions for flue-cured and burley tobacco throughout the
world. Africa, Brazil, and the United States produce approximately 60% of the flue-cured and burley tobacco grown outside of
China. We estimate that we have historically handled, through leaf sales or processing, between 35% and 45% of the annual
production of such tobaccos in Africa, between 15% and 25% in Brazil, and between 25% and 35% in the United States. These
percentages can change from year to year based on the size, price, and quality of the crops. Recently, as tobacco growing regions
have expanded in Africa, we have handled a larger proportion of the crops there. We participate in the procurement, processing,
storage, and sale of oriental tobacco through ownership of a 49% equity interest in Socotab, L.L.C., a leading processor and supplier
of oriental tobaccos. In addition, we maintain a presence, and in certain cases, a leading presence, in virtually all other major tobacco
growing regions in the world. We believe that our leading position in the leaf tobacco industry is based on our operating presence
in all of the major sourcing areas, our ability to meet customer style, volume, and quality requirements, our expertise in dealing
with large numbers of farmers, our long-standing relationships with customers, our development of processing equipment and
technologies, and our financial position. The efficiencies that we offer our customers, due to our established network of operational
expertise and infrastructure on the ground and our ability to market most styles and grades of leaf to a diverse customer base, are
also key to our success.
We also have a leading position in worldwide dark tobacco markets. Our dark tobacco operations are located in most of
the major producing countries and in other smaller markets. We operate in major dark tobacco producing countries, including the
United States, the Dominican Republic, Indonesia, Paraguay, the Philippines, Nicaragua, and Brazil. Dark tobaccos are typically
used in the manufacture of cigars, pipe tobacco, and smokeless tobacco products, and as components of certain “roll-your-own”
cigarette products.
Sales are made by our sales force and, to a much smaller degree, through the use of commissioned agents. Most customers
are long-established tobacco product manufacturers. Customer contract arrangements vary around the world and include negotiated
pricing as well as cost plus arrangements. Discussions of a customer’s longer-term needs may begin as early as one to two years
in advance of a particular crop purchase. These discussions are key to our future crop production planning. Prior to planting each
5
year, we use early customer indications for type, style, processing, and volume requirements from the upcoming season’s crop to
help us determine our farmer contracting and grower input needs in our origins. We work with our farmers and customers continually
throughout the crop season. As crops progress through the growing season, customers will inspect the crop, and a customer’s early
indications may be refined based upon emerging crop qualities and quantities and market pricing expectations. Ultimately, purchase
agreements specifying quantity, quality, grade and price are executed, leading to committed inventory allocations of harvested green
or processed leaf that we have acquired.
In the majority of the countries where we operate, we contract directly with tobacco farmers or tobacco farmer cooperatives.
In most countries outside the United States, we advance seed, fertilizer, and other agricultural inputs to farmers. These advances
are repaid by farmers with the tobacco they produce. We are dedicated to promoting a sustainable farmer base and provide our
farmers with agronomy support. Our Good Agricultural Practices programs educate farmers in such matters as the reduction of
non-tobacco related materials, product traceability, environmental sustainability, and social responsibility. In Malawi and Zimbabwe,
we also purchase some tobacco under auction systems.
Our foreign operations are subject to international business risks, including unsettled political conditions, expropriation,
import and export restrictions, exchange controls, and currency fluctuations. During the tobacco season in many of the countries
listed above, we advance funds, guarantee local loans, or do both, each in substantial amounts, for the eventual purchase of tobacco.
The majority of these seasonal advances and loan guarantees mature in one year or less upon the farmers’ delivery of contracted
tobaccos. Most advances to farmers are denominated in local currency, which is a source of foreign currency exchange rate risk.
Most tobacco sales are denominated in U.S. dollars, which reduces our foreign currency exchange risk after the tobacco has been
purchased. See Item 1A, “Risk Factors” for more information about our foreign currency exchange and other risks.
For a discussion of recent developments and trends in our business, along with factors that may affect our business, see
Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 1A, “Risk Factors.”
Seasonality
Our operations are seasonal in nature. Tobacco in Brazil is usually purchased from January through July, while buying in
Malawi, Mozambique, and other African countries typically begins around April and continues through November. Farmers begin
to sell U.S. flue-cured tobacco in late July, and the marketing season lasts for approximately four months.
We normally operate each of our processing plants for seven to nine months of the year. During this period for each region,
inventories of green tobacco, inventories of processed tobacco, and trade accounts receivable normally reach peak levels in
succession. We normally finance this expansion of current assets with cash, short-term borrowings from banks, and customer
advances, and these funding sources normally reach their peak usage in each region during its respective purchasing or processing
period. Our balance sheet at our fiscal year end reflects seasonal expansions in working capital in South America and Central
America. Our financial performance is also impacted by the seasonality of our business. In recent years, as production volumes
in Brazil have declined and volumes have increased in Africa, we have seen more of our volumes shipped and the related revenues
move into the second half of our fiscal year. Changes in crop timing in a season or changes in customer shipment schedules can
also shift recognition of revenue in a given fiscal year.
Customers
A material part of our business is dependent upon a few customers. Our five largest customers are Philip Morris International,
Inc., Imperial Tobacco Group, PLC, British American Tobacco, PLC, China Tobacco International, Inc., and Japan Tobacco, Inc.
In the aggregate, these customers have accounted for more than 60% of our consolidated revenues for each of the past three fiscal
years. For the fiscal year ended March 31, 2015, each of Philip Morris International, Inc. and Imperial Tobacco Group, PLC,
including their respective affiliates, accounted for 10% or more of our revenues, while British American Tobacco, PLC, China
Tobacco International, Inc., and Japan Tobacco, Inc. each accounted for between 7% and 10% of our revenues. The loss of, or
substantial reduction in business from, any of these customers could have a material adverse effect on our results. We have
longstanding relationships with all of these customers.
We had commitments from customers for approximately $485 million of the tobacco in our inventories at March 31, 2015.
Based upon historical experience, we expect that at least 80% of such orders will be delivered during fiscal year 2016. Most of our
product requires shipment via trucks and oceangoing vessels to reach customer destinations. Delays in the delivery of orders can
result from such factors as truck and container availability, port access and capacity, vessel scheduling, and changing customer
requirements for shipment.
As more fully described in Note 1 to the consolidated financial statements in Item 8 of this Annual Report, we recognize
sales revenue at the time that title to the tobacco and risk of loss passes to our customer. Individual shipments may be large, and
since the customer typically specifies shipping dates, our financial results may vary significantly between reporting periods due to
timing of sales. In some markets, including the United States, Italy, and Brazil, we process tobacco that is owned by our customers,
and we recognize the revenue for that service when the processing is completed.
6
Competition
Competition among leaf tobacco suppliers is based on the ability to meet customer specifications in the growing, buying,
processing, and financing of tobacco, and on the price charged for products and services. Competition varies depending on the
market or country involved. The number of competitors varies from country to country, but there is competition in most areas to
buy and sell the available tobacco. Our principal competitor is Alliance One International, Inc. (“Alliance One”). Alliance One
operates in most of the countries where we operate. Based on our estimates, we do not believe that worldwide market shares differ
substantially between the two companies. Most of our major customers are partially vertically integrated, and thus also compete
with us for the purchase of leaf tobacco in several of the major markets.
In most major markets, smaller competitors are very active. These competitors typically have lower overhead requirements
and provide less support to customers and farmers. Due to their lower cost structures, they can often offer a price on products that
is lower than our price. However, we believe that we provide quality controls and farm programs that add value for our customers
in an increasingly regulated world and make our products highly desirable. For example, we have established worldwide farm
programs designed to prevent non-tobacco related materials from being introduced into the green tobacco delivered to our factories.
In addition, we have established programs for sustainable tobacco production which include promoting Good Agricultural Practices
that encompass crop quality, environmental stewardship, and agricultural labor practices. We believe that our major customers
increasingly desire these services and that our programs increase the quality and value of the products and services we offer. We
also believe that our customers value the security of supply that we are able to provide due to our strong relationships with our
farmer base and our global footprint.
Reportable Segments
We evaluate the performance of our business by geographic region, although the dark air-cured and oriental tobacco
businesses are each evaluated on the basis of their worldwide operations. Performance of the oriental tobacco operations is evaluated
based on our equity in the pretax earnings of our affiliate. Under this structure, we have the following primary operating segments:
North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services. North America, South
America, Africa, Europe, and Asia are primarily involved in flue-cured and burley leaf tobacco operations for supply to cigarette
manufacturers. Our Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe tobacco,
and smokeless tobacco products, and our Oriental business supplies oriental tobacco to cigarette manufacturers. Our Special Services
group provides laboratory services, including physical and chemical product testing, e-cigarette and e-liquid testing, and smoke
testing for customers. Our liquid nicotine joint venture and our fruit and vegetable ingredients business are included in the Special
Services group.
The five regional operating segments serving our cigarette manufacturer customers share similar characteristics in the
nature of their products and services, production processes, class of customer, product distribution methods, and regulatory
environment. Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are
aggregated into a single reporting segment, Other Regions, because they also have similar economic characteristics. North America
is reported as an individual operating segment, because its economic characteristics differ from the other regions, generally because
its operations require lower working capital investments for crop financing and inventory. The Dark Air-Cured, Oriental, and
Special Services segments, which have differing characteristics in some of the categories mentioned above, are reported together
as Other Tobacco Operations, because each is below the measurement threshold for separate reporting.
Financial Information about Segments
Our North America and Other Regions reportable segments, which represent our flue-cured and burley tobacco operations,
accounted for 13% and 77% of our revenues and 19% and 75% of our segment operating income, respectively, in fiscal year 2015.
Our Other Tobacco Operations reportable segment accounted for 10% of our revenues and 6% of our segment operating income in
fiscal year 2015. Sales and other operating revenues and operating income attributable to our reportable segments for each of the
last three fiscal years, along with segment assets for each reportable segment at March 31, 2015, 2014, and 2013, are set forth in
Note 15 to the consolidated financial statements, which are included in Item 8 of this Annual Report. Information with respect to
the geographic distribution of our revenues and long-lived assets is also set forth in Note 15 to the consolidated financial statements.
C.
Employees
We employed over 27,000 employees throughout the world during the fiscal year ended March 31, 2015. We estimated
this figure because the majority of our personnel are seasonal employees.
D.
Research and Development
We did not expend material amounts for research and development during the fiscal years ended March 31, 2015, 2014,
or 2013.
7
E.
Patents, etc.
We hold no material patents, licenses, franchises, or concessions.
F.
Government Regulation, Environmental Matters, and Other Matters
Our business is subject to general governmental regulation in the United States and in foreign jurisdictions where we
conduct business. Such regulation includes, but is not limited to, matters relating to environmental protection. To date, governmental
provisions regulating the discharge of material into the environment have not had a material effect upon our capital expenditures,
earnings, or competitive position. See Item 1A, “Risk Factors” for a discussion of government regulations and other factors that
may affect our business.
8
Item 1A. Risk Factors
Operating Factors
In areas where we purchase leaf tobacco directly from farmers, we bear the risk that the tobacco we receive will not meet quality
and quantity requirements.
When we contract directly with tobacco farmers or tobacco farmer cooperatives, which is the method we use to purchase
tobacco in most countries, we bear the risk that the tobacco delivered may not meet customer quality and quantity requirements. If
the tobacco does not meet such market requirements, we may not be able to fill all of our customers’ orders, and such failure would
have an adverse effect on profitability and results of operations. In a contract market our obligation is to purchase the entire tobacco
plant, which encompasses many leaf styles, therefore, we also have a risk that not all of that production will be readily marketable
at prices which support acceptable margins. In addition, in many foreign countries where we purchase tobacco directly from farmers,
we provide them with financing. Unless we receive marketable tobacco that meets the quality and quantity specifications of our
customers, we bear the risk that we will not be able to fully recover our crop advances or recover them in a reasonable period of
time.
The leaf tobacco industry is competitive, and we are heavily reliant on a few large customers.
We are one of two major independent global competitors in the leaf tobacco industry, both of whom are reliant upon a few
large customers. The loss of one of those large customers or a significant decrease in their demand for our products or services could
significantly decrease our sales of products or services, which would have a material adverse effect on our results of operations. The
competition among leaf tobacco suppliers and dealers is based on the ability to meet customer requirements in the buying, processing,
and financing of tobacco, and on the price charged for products and services. We believe that we consistently meet our customers’
requirements and charge competitive prices. Since we rely upon a few significant customers, the consolidation or failure of any of
these large customers, or a significant increase in their vertical integration, could contribute to a significant decrease in our sales of
products and services.
We compete for both the purchase and sale of leaf with smaller leaf tobacco suppliers in some of the markets where we
conduct business. Some of these smaller leaf tobacco suppliers operate in more than one country. Since they typically provide little
or no support to farmers, these leaf tobacco suppliers typically have lower overhead requirements than we do. Due to their lower
cost structures, they often can offer prices on products and services that are lower than our prices. Our customers also directly source
leaf tobacco from farmers to meet some of their raw material needs. Direct sourcing provides our customers with some qualities
and quantities of leaf tobacco that they prefer not to use in their existing blends and that may be offered for sale. This competition
for both the sale and purchase of leaf could reduce the volume of the leaf we handle and could negatively impact our financial results.
Our financial results can be significantly affected by changes in the balance of supply and demand for leaf tobacco.
As a leaf tobacco supplier, our financial results can be significantly affected by changes in the overall balance of worldwide
supply and demand for leaf tobacco. The demand for leaf tobacco, which is based upon customers’ expectations of their future
requirements, can change from time to time depending upon factors affecting the demand for their products. Our customers’
expectations and their demand for leaf tobacco are influenced by a number of factors, including:
•
•
•
•
•
trends in the global consumption of cigarettes,
trends in consumption of cigars and other tobacco products,
trends in consumption of alternative tobacco products, such as e-cigarettes,
levels of competition among our customers, and
regulatory and governmental factors.
The world supply of leaf tobacco at any given time is a function of current tobacco production, inventories held by
manufacturers, and the stocks of leaf tobacco held by leaf tobacco suppliers. Production of tobacco in a given year may be significantly
affected by such factors as:
•
•
•
•
•
demographic shifts that change the number of farmers or the amount of land available to grow tobacco,
decisions by farmers to grow crops other than leaf tobacco,
elimination of government subsidies to farmers,
volume of annual tobacco plantings and yields realized by farmers,
availability of crop inputs,
• weather and natural disasters, including any adverse weather conditions that may result from climate change, and
•
crop infestation and disease.
Any significant change in these factors could cause a material imbalance in the supply of and demand for tobacco, which
would affect our results of operations.
9
Our financial results will vary according to tobacco growing conditions, customer requirements, and other factors. These factors
may also limit the ability to accurately forecast our future performance and increase the risk of an investment in our common stock
or other securities.
Our financial results, particularly our year-over-year quarterly comparisons, may be significantly affected by variations in
tobacco growing seasons and fluctuations in crop sizes. The timing of the cultivation and delivery of tobacco is dependent upon a
number of factors, including weather and other natural events, and our processing schedules and results of operations can be
significantly altered by these factors. In addition, the potential impact of climate change is uncertain and may vary by geographic
region. The possible effects, as described in various public accounts, could include changes in rainfall patterns, water shortages,
changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations
and the supply and demand for leaf tobacco. Our operations also rely on dependable and efficient transportation services. A disruption
in transportation services, as a result of climate change or otherwise, may also significantly impact our results of operations.
Further, the timing and unpredictability of customer orders and shipments may require us to keep tobacco in inventory and
may also result in variations in quarterly and annual financial results. We base sales recognition on the passage of ownership. Since
individual shipments may represent significant amounts of revenue, our quarterly and annual financial results may vary significantly
depending on the timing of needs and shipping instructions of our customers and the availability of transportation services. These
fluctuations result in varying volumes and sales in given periods, which also reduce the comparability of financial results.
Major shifts in customer requirements for tobacco supply may significantly affect our operating results.
If our customers significantly alter their requirements for tobacco volumes from certain regions, we may have to change
our production facilities and alter our fixed asset base in certain origins. Permanent or long-term reduction in demand for tobacco
from origins where we have operations may trigger restructuring and impairment charges. We may also need to make significant
capital investments in other regions to develop the needed infrastructure to meet customer supply requirements.
Weather and other conditions can affect the marketability of our products.
Tobacco crops are subject to vagaries of weather and the environment that can, in some cases, change the quality or size of
the crops. If a weather event is particularly severe, such as a major drought or hurricane, the affected crop could be destroyed or
damaged to an extent that it would be less desirable to manufacturers, which would result in a reduction in revenues. If such an
event is also widespread, it could affect our ability to acquire the quantity of tobacco required by our customers. In addition, other
factors can affect the marketability of tobacco, including, among other things, the presence of excess residues of crop protection
agents or non-tobacco related materials. A significant event impacting the condition or quality of a large amount of any of the crops
that we buy could make it difficult for us to sell these products or to fill customers’ orders.
Regulatory and Governmental Factors
Government efforts to regulate the production and consumption of tobacco products could have a significant impact on the businesses
of our customers, which would, in turn, affect our results of operations.
Nationally, the U.S. federal government and certain state and local governments have taken or proposed actions that may
have the effect of reducing U.S. consumption of tobacco products and indirectly reducing demand for our products and services.
These activities have included:
•
•
•
•
restrictions on the use of tobacco products in public places and places of employment,
legislation authorizing the U.S. Food and Drug Administration (the “FDA”) to regulate the manufacturing and marketing
of tobacco products,
increases in the federal, state, and local excise taxes on cigarettes and other tobacco products, and
the policy of the U.S. government to link certain federal grants to the enforcement of state laws restricting the sale of
tobacco products.
Numerous other legislative and regulatory anti-smoking measures have been proposed at the federal, state, and local levels.
About 5% of cigarettes manufactured worldwide are consumed in the United States.
Globally, a number of foreign governments and non-government organizations also have taken or proposed steps to restrict
or prohibit tobacco product advertising and promotion, to increase taxes on tobacco products, to indirectly limit the use of certain
types of tobacco, and to discourage tobacco product consumption. A number of such measures, including plain packaging, are
included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated and promoted globally under the
auspices of the World Health Organization (“WHO”). We cannot predict the extent or speed at which the efforts of governments or
non-governmental agencies to reduce tobacco consumption might affect the business of our primary customers. However, a significant
decrease in worldwide tobacco consumption brought about by existing or future governmental laws and regulations would reduce
demand for tobacco products and services and could have a material adverse effect on our results of operations.
10
Government actions can have a significant effect on the sourcing of tobacco. If some of the current efforts are successful, we could
have difficulty obtaining sufficient tobacco to meet our customers’ requirements, which could have an adverse effect on our
performance and results of operations.
The WHO, through the FCTC, has created a formal study group to identify and assess crop diversification initiatives and
alternatives to growing leaf tobacco in countries whose economies depend upon tobacco production. The study group began its work
in February 2007. If certain countries were to partner with the FCTC study group and seek to eliminate or significantly reduce leaf
tobacco production, we could encounter difficulty in sourcing leaf tobacco to fill customer requirements, which could have an adverse
effect on our results of operations.
Certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain styles of tobacco.
As seen in countries like Canada and Brazil and in the European Union, efforts have been taken to eliminate ingredients from the
manufacturing process for tobacco products. Such decisions could cause a change in requirements for certain styles of tobacco in
particular countries. Shifts in customer demand from one type of tobacco to another could create sourcing challenges as requirements
move from one origin to another.
Trade proposals currently under consideration include provisions that could effectively allow governments to regulate
tobacco products differently than other products. These “carve outs” could negatively impact the industry and reduce requirements
for leaf tobacco.
In addition, continued government and public emphasis on environmental issues, including climate change, conservation,
and natural resource management, could result in new or more stringent forms of regulatory oversight of industry activities, which
may lead to increased levels of expenditures for environmental controls, land use restrictions affecting us or our suppliers, and other
conditions that could have a material adverse effect on our business, financial condition, and results of operations. For example,
certain aspects of our business generate carbon emissions. Regulatory restrictions on greenhouse gas emissions have been proposed.
These may include limitations on such emissions, taxes or emission allowance fees on such emissions, various restrictions on industrial
operations, and other measures that could affect land-use decisions, the cost of agricultural production, and the cost and means of
processing and transporting our products. These actions could adversely affect our business, financial condition, and results of
operations.
Because we conduct a significant portion of our operations internationally, political and economic uncertainties in certain countries
could have an adverse effect on our performance and results of operations.
Our international operations are subject to uncertainties and risks relating to the political stability of certain foreign
governments, principally in developing countries and emerging markets, and also to the effects of changes in the trade policies and
economic regulations of foreign governments. These uncertainties and risks, which include undeveloped or antiquated commercial
law, the expropriation, indigenization, or nationalization of assets, and the authority to revoke or refuse to renew business licenses
and work permits, may adversely impact our ability to effectively manage our operations in those countries. We have substantial
capital investments in South America and Africa, and the performance of our operations in those regions can materially affect our
earnings. If the political situation in any of the countries where we conduct business were to deteriorate significantly, our ability to
recover assets located there could be impaired. To the extent that we do not replace any lost volumes of tobacco with tobacco from
other sources, or we incur increased costs related to such replacement, our financial condition or results of operations, or both, would
suffer.
Changes in tax laws in the countries where we do business may adversely affect our results of operations.
Through our subsidiaries, we are subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of
tax laws can affect our earnings, as can the resolution of various pending and contested tax issues. In most jurisdictions, we regularly
have audits and examinations by the designated tax authorities, and additional tax assessments are common. We believe that we
comply with applicable tax laws in the jurisdictions where we operate, and we vigorously contest all significant tax assessments
where we believe we are in compliance with the tax laws.
Financial Factors
Failure of our customers or suppliers to repay extensions of credit could materially impact our results of operations.
We extend credit to both suppliers and customers. A significant bad debt provision related to amounts due could adversely
affect our results of operations. In addition, crop advances to farmers are generally secured by the farmers’ agreement to deliver
green tobacco. In the event of crop failure, delivery failure, or permanent reductions in crop sizes, full recovery of advances may
never be realized, or otherwise could be delayed until future crops are delivered. See Notes 1 and 14 to the consolidated financial
statements in Item 8 for more information on these extensions of credit.
11
Fluctuations in foreign currency exchange rates may affect our results of operations.
We account for most of our tobacco operations using the U.S. dollar as the functional currency. The international tobacco
trade generally is conducted in U.S. dollars, and we finance most of our tobacco operations in U.S. dollars. Although this generally
limits foreign exchange risk to the economic risk that is related to leaf purchase and production costs, overhead, and income taxes
in the source country, significant currency movements could materially impact our results of operations. Changes in exchange rates
can make a particular crop more or less expensive in U.S. dollar terms. If a particular crop is viewed as expensive in U.S. dollar
terms, it may be less attractive in the world market. This could negatively affect the profitability of that crop and our results of
operations. In certain tobacco markets that are primarily domestic, the local currency is the functional currency. Examples of these
markets are Hungary, Poland, and the Philippines. Similarly, the local currency is the functional currency in other markets, such as
Western Europe, where export sales have been denominated primarily in local currencies. In these markets, reported earnings are
affected by the translation of the local currency into the U.S. dollar. See Item 7A, “Qualitative and Quantitative Disclosure About
Market Risk” for additional discussion related to foreign currency exchange risk.
Our purchases of tobacco are generally made in local currency, and we also provide farmer advances that are denominated
in the local currency. We account for currency remeasurement gains or losses on those advances as period costs, and they are usually
accompanied by offsetting increases or decreases in the purchase cost of tobacco, which is priced in the local currency. The effect
of differences in the cost of tobacco is generally not realized in our earnings until the tobacco is sold, which often occurs in a quarter
or fiscal year subsequent to the recognition of the related remeasurement gains or losses. The difference in timing could affect our
profitability in a given quarter or fiscal year.
We have used currency hedging strategies to reduce our foreign currency exchange rate risks in some markets. In addition,
where we source tobacco in countries with illiquid or nonexistent forward foreign exchange markets, we often manage our foreign
exchange risk by matching funding for inventory purchases with the currency of sale and by minimizing our net investment in these
countries. To the extent that we have net monetary assets or liabilities in local currency, and those balances are not hedged, we may
have currency remeasurement gains or losses that will affect our results of operations.
Changes in interest rates may affect our results of operations.
We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge
agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order,
which could mitigate a portion of the floating interest rate exposure on short-term borrowings. To the extent we are unable to match
these interest rates, a decrease in interest rates could increase our net financing costs. We also periodically have large cash balances
and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs.
Decreases in short-term interest rates could reduce the income we derive from those investments. Changes in interest rates also
affect expense related to our defined benefit pension plan, as described below.
Low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions may
increase our pension expense and may require us to fund a larger portion of our pension obligations, thus, diverting funds from other
potential uses.
We sponsor domestic defined benefit pension plans that cover certain eligible employees. Our results of operations may
be positively or negatively affected by the amount of expense we record for these plans. U.S. generally accepted accounting principles
(“GAAP”) require that we calculate expense for the plans using actuarial valuations. These valuations reflect assumptions about
financial market and other economic conditions that may change based on changes in key economic indicators. The most significant
year-end assumptions we used to estimate pension expense for fiscal year 2015 were the discount rate, the expected long-term rate
of return on plan assets, and the mortality rates. In addition, we are required to make an annual measurement of plan assets and
liabilities, which may result in a significant change to shareholders’ equity through a reduction or increase to the “Pension and other
postretirement benefits plan” component of Accumulated Other Comprehensive Loss. At the end of fiscal year 2015, the projected
benefit obligation of our U.S. pension plan was $230 million and plan assets were $204 million. For a discussion regarding how
our financial statements can be affected by pension plan valuation assumptions, see “Critical Accounting Estimates – Pension and
Other Postretirement Benefit Plans” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
in Item 7 and in Note 11 to the consolidated financial statements in Item 8. Although GAAP expense and pension funding contributions
are not directly related, key economic factors that affect GAAP expense can also affect the amount of cash we are required to contribute
to our pension plans under requirements of the Employee Retirement Income Security Act (“ERISA”). Failure to achieve expected
returns on plan assets could also result in an increase to the amount of cash we would be required to contribute to our pension plans.
In order to maintain or improve the funded status of our plans, we may also choose to contribute more cash to our plans than required
by ERISA regulations.
Item 1B. Unresolved Staff Comments
None
12
Item 2. Properties
We own the following significant properties (greater than 500,000 square feet):
Location
Flue-Cured and Burley Leaf Tobacco Operations:
North America:
United States
Principal Use
Building Area
(Square Feet)
Nash County, North Carolina .......................................................................... Factory and storages
1,312,000
Other Regions:
Brazil
Santa Cruz ....................................................................................................... Factory and storages
2,386,000
Malawi
Lilongwe.......................................................................................................... Factory and storages
942,000
Mozambique
Tete .................................................................................................................. Factory and storages
748,000
Philippines
Agoo, La Union ............................................................................................... Factory and storages
770,000
Tanzania
Morogoro......................................................................................................... Factory and storages
803,000
Zimbabwe
Harare (1) .......................................................................................................... Factory and storages
1,445,000
Other Tobacco Operations:
United States
Lancaster, Pennsylvania .................................................................................. Factory and storages
793,000
(1)
Owned by an unconsolidated subsidiary.
We lease headquarters office space of about 50,000 square feet at 9201 Forest Hill Avenue in Richmond, Virginia, which
we believe is adequate for our current needs.
Our business involves, among other things, storing and processing green tobacco and storing processed tobacco. We operate
processing facilities in major tobacco growing areas. In addition, we require tobacco storage facilities that are in close proximity to
the processing facilities. We own most of the tobacco storage facilities, but we lease additional space as needs arise, and expenses
related to such leases are not material. We believe that the properties currently utilized in our tobacco operations are maintained in
good operating condition and are suitable and adequate for our purposes at our current volumes.
In addition to our significant properties listed above, we own other processing facilities in the following countries: Germany,
Hungary, Italy, the Netherlands, Poland, and the United States. In addition, we have ownership interests in processing plants in
Guatemala and Mexico and have access to processing facilities in other areas, such as India, the People’s Republic of China, South
Africa, and Zambia. Socotab L.L.C., an oriental tobacco joint venture in which we own a noncontrolling interest, owns tobacco
processing plants in Turkey, Macedonia, and Bulgaria.
Except for the Lancaster, Pennsylvania facility, the facilities described above are engaged primarily in processing tobaccos
used by manufacturers in the production of cigarettes. The Lancaster facility, as well as facilities in Brazil, the Dominican Republic,
Indonesia, and Paraguay, process tobaccos used in making cigar, pipe, and smokeless products, as well as components of certain
“roll-your-own” products.
We expect to complete the construction of a 120,000 square-foot processing facility for our new fruit and vegetable ingredients
business and begin operations in that facility during fiscal year 2016. The facility is located in Nash County, North Carolina.
13
Item 3. Legal Proceedings
European Commission Fines in Italy
In 2002, we reported that we were aware that the European Commission (the “Commission”) was investigating certain
aspects of the leaf tobacco markets in Italy. One of our subsidiaries, Deltafina S.p.A. (“Deltafina”), buys and processes tobacco in
Italy. We reported that we did not believe that the Commission investigation in Italy would result in penalties being assessed against
us or our subsidiaries that would be material to our earnings. The reason we held this belief was that we had received conditional
immunity from the Commission because Deltafina had voluntarily informed the Commission of the activities that were the basis of
the investigation.
On December 28, 2004, we received a preliminary indication that the Commission intended to revoke Deltafina’s immunity
for disclosing in April 2002 that it had applied for immunity. Neither the Commission’s Leniency Notice of February 19, 2002, nor
Deltafina’s letter of provisional immunity, contains a specific requirement of confidentiality. The potential for such disclosure was
discussed with the Commission in March 2002, and the Commission never told Deltafina that the disclosure would affect Deltafina’s
immunity. On November 15, 2005, we received notification from the Commission that the Commission had imposed fines totaling
€30 million on Deltafina and Universal Corporation jointly for infringing European Union antitrust law in connection with the
purchase and processing of tobacco in the Italian raw tobacco market. In January 2006, Universal Corporation and Deltafina each
filed appeals in the General Court of the European Union (“General Court”). Deltafina’s appeal was held on September 28, 2010.
For strategic reasons related to the defense of the Deltafina appeal, we withdrew our appeal. On September 9, 2011, the General
Court issued its decision, in which it rejected Deltafina’s application to reinstate immunity. Deltafina appealed the decision of the
General Court to the European Court of Justice, and a hearing was held in November 2012. Effective with the September 9, 2011
General Court decision, we recorded a charge for the full amount of the fine (€30 million) plus accumulated interest (€5.9 million).
The charge totaled $49.1 million at the exchange rate in effect on the date of the General Court decision. Deltafina previously
provided the Commission a bank guarantee in the amount of the fine plus accumulated interest in order to stay execution during the
appeals process. In January 2013, the guarantee was fully collateralized with a bank deposit. On June 12, 2014, the European Court
of Justice issued its final decision on the matter, in which it rejected Deltafina's application to reinstate immunity. We and Deltafina
paid the final amount of the fine and interest, approximately €38.9 million ($53.0 million), before June 30, 2014. Upon payment,
the bank guarantee was terminated and the related deposit was returned. The payment of the fine and interest did not have a material
impact on our operations or the operations at Deltafina.
Other Legal Matters
In addition to the above-mentioned matter, some of our subsidiaries are involved in other litigation or legal matters incidental
to their business activities. While the outcome of these matters cannot be predicted with certainty, we are vigorously defending the
matters and do not currently expect that any of them will have a material adverse effect on our business or financial position. However,
should one or more of these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations
for a particular fiscal reporting period could be material.
Item 4. Mine Safety Disclosures
Not applicable.
14
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Common Equity
Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “UVV.” The following table
sets forth the high and low sales prices per share of the common stock on the NYSE Composite Tape, based upon published financial
sources, and the dividends declared on each share of common stock for the quarter indicated.
Fiscal Year Ended March 31, 2015
Cash dividends declared ...................................................................................
$
0.51 $
0.51 $
0.52 $
0.52
First Quarter
Second Quarter Third Quarter
Fourth Quarter
Market price range:
High................................................................................................................
Low ................................................................................................................
56.82
52.16
56.35
44.39
45.63
38.53
48.10
39.27
Fiscal Year Ended March 31, 2014
Cash dividends declared ...................................................................................
$
0.50 $
0.50 $
0.51 $
0.51
Market price range:
High................................................................................................................
Low ................................................................................................................
61.46
54.45
63.36
48.43
54.60
50.06
58.99
49.84
Our current dividend policy anticipates the payment of quarterly dividends in the future. However, the declaration and
payment of dividends to holders of common stock is at the discretion of the Board of Directors and will be dependent upon our future
earnings, financial condition, and capital requirements. Under the terms of our Series B 6.75% Convertible Perpetual Preferred
Stock (the “Preferred Stock”), we may not declare or pay dividends on our common stock unless dividends on the Preferred Stock
for the four most recent consecutive dividend periods have been declared and paid. The Preferred Stock contains provisions that
prohibit the payment of cash dividends if certain income and shareholders’ equity levels are not met. Under certain of our credit
facilities, we must meet financial covenants relating to minimum tangible net worth and maximum levels of debt. If we were not in
compliance with them, these financial covenants could restrict our ability to pay dividends. We were in compliance with all such
covenants at March 31, 2015. At May 20, 2015, there were 1,220 holders of record of our common stock. See Notes 6 and 12 to
the consolidated financial statements in Item 8 for more information on debt covenants and equity securities.
Purchases of Equity Securities
The following table summarizes our repurchases of our common stock and our Series B 6.75% Convertible Perpetual
Preferred Stock during the three-month period ended March 31, 2015:
Common Stock
Series B 6.75% Convertible Perpetual
Preferred Stock
Period (1)
Total Number
of Shares
Repurchased
Average
Price Paid
Per Share (2)
Total Number
of Shares
Repurchased
as Part of
Publicly
Announced
Plans or
Programs (3)
Total Number
of Shares
Repurchased
Average
Price Paid
Per Share (2)
Total Number
of Shares
Repurchased
as Part of
Publicly
Announced
Plans or
Programs (3)
Dollar Value of
Shares that
May Yet Be
Purchased
Under the
Plans or
Programs (3)
January 1-31, 2015 ..................
214,900
$
February 1-28, 2015 ................
March 1-31, 2015 ....................
25,405
—
40.06
41.86
—
214,900
25,405
—
1,106
$
985.00
$
1,106
$
68,339,934
—
—
—
—
—
—
67,276,553
67,276,553
Total.........................................
240,305
$
40.25
240,305
1,106
$
985.00
1,106
$
67,276,553
(1)
(2)
(3)
Repurchases are based on the date the shares were traded. This presentation differs from the consolidated statement of cash flows, where the cost of share
repurchases is based on the date the transactions were settled.
Amounts listed for average price paid per share include broker commissions paid in the transactions.
A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 5, 2013. This stock
repurchase plan authorizes the purchase of up to $100 million in common and/or preferred stock in open market or privately negotiated transactions, subject to
market conditions and other factors. This stock repurchase program will expire on the earlier of November 15, 2015, or when we have exhausted the funds
authorized for the program.
15
Item 6. Selected Financial Data
Summary of Operations
Sales and other operating revenues.................................................................... $ 2,271,801
$ 2,542,115
$ 2,461,699
$ 2,446,877
$ 2,571,527
Fiscal Year Ended March 31,
2015
2014
2013
2012
2011
(in thousands, except share and per share data, ratios, and
number of shareholders)
Segment operating income (1) ............................................................................. $
167,225
Operating income............................................................................................... $
167,874
Net income ......................................................................................................... $
120,461
Net income attributable to Universal Corporation (2) ......................................... $
114,608
Earnings available to Universal Corporation common shareholders................. $
99,748
Return on beginning common shareholders’ equity ..........................................
8.6%
Earnings per share attributable to
Universal Corporation common shareholders:
Basic............................................................................................................. $
Diluted.......................................................................................................... $
4.33
4.06
Financial Position at Year End
$
$
$
$
$
$
$
175,175
246,151
155,155
149,009
134,159
$
$
$
$
$
$
$
232,757
223,009
140,919
132,750
117,900
12.1%
5.05
4.66
$
$
$
$
$
$
$
233,548
180,304
100,819
92,057
77,207
7.9%
3.32
3.25
$
$
$
$
$
$
$
257,925
254,600
164,550
156,565
141,715
15.6%
5.94
5.42
12.8%
5.77
5.25
Current ratio .......................................................................................................
6.03
3.68
2.80
4.31
3.08
Total assets......................................................................................................... $ 2,198,473
$ 2,270,907
$ 2,306,155
$ 2,266,919
$ 2,227,867
Long-term obligations........................................................................................ $
370,000
$
240,000
$
181,250
$
392,500
$
320,193
Working capital.................................................................................................. $ 1,363,697
$ 1,218,270
$ 1,123,376
$ 1,297,921
$ 1,065,883
Total Universal Corporation shareholders’ equity............................................. $ 1,362,725
$ 1,378,230
$ 1,258,571
$ 1,183,451
$ 1,185,606
General
Ratio of earnings to fixed charges .....................................................................
Ratio of earnings to combined fixed charges and preference dividends............
8.46
4.05
Number of common shareholders......................................................................
1,225
10.73
5.49
1,295
8.87
4.69
1,354
7.53
4.07
1,408
9.41
5.17
1,447
Weighted average common shares outstanding:
Basic................................................................................................................
23,035,920
23,238,978
23,354,793
23,227,884
23,859,373
Diluted.............................................................................................................
28,221,264
28,392,033
28,478,058
28,339,307
28,887,552
Dividends per share of convertible perpetual preferred stock (annual)............. $
67.50
Dividends per share of common stock (annual) ................................................ $
2.06
Book value per common share........................................................................... $
50.95
$
$
$
67.50
2.02
50.19
$
$
$
67.50
1.98
44.79
$
$
$
67.50
1.94
41.73
$
$
$
67.50
1.90
41.85
(1) The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant charges or credits),
plus equity in the pretax earnings of unconsolidated affiliates. See Note 15 to the consolidated financial statements in Item 8 of this Annual Report.
(2) We hold less than a 100% financial interest in certain consolidated subsidiaries, and a portion of net income is attributable to the noncontrolling interests in
those subsidiaries.
16
The calculations of the ratio of earnings to fixed charges and the ratio of earnings to combined fixed charges and preference
dividends are shown in Exhibit 12. Fixed charges primarily represent interest expense we incurred during the designated fiscal year,
and preference dividends represent the pre-tax equivalent of dividends on preferred stock.
Significant items included in the operating results in the above table are as follows:
•
•
•
•
•
Fiscal Year 2015 – a $12.7 million benefit to pretax earnings from the reversal of a valuation allowance on the remaining
unused balance of the excise tax credits realized from the favorable outcome of litigation by our subsidiary in Brazil
in fiscal year 2014. In addition, we recorded a consolidated income tax benefit of $8.0 million arising from the ability
of our subsidiary, Deltafina S.p.A. ("Deltafina"), to pay a significant portion of the European Commission fine and
related interest charges settled during the first quarter following the unsuccessful appeal of the case related to tobacco
buying practices in Italy. The effect of those items was partially offset by restructuring costs of $4.9 million, primarily
related to downsizing certain functions at our operations in Brazil and the decision to suspend our operations in Argentina.
On a combined basis, the net effect of these items increased income before income taxes by $7.8 million and net income
by $13.1 million, or $0.46 per diluted share.
Fiscal Year 2014 – an $81.6 million gain resulting from the favorable outcome of litigation by our operating subsidiary
in Brazil related to previous years’ excise tax credits. In addition to the gain, we recorded restructuring costs of $6.7
million, primarily related to the closure of a tobacco processing facility in Brazil and the consolidation of these operations
into our main processing facility there. The net effect of the gain and the restructuring costs increased net income
before income taxes by $74.9 million and net income by $48.7 million, or $1.72 per diluted share.
Fiscal Year 2013 – $4.1 million in restructuring costs, primarily related to workforce reductions in Africa. The effect
of these charges was a reduction in net income of $1.8 million, or $0.06 per diluted share.
Fiscal Year 2012 – a $49.1 million charge to accrue a fine and accumulated interest imposed jointly on the Company
and Deltafina by the European Commission related to tobacco buying practices in Italy. The charge reflected a September
2011 appeals court decision rejecting Deltafina's application to reinstate its immunity in the case. No income tax benefit
was recorded on the non-deductible fine portion of the charge. In addition to that charge, we recorded restructuring
costs of $11.7 million, including approximately $8.6 million for employee termination benefits, primarily related to
our operations in the U.S. and South America, and $3.1 million for costs to exit a supplier arrangement in Europe.
Results for the year also included a gain of $11.1 million on the sale of land and buildings in Brazil that were most
recently used for storage activities and a $9.6 million gain on insurance settlement proceeds to replace factory and
equipment lost in a fire at a plant in Europe. On a combined basis, the net effect of these items decreased income before
income taxes by $40.0 million and net income by $40.3 million, or $1.42 per diluted share.
Fiscal Year 2011 – a $7.4 million reversal of a portion of a charge recorded in fiscal year 2005 to accrue a fine imposed
by the European Commission on Deltafina related to tobacco buying practices in Spain. The reversal reflected a
favorable European Union’s General Court decision in Deltafina’s appeal of the fine. We also recorded a $19.4 million
gain on the assignment of farmer contracts and sale of related assets in Brazil to an operating subsidiary of a major
customer. In addition to those items, which benefited fiscal year 2011 earnings, we recorded $21.5 million in
restructuring and impairment costs during the year. A significant portion of those costs related to our decision to close
our leaf tobacco processing operations in Canada and sell the assets of those operations. Restructuring charges were
also recorded to recognize costs associated with voluntary early retirement offers in our U.S. operations and additional
voluntary and involuntary separations in various other locations. On a combined basis, the net effect of these items
increased income before income taxes by $5.3 million and net income by $3.3 million, or about $0.12 per diluted share.
17
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of,
and should be read in conjunction with, Part I, Item 1, “Business” and Item 8, “Financial Statements and Supplementary Data.”
For information on risks and uncertainties related to our business that may make past performance not indicative of future results,
or cause actual results to differ materially from any forward-looking statements, see “General,” and Part I, Item 1A, “Risk Factors.”
OVERVIEW
We are the leading global leaf tobacco supplier. We derive most of our revenues from sales of processed tobacco to
manufacturers of tobacco products throughout the world and from fees and commissions for specific services. We hold a strategic
position in the world leaf markets where we work closely with both our customers and farmers to ensure that we deliver a compliant
product that meets our customers' needs while promoting a strong supplier base. We adapt to meet changes in customer requirements
as well as broader changes in the leaf markets while continuing to provide the stability of supply and high level of service that
distinguishes us in the marketplace. We believe that we have successfully met the needs of both our customers and suppliers while
adapting to changes in leaf markets. Consequently, we have delivered strong results to our shareholders. Over the last three fiscal
years, we have strengthened our balance sheet by repaying almost $100 million in debt, generated over $450 million in net cash flow
from operations, and returned almost $240 million to our shareholders through a combination of dividends and share repurchases.
Despite smaller crops, rising leaf production costs, and margin pressures in most regions, we delivered better performance
in fiscal year 2013 than we had anticipated at the beginning of the fiscal year. Some of this success was attributable to the sale of
previously uncommitted inventories and carryover shipments of the prior year's large African and South American crops. In addition,
we benefited from lower selling, general, and administrative costs. Certain of these costs reductions were unpredictable - such as
currency remeasurement and exchange gains - and may not be recurring, while others were a result of our targeted cost reduction
and efficiency improvement efforts.
We also performed well in the face of a challenging environment in fiscal year 2014. Due to larger crops, shipping volumes
in the second half of fiscal year 2014 exceeded those in the comparable period of fiscal year 2013. These increased volumes partially
offset lower levels of carryover volumes in the first half of fiscal year 2014, weaker margins in Brazil from volatile Brazilian leaf
markets, and negative foreign currency remeasurement and exchange loss comparisons. Our higher working capital cash requirements
in fiscal year 2014 were a sharp contrast to the returns of working capital seen in fiscal year 2013, when we had the advantage of
sales of uncommitted inventory and large carryover crops that bolstered cash flows. In fiscal year 2014, purchases of larger crops,
tighter margins in Brazil from higher green leaf costs, and investments in production growth in Africa utilized much of the substantial
levels of cash flow from fiscal year 2013.
Given fiscal year 2015’s oversupplied market conditions, we are pleased with the results we achieved. We ended the year
with strong fourth quarter results, which helped to bring our segment operating earnings for the fiscal year in line with our expectations.
We also realized higher margins, maintained our solid financial position, and returned over $90 million to our shareholders in dividends
and share repurchases this fiscal year. We believe that our performance demonstrates our ability to execute well on our objective of
delivering a compliant product in an efficient manner to our customers, under challenging circumstances.
We are well-positioned as we enter fiscal year 2016 with substantial cash balances and manageable uncommitted inventory
levels. Markets in Africa and Brazil have opened at a similar pace compared to fiscal year 2015, and crop qualities are mixed, with
production volumes expected to be lower in most origins. Although we are not seeing significant delays in customer orders, we
expect shipping instructions to be weighted towards the second half of our fiscal year. In addition, while our own leaf inventories
are well-managed, global tobacco leaf inventory volumes are high. This may have the effect of extending the duration of the
oversupply conditions, despite reduced new crop production and a more positive outlook for demand from some customers based
on recent recoveries in certain of their retail markets.
Looking beyond near-term market conditions, we are optimistic about the future as we believe there are several trends in
our business that could provide opportunities for us to increase our market share and to offer additional services to our customers.
We have recently seen an increase in the level of supply chain services, which include direct purchasing, that we provide our customers,
notably in the United States, Mexico, Brazil, and the Dominican Republic. We believe these moves acknowledge the efficiencies
and services that global leaf suppliers bring to the entire supply chain. In addition, we believe that compliant leaf requirements and
reduction in sourcing complexity will continue to be important to our customers and should favor stable global leaf suppliers who
are able to meet these requirements.
18
RESULTS OF OPERATIONS
Amounts described as net income and earnings per diluted share in the following discussion are attributable to Universal
Corporation and exclude earnings related to non-controlling interests in subsidiaries. The total for segment operating income
referred to in the discussion below is a non-GAAP financial measure. This measure is not a financial measure calculated in accordance
with GAAP and should not be considered as a substitute for net income, operating income, cash flows from operating activities or
any other operating performance measure calculated in accordance with GAAP, and it may not be comparable to similarly titled
measures reported by other companies. We have provided a reconciliation of the total for segment operating income to consolidated
operating income in Note 15. "Operating Segments" to the consolidated financial statements in Item 8. We evaluate our segment
performance excluding certain significant charges or credits. We believe this measure, which excludes these items that we believe
are not indicative of our core operating results, provides investors with important information that is useful in understanding our
business results and trends.
Fiscal Year Ended March 31, 2015, Compared to the Fiscal Year Ended March 31, 2014
Net income for the fiscal year ended March 31, 2015, was $114.6 million, or $4.06 per diluted share, compared with last
year’s net income of $149.0 million, or $5.25 per diluted share. Last year’s results included a gain of $81.6 million before tax ($53.1
million after tax, or $1.87 per diluted share), from the favorable outcome of litigation in Brazil related to previous years’ excise tax
credits. Results for the current fiscal year included a further gain related to those tax credits, of $12.7 million before tax ($0.29 per
diluted share) recorded in the fourth fiscal quarter from updated projections of the utilization of the credits before expiration. The
current year also included an income tax benefit of $8.0 million ($0.28 per diluted share) arising from a subsidiary’s payment of a
portion of a fine following the resolution of a court case. Pretax restructuring costs of $4.9 million ($0.11 per diluted share) and $6.7
million ($0.15 per diluted share) were also incurred for fiscal years 2015 and 2014, respectively. Excluding those items in both
years, net income for the fiscal year increased $1.2 million ($0.07 per diluted share) compared to the same period last year. Segment
operating income, which excludes those items, was $167.2 million for fiscal year 2015, a decrease of $8.0 million from the prior
year. That reduction was primarily attributable to this year’s lower sales volumes, partially mitigated by a reduction in selling,
general, and administrative costs. Revenues of $2.3 billion for fiscal year 2015 declined 11% compared with the previous year,
driven mainly by those lower overall volumes and modestly lower green leaf costs.
Flue-cured and Burley Leaf Tobacco Operations
Other Regions
Operating income for the Other Regions segment for the fiscal year ended March 31, 2015, was $125.8 million, down 6%
compared to $133.4 million in the previous fiscal year. The decrease was attributable mainly to reduced sales volumes in all regions
along with inventory writedowns, primarily in Africa and South America, reflecting this year’s oversupply market conditions. The
impact of those factors was somewhat mitigated by improved gross margins, particularly in Brazil, where volatile markets increased
green leaf costs last year, as well as benefits from lower selling, general and administrative costs. Results for Europe were also
negatively influenced by currency translation effects from a stronger U.S. dollar. Selling, general, and administrative expenses for
the segment declined for the fiscal year, mostly from lower currency remeasurement and exchange losses in the Philippines and
Brazil, lower provisions for supplier advances, and positive comparisons of value-added tax valuation allowances, partly offset by
higher customer claims. Revenues for the segment were down about 10% to $1.7 billion, on reduced volumes and lower average
green leaf prices.
North America
Operating income for the North America segment for the fiscal year ended March 31, 2015 was $31.1 million, up $7.8
million compared with the previous year, on increased third party processing business and a more favorable sales mix, despite lower
overall sales volumes. Revenues for the segment for fiscal year 2015 decreased by 13% to $305.0 million on reduced sales volumes
and lower green leaf prices. Selling, general, and administrative costs for this segment were relatively flat for fiscal year 2015.
Other Tobacco Operations
For the fiscal year ended March 31, 2015, the Other Tobacco Operations segment operating income was down $8.2 million
to $10.3 million compared with the same period of the prior year. Results for the dark tobacco operations contributed significantly
to the decline, as lower sales volumes, in part due to shipment timing, were partially mitigated by favorable currency remeasurement
comparisons, mainly in Indonesia. Results for the special services group also contributed to the decline, reflecting startup costs for
the new food ingredients business. However, results from the oriental joint venture improved for the fiscal year despite sales volume
declines influenced by shipment timing comparisons. The impact from the volume declines was more than offset by favorable
variances from the prior year’s currency remeasurement losses and lower selling, general and administrative costs. Revenues for
the segment were down by $34.3 million to $227.0 million for the year ended March 31, 2015, compared to the previous year,
primarily attributable to the lower volumes for the dark tobacco operations, as well as lower overall volumes and the timing of
shipments of oriental tobaccos into the United States.
19
Other Items
Cost of goods sold decreased by about 12% to $1.9 billion for the fiscal year ended March 31, 2015, consistent with lower
overall sales volumes and lower green leaf prices compared with the previous year. Selling, general, and administrative costs decreased
by $11.8 million for fiscal year 2015, compared with fiscal year 2014. The decline for the fiscal year was primarily related to lower
currency remeasurement and exchange costs, provisions for suppliers, and value-added tax allowances, partly offset by higher
customer claims.
Interest expense of $17.1 million for fiscal year 2015 declined by about 16%, compared to the prior fiscal year. The reduction
was mostly due to lower average interest rates during the period, offset in part by slightly higher average debt balances. The
consolidated effective income tax rates on pretax earnings were approximately 24% and 33% for the fiscal years ended March 31,
2015 and 2014, respectively. Income taxes for fiscal year 2015 were reduced by a non-recurring benefit of $8.0 million arising from
the partial payment of the European Commission fine by our Italian subsidiary in June 2014. Excluding that item, the consolidated
effective tax rate for fiscal 2015 was about 29%. The rates for both years, excluding adjustments, were below the 35% federal statutory
rate mainly because of the effect of changes in exchange rates on deferred income tax assets and liabilities, as well as lower effective
rates on dividend income from certain foreign subsidiaries.
On December 30, 2014, the Company executed a new senior unsecured credit facility agreement with a group of banks,
which consolidated and extended maturities of its previous short-term revolving credit and long-term borrowing facilities. The new
agreement includes a $430 million five-year revolving credit facility, a $150 million five-year term loan, and a $220 million seven-
year term loan. The revolving credit facility contains terms and conditions that are substantially similar to the Company’s previous
revolving credit facility. The term loans, which were fully funded at closing, require no amortization and are prepayable without
penalty prior to maturity. The facilities include a customary accordion feature allowing for additional borrowings of up to $100
million under certain conditions. Currently, borrowings under the revolving credit agreement bear interest at variable rates based
on LIBOR plus a margin of 1.50% to 1.75%. The Company subsequently entered interest rate swap agreements to fix the variable
interest component of the five- and seven-year term loans to 1.44% and 1.73%, respectively. The effective rates on the five- and
seven-year term loans were 2.94% and 3.48%, respectively, as of May 18, 2015.
Fiscal Year Ended March 31, 2014, Compared to the Fiscal Year Ended March 31, 2013
Net income for the fiscal year ended March 31, 2014, was $149.0 million, or $5.25 per diluted share, compared with net
income for the fiscal year ended March 31, 2013, of $132.8 million, or $4.66 per diluted share. Fiscal year 2014’s results included
a gain in the first fiscal quarter of $81.6 million before tax ($53.1 million after tax, or $1.87 per diluted share), from the favorable
outcome of litigation in Brazil related to previous years’ excise tax credits. The annual results also included pretax restructuring
costs of $6.7 million ($0.15 per share) and $4.1 million ($0.06 per share) for fiscal years 2014 and 2013, respectively. Segment
operating income, which excludes those items, was $175.2 million for fiscal year 2014, a decrease of $57.6 million from the prior
year. That reduction was primarily attributable to weaker margins in Brazil from higher green leaf costs, increased currency
remeasurement and exchange costs, and the higher sales of carryover and uncommitted inventories in fiscal year 2013. Revenues
of $2.5 billion for fiscal year 2014 were up 3.3% compared with revenues for fiscal year 2013, as slightly lower volumes were offset
by higher prices.
Flue-cured and Burley Leaf Tobacco Operations
Other Regions
Within our flue-cured and burley leaf tobacco operations, operating income for our Other Regions segment for the fiscal
year ended March 31, 2014, declined by 31% to $133.4 million compared with the fiscal year ended March 31, 2013. The reduction
was driven primarily by results in South America, on lower volumes from fewer carryover shipments and weaker margins from
higher green leaf prices. Africa results were negatively impacted by a less favorable product mix despite increased shipment volumes
from larger current crops. The weaker results in those regions were partly mitigated by improved results in Europe as well as in Asia,
where trading volumes were higher. Selling, general, and administrative expenses for the segment were significantly higher for
fiscal year 2014, mostly due to unfavorable net foreign currency remeasurement and exchange comparisons, as losses in fiscal year
2014 compared to gains in fiscal year 2013, mostly in Africa, South America, and Asia. Revenues for this segment for fiscal year
2014 increased by about 3% to $1.9 billion compared with fiscal year 2013, reflecting modestly reduced volumes and higher green
leaf prices.
North America
Operating income for our North America segment for fiscal year 2014 was $23.2 million, up $3.5 million compared with
fiscal year 2013, on a more favorable product mix and lower overheads, including postretirement benefit costs. Revenues for this
segment increased 4% to $348.6 million on a combination of reduced volumes, higher green leaf costs, and improved product mix.
20
Other Tobacco Operations
In our Other Tobacco Operations segment, operating income was down $2.0 million to $18.5 million for fiscal year 2014,
compared with the comparable period of fiscal year 2013, primarily due to lower results for the oriental joint venture. In fiscal 2014,
the oriental business achieved higher revenues and reduced operating expenses which were more than offset by large currency
remeasurement and exchange losses from the devaluation of the Turkish lira. Our dark tobacco operations saw earnings improvements
from a better product mix for fiscal year 2014, although these benefits were nearly offset by higher foreign currency remeasurement
and exchange losses, mainly from the Indonesian rupiah.
Revenues for this segment increased by about 2% to $261.3 million for fiscal year 2014. Higher volumes attributable to
the timing of shipments of oriental tobaccos into the United States, combined with lower volumes in the dark tobacco operations,
drove the revenue change.
Other Items
Cost of goods sold increased by about 5% to $2.1 billion for the fiscal year ended March 31, 2014, reflecting higher green
leaf costs compared with the fiscal year ended March 31, 2013. Selling, general, and administrative costs increased by $26.7 million
for fiscal year 2014, compared with fiscal year 2013. The large increase for fiscal year 2014 was primarily related to unfavorable
comparisons from currency remeasurement and exchange losses, which amounted to $20.3 million compared with gains of $9.6
million in fiscal year 2013.
Interest expense of $20.3 million for fiscal year 2014 declined by about 8%, compared to fiscal year 2013. The reduction
was mostly due to lower average debt levels and interest rates during the period. The consolidated effective income tax rates on
pretax earnings were approximately 33% and 32% for the fiscal years ended March 31, 2014 and 2013, respectively. The rates for
both periods were lower than the 35% federal statutory rate mainly because of the effect of changes in exchange rates on deferred
income tax assets and liabilities, as well as lower effective rates on dividend income from certain foreign subsidiaries.
In the first fiscal quarter of 2014, we recorded an $81.6 million gain resulting from the favorable conclusion during the
quarter of a longstanding lawsuit challenging the Brazilian government’s denial of our rights to claim certain excise tax credits
generated in previous years. The outcome of the case entitles us to the previously denied excise tax credits, as well as additional
credits for interest from the dates the tax credits should have been available (approximately $104 million at the date the lawsuit was
concluded). All avenues of appeal by either party were exhausted, and we are now permitted to utilize the total amount of the credits
to offset future federal tax obligations for a period of up to five years. The amount of the gain, which is reported in Other Income,
reflects our current estimate of the actual tax credits that are likely to be realized before they expire.
On October 15, 2013, we repaid at maturity $200 million principal amount of 5.2% medium term notes. Subsequently, we
entered into a $175 million senior term loan agreement with a group of banks. The loan is unsecured and matures in five years. Loans
outstanding under the agreement currently bear interest at LIBOR plus 1.50% and may be prepaid at any time without premium or
penalty. The financial covenants under the new term loan agreement are substantially similar to those of our $450 million senior
unsecured committed revolving credit facility, including maintaining a minimum level of tangible net worth and observing limits on
debt levels.
Accounting Pronouncements
We adopted Financial Accounting Standards Board ("FASB") Accounting Standards Update 2013-02, “Comprehensive
Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,” effective at the
beginning of fiscal year 2014. The new guidance requires companies to report the effect of significant reclassifications out of
accumulated other comprehensive income (loss) on the respective line items in net income unless the amounts are not reclassified
in their entirety to net income. For amounts that are not reclassified in their entirety to net income in the same reporting period,
companies are required to cross-reference other disclosures that provide additional detail about those amounts. Since the new guidance
requires additional disclosures only, it did not have any impact on our results of operations, cash flows, or financial position. The
required disclosures are provided in Note 16 to the consolidated financial statements in Item 8.
In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU
2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting
principles (“U.S. GAAP”). ASU 2014-09 was developed under a joint project with the International Accounting Standards Board
(“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting
Standards. Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are
transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.
The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.
It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management
judgment and involve more estimates than the current guidance. ASU 2014-09 is effective for annual periods beginning after
December 15, 2016, including all interim periods within the year of adoption. However, the FASB has recently proposed a one-year
deferral of the effective date. Companies are allowed to select between two transition methods: (1) a full retrospective transition
method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method
21
that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Assuming
the proposed one-year deferral of the effective date is issued by the FASB as expected, we would expect to adopt ASU 2014-09
effective April 1, 2018, which is the beginning of our fiscal year ending March 31, 2019. We are currently evaluating the impact
that the adoption of ASU 2014-09 will have on our consolidated financial statements and have not made any decision on the method
of adoption.
22
Overview
LIQUIDITY AND CAPITAL RESOURCES
Our working capital requirements in fiscal year 2015 were lower compared to fiscal year 2014 primarily due to lower crop
purchase volumes and green tobacco prices. However, market oversupply conditions, which delayed purchasing, processing, and
crop shipments this year, extended the duration of our working capital needs in most origins. We generated $226.5 million in net
cash flows to fund our operating activities during the fiscal year, and our liquidity was sufficient to meet our needs. We also continued
our conservative financial policies, maintained our discipline on using our free cash flow, and returned funds to shareholders.
Our liquidity and capital resource requirements are predominately short-term in nature and primarily relate to working
capital required for tobacco crop purchases. Working capital needs are seasonal within each geographic region. The geographic
dispersion and the timing of working capital needs permit us to predict our general level of cash requirements, although crop sizes,
prices paid to farmers, shipment and delivery timing, and currency fluctuations affect requirements each year. Peak working capital
requirements are generally reached during the first and second fiscal quarters. Each geographic area follows a cycle of buying,
processing, and shipping tobacco, and in many regions we also provide agricultural materials to farmers during the growing season.
The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping
requirements, which may change the level or the duration of crop financing. Despite a predominance of short-term needs, we maintain
a portion of our total debt as long-term to reduce liquidity risk. We also periodically have large cash balances that we utilize to meet
our working capital requirements.
We believe that our financial resources are adequate to support our capital needs for at least the next twelve months. Our
seasonal borrowing requirements primarily relate to purchasing crops in South America and Africa and can increase from March to
September by more than $300 million. The funding required can vary significantly depending upon such factors as crop sizes, the
price of leaf, the relative strength of the U.S. dollar, and the timing of shipments and customer payments. We deal with this uncertainty
by maintaining substantial credit lines and cash balances. In addition to our operating requirements for working capital, we expect
to spend around $60 to $65 million during fiscal year 2016 for capital expenditures to maintain our facilities, complete the construction
of a new manufacturing facility for our food ingredients business, and invest in opportunities to grow and improve our tobacco
business. We also expect to provide about $12 million in funding to our pension plans. We have no long-term debt maturing before
fiscal year 2020. After balancing our capital structure, any excess cash flow from operations after dividends and capital expenditures
will be available to fund expansion, purchase our stock, or otherwise enhance shareholder value.
Cash Flow
Our operations generated about $226.5 million in operating cash flows in fiscal year 2015. That amount was about $230
million higher than the $3.5 million we required during the same period last fiscal year, primarily due to lower crop purchase volumes
and green leaf prices. During the fiscal year ended March 31, 2015, we increased our cash balances by $85.3 million, spent $58.4
million on capital projects, returned $94.9 million to shareholders in the form of dividends and repurchases of our common and
preferred stock, and refinanced a major portion of our capital structure, extending our debt maturities. At March 31, 2015, cash
balances totaled $248.8 million.
Working Capital
Working capital at March 31, 2015, was about $1.4 billion, up $145.4 million from last year's level. The $85.3 million
increase in cash and cash equivalents was partially offset by fewer advances to suppliers on smaller anticipated 2015 crops, down
$19.7 million. We extended our debt maturities as part of our $800 million refinancing in December 2014 and, as a result, we have
no principal payments due on our long-term debt over the next twelve months.
Tobacco inventories of $636.5 million at March 31, 2015, were relatively flat compared to inventory levels at the end of
the prior fiscal year. We usually finance inventory with a mix of cash, notes payable, and customer deposits, depending on our
borrowing capabilities, interest rates, and exchange rates, as well as those of our customers. We generally do not purchase material
quantities of tobacco on a speculative basis. However, when we contract directly with farmers, we are often obligated to buy all stalk
positions, which may contain less marketable leaf styles. Our uncommitted tobacco inventories decreased by approximately $20.3
million to $151.1 million, or about 24% of tobacco inventory, at March 31, 2015. Uncommitted inventories at March 31, 2014, were
$171.4 million, which represented 27% of tobacco inventory. The level of these uncommitted inventories is influenced by timing
of farmer deliveries of new crops, as well as the timing of customer deliveries.
In the quarter ended June 30, 2014, following our unsuccessful appeal, we paid the European Commission fine related to
market activities in Italy. In order to stay execution during the appeals process, we had put in place a bank guarantee in favor of the
Commission in the amount of the fine plus accumulated interest and had collateralized that guarantee with a bank deposit. Following
payment of the fine and the return of the bank deposit, other current assets and accounts payable and accrued expenses were each
reduced by approximately $54 million.
23
Share Repurchase Activity
Our Board of Directors approved our current share repurchase program in November 2013. The program expires in November
2015 and authorizes the purchase of up to $100 million of our common and preferred stock. Under the authorization, we may
purchase shares from time to time on the open market or in privately negotiated transactions at prices not exceeding prevailing market
rates. During fiscal year 2015, we purchased 719,993 shares of common stock at an aggregate cost of $31.2 million (average price
per share of $43.37) and 1,509 shares of preferred stock at an aggregate cost of $1.5 million (average price per share of $992.27).
In determining our level of common share repurchase activity, our intent is to use only cash available after meeting our anticipated
capital investment, dividend, and working capital requirements. Repurchases of shares under the repurchase program may vary
based on management discretion, as well as changes in cash flow generation and availability. At March 31, 2015, our available
authorization under our current share repurchase program was $67.3 million, and approximately 22.6 million common shares and
218,490 preferred shares were outstanding.
Capital Spending
Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency,
or position us for future growth. In deciding where to invest capital resources, we look for opportunities where we believe we can
earn an adequate return, leverage our assets and expertise, and enhance our farmer base. Our capital expenditures totaled $58.4
million in fiscal year 2015 and $45.8 million in fiscal year 2014. Increased capital spending in fiscal years 2014 and 2015 is attributable
mainly to production expansion projects in Africa and construction of our new manufacturing facility for our food ingredients business.
Depreciation expense was approximately $35.4 million and $37.3 million, respectively, in each of fiscal years 2015 and 2014.
Generally, our routine capital spending is at a level below depreciation expense in order to maintain strong cash flow. However,
from time to time, we undertake projects that increase spending beyond those limits when we identify opportunities to improve
efficiencies, add value for our customers, and position ourselves for future growth. We currently plan to spend approximately $60
to $65 million in fiscal year 2016 on capital projects for maintenance of our facilities, completion of the new manufacturing facility
for our food ingredients business, and other investments to grow and improve our tobacco business.
Outstanding Debt and Other Financing Arrangements
We consider the sum of notes payable and overdrafts, long-term debt (including the current portion), and customer advances
and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt. We also consider our
net debt plus shareholders' equity to be our net capitalization. Net debt decreased by $60.2 million to $211.3 million during the fiscal
year ended March 31, 2015. The decrease primarily reflects higher cash balances, partially offset by higher debt levels. Net debt
as a percentage of net capitalization was approximately 13% at March 31, 2015, down from 16% at March 31, 2014, and it remains
lower than our target range for peak borrowings of 30% to 40% of net capitalization.
In December 2014, we entered into a new bank credit agreement that established a five-year committed revolving credit
facility of $430 million, a funded $150 million five-year term loan, and a funded $220 million seven-year term loan. Both term loans
require no amortization and may be prepaid without penalty prior to maturity. The new revolving credit facility replaced a $450
million revolving credit facility that would have matured in November 2016. We concurrently repaid $248.8 million outstanding
on term loans under previous bank credit facilities and approximately $120 million in borrowings under the previous revolving credit
facility. In addition, on December 1, 2014, we repaid at maturity our $100 million 6.25% medium-term note using cash on hand and
revolver borrowings. The financial covenants under the new revolving credit facility are similar to those of the previous facility and
require us to maintain certain levels of tangible net worth and observe restrictions on debt levels. As of March 31, 2015, we had no
borrowings under the revolving credit facility, and we were in compliance with all covenants of our debt agreements.
As of March 31, 2015, we, together with our consolidated affiliates, had approximately $388 million in uncommitted lines
of credit, of which approximately $328 million were unused and available to support seasonal working capital needs. We also have
an active, undenominated universal shelf registration filed with the SEC in November 2014, that provides for future issuance of
additional debt or equity securities. We have no long-term debt maturing in fiscal year 2016.
Derivatives
From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates. Upon repayment
of outstanding term loans in December 2014, we terminated $74 million notional amount of swap agreements. The fair value of
these swap agreements was a liability of approximately $0.6 million. In January 2015, we entered into interest rate swap agreements
that convert the variable benchmark LIBOR rate on the new term loans entered into in December 2014 to a fixed rate. With the swap
agreements in place, the effective interest rates on the $150 million five-year term loan and the $220 million seven-year term loan
were 2.95% and 3.49%, respectively, as of March 31, 2015. These agreements were entered into to eliminate the variability of cash
flows in the interest payments on our variable-rate five- and seven-year term loans and are accounted for as cash flow hedges. Under
the swap agreements, we receive variable rate interest and pay fixed rate interest. At March 31, 2015, the fair value of our open
interest rate hedge swaps was a net liability of approximately $3 million .
24
We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast
purchases of tobacco and related processing costs in Brazil, as well as our net monetary asset exposure in local currency there. We
generally account for our hedges of forecast tobacco purchases as cash flow hedges. At March 31, 2015, the fair value of those open
contracts was a net liability of approximately $0.3 million. We also had other forward contracts outstanding that were not designated
as hedges, and the fair value of those contracts was a net asset of approximately $5 million at March 31, 2015. For additional
information, see Note 9 to the consolidated financial statements in Item 8.
Pension Funding
Funds supporting our ERISA-regulated U.S. defined benefit pension plan increased by $10 million during fiscal year 2015
to $204 million, as contributions and asset returns exceeded benefit payments. Following the changes to the plan benefit formula
during fiscal year 2014, the accumulated benefit obligation (“ABO”) and the projected benefit obligation (“PBO”) were both
approximately $230 million as of March 31, 2015. The ABO and PBO are calculated on the basis of certain assumptions that are
outlined in Note 11 to the consolidated financial statements in Item 8. We expect to make contributions of about $12 million to our
pension plans, including $5 million to our ERISA-regulated plan, during the next year. It is our policy to regularly monitor the
performance of the funds and to review the adequacy of our funding and plan contributions.
Contractual Obligations
Our contractual obligations as of March 31, 2015, were as follows:
(in thousands of dollars)
Total
2016
2017-2018
2019-2020
After 2020
Notes payable and long-term debt (1) ..........................................................................
$
503,423
$
72,912
$
24,114
$
173,012
$
233,385
Operating lease obligations ........................................................................................
40,529
10,826
13,975
7,738
7,990
Inventory purchase obligations:
Tobacco ....................................................................................................................
891,667
555,488
336,179
Agricultural materials...............................................................................................
Other purchase obligations.........................................................................................
42,017
23,636
42,017
23,636
—
—
—
—
—
—
—
—
Total..........................................................................................................................
$ 1,501,272
$
704,879
$
374,268
$
180,750
$
241,375
(1)
Includes interest payments. Interest payments on $429.9 million of variable rate debt were estimated based on rates as of March 31, 2015. The Company has
entered interest rate swaps that effectively convert the interest payments on the $370.0 million outstanding balance of its two bank term loans from variable to
fixed. The fixed rate has been used to determine the contractual interest payments for all periods.
In addition to principal and interest payments on notes payable and long-term debt, our contractual obligations include
operating lease payments, inventory purchase commitments, and capital expenditure commitments. Operating lease obligations
represent minimum payments due under leases for various production, storage, distribution, and other facilities, as well as vehicles
and equipment. Tobacco inventory purchase obligations primarily represent contracts to purchase tobacco from farmers. The amounts
shown above are estimates since actual quantities purchased will depend on crop yield, and prices will depend on the quality of the
tobacco delivered. About 43% of our crop year contracts to purchase tobacco are with farmers in Brazil. We have partially funded
our tobacco purchases in Brazil and in other regions with advances to farmers and other suppliers, which totaled approximately $115
million, net of allowances, at March 31, 2015. In addition, we have guaranteed bank loans to farmers in Brazil that relate to a portion
of our tobacco purchase obligations there. At March 31, 2015, we were contingently liable under those guarantees for outstanding
balances of approximately $17 million (including accrued interest), and we had recorded a liability of approximately $2 million for
the fair value of those guarantees. As tobacco is purchased and the related bank loans are repaid, our contingent liability is reduced.
25
CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
In preparing the financial statements in accordance with GAAP, we are required to make estimates and assumptions that
have an impact on the assets, liabilities, revenue, and expense amounts reported. These estimates can also affect our supplemental
information disclosures, including information about contingencies, risks, and financial condition. We believe, given current facts
and circumstances, that our estimates and assumptions are reasonable, adhere to GAAP, and are consistently applied. However,
changes in the assumptions used could result in a material adjustment to the financial statements. Our critical accounting estimates
and assumptions are in the following areas:
Inventories
Inventories of tobacco are valued at the lower of cost or market with cost determined under the specific cost method. Raw
materials are clearly identified at the time of purchase. We track the costs associated with raw materials in the final product lots,
and maintain this identification through the time of sale. We also capitalize direct and indirect costs related to processing raw
materials. This method of cost accounting is referred to as the specific cost or specific identification method. We write down
inventory for changes in market value based upon assumptions related to future demand and market conditions if the indicated market
value is below cost. Future demand assumptions can be impacted by changes in customer sales, changes in customers’ inventory
positions and policies, competitors’ pricing policies and inventory positions, and varying crop sizes and qualities. Market conditions
that differ significantly from those assumed by management could result in additional write-downs. We experience inventory write-
downs routinely. Inventory write-downs in fiscal years 2015, 2014, and 2013 were $18.6 million, $7.6 million, and $1.5 million,
respectively. The higher levels of inventory write-downs for fiscal years 2015 and 2014 generally reflect the effects of oversupply
conditions in the global leaf tobacco markets.
Advances to Suppliers and Guarantees of Bank Loans to Suppliers
In many sourcing origins, we provide tobacco growers with agronomy services and seasonal crop advances of, or for, seed,
fertilizer, and other supplies. These advances are short term in nature and are customarily repaid upon delivery of tobacco to us. In
several origins, we have also made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In
Brazil, we also guarantee bank loans made to farmers for the same purposes. In some years, due to low crop yields and other factors,
individual farmers may not deliver sufficient volumes of tobacco to repay maturing advances. In those cases, we may extend
repayment of the advances into the following crop year or satisfy the guarantee by acquiring the loan from the bank. In either
situation, we will incur losses whenever we are unable to recover the full amount of the loans and advances. At each reporting period,
we must make estimates and assumptions in determining the valuation allowance for advances to farmers and the liability to accrue
for our obligations under bank loan guarantees. At March 31, 2015, the gross balance of advances to suppliers totaled approximately
$156 million, and the related valuation allowance totaled approximately $35 million. The fair value of the loan guarantees for farmers
in Brazil was a liability of approximately $2 million at March 31, 2015.
Recoverable Value-Added Tax Credits
In many foreign countries, we pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and
processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax,
and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at
which the tax is assessed. When we sell tobacco to customers in the country of origin, we generally collect VAT on those sales. We
are normally permitted to offset our VAT payments against those collections and remit only the incremental VAT collections to the
tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where our tobacco sales are predominately
for export markets, we often do not generate enough VAT collections on downstream sales to fully offset our VAT payments. In
those situations, we can accumulate unused VAT credits. Some jurisdictions have procedures that allow companies to apply for
refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not
uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies
to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally
be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may
be heavily discounted from the face value of the credits. Due to these factors, in some countries we can accumulate significant
balances of VAT credits over time. We review these balances on a regular basis, and we record valuation allowances on the credits
to reflect amounts that we do not expect to recover, as well as discounts anticipated on credits we expect to sell or transfer. In
determining the appropriate valuation allowance to record in a given jurisdiction, we must make various estimates and assumptions
about factors affecting the ultimate recovery of the VAT credits. At March 31, 2015, the gross balance of recoverable tax credits
(primarily VAT) totaled approximately $60 million, and the related valuation allowance totaled approximately $23 million.
26
Goodwill
We review the carrying value of goodwill for potential impairment on an annual basis and at any time that events or business
conditions indicate that it may be impaired. As permitted under Accounting Standards Codification Topic 350 (“ASC 350”), at March
31, 2015, we elected to base our initial assessment of potential impairment on qualitative factors. Those factors did not indicate any
impairment of our recorded goodwill. Prior to fiscal year 2015, we followed the quantitative approach in ASC 350 in assessing the
fair value of our goodwill, which involved the use of discounted cash flow models (Level 3 of the fair value hierarchy under GAAP).
The calculations in these models were not based on observable market data from independent sources and therefore required significant
management judgment with respect to operating earnings growth rates and the selection of an appropriate discount rate. Significant
adverse changes in our operations or our estimates of future cash flows for a reporting unit with recorded goodwill, such as those
caused by unforeseen events or changes in market conditions, could result in an impairment charge. Over 90% of our goodwill
balance relates to our reporting unit in Brazil.
Fair Value Measurements
We hold various financial assets and financial liabilities that are required to be measured and reported at fair value in our
financial statements, including money market funds, trading securities associated with deferred compensation plans, interest rate
swaps, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. We follow the relevant
accounting guidance in determining the fair values of these financial assets and liabilities. Quoted market prices (Level 1 of the fair
value hierarchy) are used in most cases to determine the fair values of trading securities. Money market funds are valued based on
net asset value (“NAV”), which is computed based on amortized cost (Level 2 of the fair value hierarchy). Interest rate swaps, and
forward foreign currency exchange contracts are valued based on dealer quotes using discounted cash flow models matched to the
contractual terms of each instrument (Level 2 of the fair value hierarchy). The fair value of the guarantees of bank loans to tobacco
growers, which was approximately $2 million at March 31, 2015, is derived using an internally-developed discounted cash flow
model. The model requires various inputs, including historical loss percentages for comparable loans and a risk-adjusted interest
rate. Because significant management judgment is required in determining and applying these inputs to the valuation model, our
process for determining the fair value of these guarantees is classified as Level 3 of the fair value hierarchy. At March 31, 2015, a
1% increase in the expected loss percentage for all guaranteed farmer loans would not have had a material effect on the fair value
of the guarantee obligation. In addition, a 1% change in the risk-adjusted interest rate would not have had a material effect on the
fair value of the guarantee obligation. We incorporate credit risk in determining the fair values of our financial assets and financial
liabilities, but that risk did not materially affect the fair values of any of those assets or liabilities at March 31, 2015.
Income Taxes
Our consolidated effective income tax rate is based on our expected taxable income, tax laws and statutory tax rates, and
tax planning opportunities in the various jurisdictions in which we operate. Significant judgment is required in determining the
effective tax rate and evaluating our tax position. We are subject to the tax laws of many jurisdictions, and could be subject to a tax
audit in each of these jurisdictions, which could result in adjustments to tax expense in future periods. In the event that there is a
significant, unusual, or one-time item recognized in our results, the tax attributed to that discrete item would be recorded at the same
time as the item.
We have no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently or indefinitely
reinvested. We assume that all undistributed earnings of our foreign subsidiaries will be repatriated back to their parent entities in
the United States where the funds are best placed to meet our cash flow requirements. In addition, we strive to mitigate economic,
political, and currency risk by following a disciplined annual approach to the distribution of excess capital back to the U.S. Based
on these assumptions, in our income tax expense for each reporting period we fully provide for all additional U.S. income taxes that
are expected to be due on these distributions.
Our accounting for uncertain tax positions requires that we review all significant tax positions taken, or expected to be
taken, in income tax returns for all jurisdictions in which we operate. In this review, we must assume that all tax positions will
ultimately be audited, and either accepted or rejected based on the applicable tax regulations by the tax authorities for those
jurisdictions. We must recognize in our financial statements only the tax benefits associated with tax positions that are “more likely
than not” to be accepted upon audit, at the greatest amount that is considered “more likely than not” to be accepted. These
determinations require significant management judgment, and changes in any given quarterly or annual reporting period could affect
our consolidated income tax rate.
Tax regulations require items to be included in the tax return at different times than the items are reflected in the financial
statements. As a result, our effective tax rate reflected in the financial statements is different than that reported in our tax returns.
Some of these differences are permanent, such as expenses that are not tax deductible, while others are related to timing issues, such
as differences in depreciation methods. Timing differences create deferred tax assets and liabilities. Deferred tax liabilities generally
represent tax expense recognized in our financial statements for which payment has been deferred or income taxes related to expenses
that have not yet been recognized in the financial statements, but have been deducted in our tax return. Deferred tax assets generally
represent items that can be used as a tax deduction or credit in future tax returns for which we have already recorded the tax benefit
in our financial statements. We record valuation allowances for deferred tax assets when the amount of estimated future taxable
27
income is not likely to support the use of the deduction or credit. Determining the amount of such valuation allowances requires
significant management judgment, including estimates of future taxable income in multiple tax jurisdictions where we operate. Based
on our periodic earnings forecasts, we project the upcoming year’s taxable income to help us evaluate our ability to realize deferred
tax assets.
The functional currency in most of our significant foreign operations is the U.S. dollar, as export tobacco sales are generally
made in dollars. Purchasing and processing costs are usually incurred in local currency. When the U.S. dollar is weakening relative
to the local currency, purchasing and processing costs increase in dollar terms, resulting in higher cost inventory. The sale of that
inventory in dollars generates less taxable income in local currency, which results in lower income taxes owed when translated into
U.S. dollars. This causes the effective income tax rate on dollar income to be lower than the statutory rate in the local country. The
reverse can occur when the local currency is weakening relative to the U.S. dollar, thereby causing the effective income tax rate on
dollar earnings to be above the statutory rate. This impact on our effective income tax rate in a country can be significant during a
normal crop cycle. A prolonged period of strengthening or weakening over more than one crop may increase the impact if we sell
material quantities of old crop inventories. Lower-taxed foreign source income increases our ability to use foreign tax credits. Higher-
taxed foreign source income has the reverse effect. When these changes occur in our larger operations, such as our operations in
Brazil, they can have a material impact on our overall tax position.
For additional disclosures on income taxes, see Notes 1 and 5 to the consolidated financial statements in Item 8.
Pension and Other Postretirement Benefit Plans
The measurement of our pension and other postretirement benefit obligations and costs at the end of each fiscal year requires
that we make various assumptions that are used by our actuaries in estimating the present value of projected future benefit payments
to all plan participants. Those assumptions take into consideration the likelihood of potential future events such as salary increases
and demographic experience. The assumptions we use may have an effect on the amount and timing of future contributions to our
plans. The plan trustee conducts an independent valuation of the fair value of pension plan assets. The significant assumptions used
in the calculation of our pension and other postretirement benefit obligations are:
• Discount rate – The discount rate is based on investment yields on a hypothetical portfolio of actual long-term corporate
bonds rated AA that align with the cash flows for our benefit obligations.
•
Salary scale – The salary scale assumption is based on our long-term actual experience for salary increases, the near-
term outlook, and expected inflation.
• Expected long-term return on plan assets – The expected long-term return on plan assets reflects asset allocations and
investment strategy adopted by the Pension Investment Committee of the Board of Directors.
• Retirement and mortality rates – Retirement rates are based on actual plan experience along with our near-term outlook.
Early retirement assumptions are based on our actual experience. Mortality rates are based on standard industry group
annuity mortality tables which are updated to reflect projected improvements in life expectancy.
• Healthcare cost trend rates – For postretirement medical plan obligations and costs, we make assumptions on future
inflationary increases in medical costs. These assumptions are based on our actual experience, along with third-party
forecasts of long-term medical cost trends.
From one fiscal year to the next, the rates we use for each of the above assumptions may change based on market developments
and other factors. The discount rate reflects prevailing market interest rates at the end of the fiscal year when the benefit obligations
are actuarially measured and will increase or decrease based on market patterns. The expected long-term return on plan assets may
change based on changes in investment strategy for plan assets or changes in indicated longer-term yields on specific classes of plan
assets. Based on the high percentage of retired and inactive participants in our ERISA-regulated domestic defined benefit pension
plan (approximately 75% of total participants), as well as the high funded status of the plan, the Pension Investment Committee
adopted changes to the underlying plan assets during fiscal year 2015 to move toward a liability-driven investment strategy. We
reduced our expected long-term return on assets assumption by 50 basis points at March 31, 2015 to reflect those changes. We also
adopted updated mortality tables at March 31, 2015 based on recently-completed actuarial studies that reflect improvements in life
expectancy. In addition to the changes in actuarial assumptions from year to year, actual plan experience affecting our benefit
obligations, such as actual returns on plan assets and actual mortality experience, will differ from the assumptions used to measure
the obligations. The effects of these changes and differences increase or decrease the obligation we record for our pension and other
postretirement benefit plans, and they also create gains and losses that are accumulated and amortized over future periods, thus
affecting the expense we recognize for these plans over those periods. These effects may be significant. For example, between fiscal
year 2009 and fiscal year 2013, the discount rates used to measure the obligations for our domestic benefit plans declined by more
than 3.50%, reflecting the significant decline in interest rates and bond yields in the U.S. market. Over this period, our related benefit
obligation increased by more than $100 million (approximately 50%) and our annual expense increased by more than $4 million
(more than 40%). The reduction in discount rates accounted for a large portion of the increase in the benefit obligation and annual
expense. In fiscal year 2014, the discount rates used to determine the benefit obligations and related expense increased slightly,
28
reversing a portion of the effects seen from fiscal years 2009 through 2013. However, our benefit obligations increased again in
fiscal year 2015 due to a decrease in discount rates, along with the adoption of the updated mortality tables.
As of March 31, 2015, the effect of the indicated increase or decrease in the selected pension and other postretirement
benefit valuation assumptions is shown below. The effect assumes no change in benefit levels.
(in thousands of dollars)
Changes in Assumptions for Pension Benefits
Discount Rate:
Effect on
2015
Projected
Benefit
Obligation
Increase
(Decrease)
Effect on
2016 Annual
Expense
Increase
(Decrease)
1% increase ...............................................................................................................................................................................
$
(29,654) $
1% decrease ..............................................................................................................................................................................
36,171
Expected Long-Term Return on Plan Assets:
1% increase ...............................................................................................................................................................................
1% decrease ..............................................................................................................................................................................
Changes in Assumptions for Other Postretirement Benefits
Discount Rate:
1% increase ...............................................................................................................................................................................
1% decrease ..............................................................................................................................................................................
Healthcare Cost Trend Rate:
1% increase ...............................................................................................................................................................................
1% decrease ..............................................................................................................................................................................
—
—
(3,813)
4,591
1,300
(1,191)
(2,668)
3,189
(1,792)
1,791
(173)
(1)
69
(64)
A 1% increase or decrease in the salary scale assumption would not have a material effect on the projected benefit obligation
or on annual expense for the Company's pension benefits. See Note 11 to the consolidated financial statements in Item 8 for additional
information on pension and postretirement benefit plans.
Other Estimates and Assumptions
Other management estimates and assumptions are routinely required in preparing our financial statements, including the
determination of valuation allowances on accounts receivable and the fair value of long-lived assets. Changes in market and economic
conditions, local tax laws, and other related factors are considered each reporting period, and adjustments to the accounts are made
based on management’s best judgment.
29
OTHER INFORMATION REGARDING TRENDS
AND MANAGEMENT’S ACTIONS
Our financial performance depends on our ability to obtain an appropriate price for our products and services, to secure
the tobacco volumes and quality desired by our customers, and to maintain efficient, competitive operations. We continually monitor
issues and opportunities that may impact the supply of and demand for leaf tobacco, the volumes of leaf tobacco that we handle,
and the services we provide.
Supply
Crops sold in fiscal year 2015 were larger than in the prior fiscal year in many of our key sourcing areas for flue-cured
and burley tobacco. Flue-cured production outside of China was up approximately 10%, and burley production was up approximately
9%. The larger crops followed increases in crop sizes in fiscal year 2014 and contributed to an oversupply of tobacco in fiscal year
2015. Crop sizes for flue-cured, burley and oriental tobaccos available for export are expected to decrease in fiscal year 2016.
However, we expect total production levels in fiscal year 2016 will continue to exceed demand.
Production
Worldwide flue-cured tobacco production outside of China increased by about 10% in fiscal year 2015 to 2.2 billion kilos.
China is an extremely large market that is predominately domestic. Because very little of that tobacco is available outside of that
country to trade, we generally exclude Chinese crops when we consider worldwide production. However, the current buildup of
domestic stocks in China is quite significant, and may influence the global supply/demand balance due to efforts to reduce production
and imports there. Burley crops increased by about 9% in fiscal year 2015. We estimate that at March 31, 2015, industry uncommitted
flue-cured and burley inventories totaled about 131 million kilos, an increase of about 176% from March 31, 2014 levels.
We believe flue-cured production (excluding China) will decrease by about 9%, to about 2.0 billion kilos, in fiscal year
2016. Burley production is forecast to decrease by about 12%. We also believe that oriental tobacco as a whole has moved into a
balanced position. We forecast that dark air-cured production will remain flat in fiscal year 2016.
Looking forward beyond 2016, we believe that global tobacco production will remain relatively stable to meet slightly
declining total demand. South America, Asia, Africa, and North America will remain key sourcing regions for flue-cured and burley
tobaccos. Over the last decade, Africa has experienced growth in flue-cured and burley tobacco production of almost 250 million
kilos. We expect Africa to continue to be an important tobacco source and to lead tobacco production growth outside of China.
Pricing
Factors that affect green tobacco prices include global supply and demand, market conditions, production costs, foreign
exchange rates, and competition from other crops. We work with farmers to maintain tobacco production and to secure product at
price levels that are attractive to both the farmers and our customers. Our objective is to secure compliant tobacco that is produced
in a cost-effective manner under a sustainable business model with the desired quality for our customers. In some areas, tobacco
competes with agricultural commodity products for farmer production. If prices for soybeans, wheat, rice, and seed oils rise in
certain origins, green tobacco prices may have to rise to maintain tobacco production levels. This could be a factor in efforts of the
WHO to shift farmer production away from leaf tobacco to other crops. In the past, leaf shortages in specific markets or on a
worldwide basis have also led to green tobacco price increases.
Demand
Over the last three decades, the percentage of the global population that smokes has fallen, but the number of smokers has
increased due to global population growth. Industry data also shows that over the past ten years, total world consumption of cigarettes
grew at the compound annual rate of 0.3%, including annual growth of about 3.0% in China. Outside China, consumption fell by
about 1.4% during the ten-year period. However, there are indications that growth in world consumption of cigarettes may have
peaked and that the rate of growth is slowing in some key areas, particularly China. We expect that near term global demand for
leaf tobacco will decline slightly primarily due to declining cigarette consumption in developed markets partially offset by modest
growth in consumption in emerging markets (Asia, the Middle East, and Africa), influenced by demographic trends such as population
growth and increasing disposable income.
Our sales consist primarily of flue-cured and burley tobaccos. Those types of tobacco, along with oriental tobaccos, are
used in American-blend cigarettes which are primarily smoked in Western Europe and the United States. English-blend cigarettes
which use flue-cured tobacco are mainly smoked in Asia and other emerging markets. Industry data shows that consumption of
American-blend cigarettes has declined at a compound annual rate of 2.2% for the ten years ended in 2014. As cigarette consumption
declines in developed markets and increases in the emerging markets, there may be less demand for burley and oriental tobaccos
and more demand for flue-cured tobacco. However, demand is affected by many factors, including regulation, product taxation,
illicit trade, alternative tobacco products, and Chinese imports. To the extent that domestic leaf production in China does not meet
requirements for Chinese cigarette brands, those styles of tobacco could be sourced from other origins where we have major market
positions. On a year-to-year basis, we are also susceptible to fluctuations in leaf supply due to crop sizes and leaf demand as
manufacturers adjust inventories or respond to changes in cigarette markets. Recent declines in some of our customers’ sales volumes
30
in the U.S. and Western European markets, partially due to weak economic conditions, reduced demand for leaf tobacco in fiscal
year 2015. Despite modest curbs in projected crop year 2015 leaf tobacco production, we currently expect oversupply conditions
will continue into fiscal year 2016, as we believe that packed tobacco inventories and production levels need to come down further
to match demand. We also sell dark tobacco which is used in cigars and other smokeless products. We expect demand for this
category of tobacco to also decline slightly.
Regulation and Product Taxation
Decreased social acceptance of smoking and increased pressure from anti-smoking groups have had an ongoing adverse
effect on the percentage of the population using tobacco products, particularly in the United States and Western Europe. Also, many
foreign governments have taken or proposed steps to restrict or prohibit cigarette advertising and promotion, to increase taxes on
cigarettes, to prohibit smoking in public areas, and to discourage cigarette consumption. A number of such measures are included
in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated under the auspices of the WHO and offers
guidelines for discouraging or controlling tobacco use. Countries that are parties to the FCTC may choose the level of implementation
of the guidelines that is most suitable with their approach to tobacco control. In some cases, such restrictions are more onerous
than those proposed or in effect in the United States. We cannot predict the extent to which government efforts to reduce tobacco
consumption might affect the business of our primary customers. However, a significant decrease in worldwide tobacco consumption,
as well as shifts to modified risk tobacco products brought about by existing or future governmental laws and regulations, could
reduce demand for leaf tobacco and services and could have a material adverse effect on our results of operations.
In addition, certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain types
and styles of tobacco. As seen in Canada, Brazil, and the European Union, efforts have been taken to eliminate flavorings from
tobacco products. Such decisions could cause a change in requirements for certain tobaccos in particular countries. Shifts in
customer demand from one type of tobacco to another could create sourcing issues as requirements move from one origin to another.
Furthermore, instruction at the farm level may be required to produce the changing styles of tobacco needed by tobacco product
manufacturers. Given our established and well-developed programs at the farm level worldwide, we are particularly well positioned
to meet manufacturer requirements.
In 2009, the U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act (“the Act”). This legislation
authorizes the FDA to regulate the manufacturing and marketing of tobacco products. To date, the FDA has banned flavored
cigarettes, restricted youth access to tobacco products, banned advertising claims regarding certain tobacco products, established
new smokeless tobacco warnings, and issued new cigarette health warnings. In addition, the FDA established the Center for Tobacco
Products (“CTP”). The CTP has focused on establishing the scientific foundation and regulatory framework for regulating tobacco
products in the United States and on April 24, 2014, released proposed “deeming” regulations which encompass additional
manufactured tobacco products. Under these proposed regulations, tobacco products such as cigars and alternative tobacco products,
including e-cigarettes, will be regulated by the FDA. In addition, the proposed regulations require that tobacco product manufacturers
provide the FDA with a list of ingredients in their products. It may take several years for the proposed regulations to be finalized
and implemented. Regulations impacting our customer base that change the requirements for leaf tobacco will inherently impact
our business. As discussed, we have established programs that begin at the farm level to assist our customers with raw material
information to support leaf traceability and customer testing requirements. Additionally, given our global presence, we also have
the ability to source different types and styles of tobacco for our customers should their needs change due to regulation of ingredients.
A number of governments, particularly federal and local governments in the United States and the European Union, impose
excise or similar taxes on tobacco products. There has been, and will likely continue to be, new legislation proposing new or
increased taxes on tobacco products. In some cases, proposed legislation seeks to significantly increase existing taxes on tobacco
products, or impose new taxes on products that to date have not been subject to tax. Increases in product taxation may have an
influence on the level of illicit trade, which will affect the global leaf markets.
Illicit Trade
Illicit trade is another factor which influences demand for leaf tobacco. Industry estimates of the illegal, unregulated black
market for cigarettes are approximately 10% of global consumption, or one in every 10 cigarettes consumed. The European
Commission estimates that illicit trade in cigarettes costs the European Union over €10 billion annually. We are supportive of
industry efforts to eradicate illicit trade.
Alternative Tobacco Products
Many of the major tobacco product manufacturers have been developing next generation products. These include e-
cigarettes, liquid vaporizers, and heat-not-burn products. E-cigarettes and liquid vaporizers use liquid nicotine, which is
predominately derived from leaf tobacco, and heat-not-burn products use leaf tobacco. At this time it is unclear as to how these
new products will affect demand for leaf tobacco. Our AmeriNic joint venture produces liquid nicotine for the vapor products
industry. At this time, regulation of these products as well as consumer acceptance and their influence on smoking trends are unclear,
and we continue to monitor industry developments. E-cigarettes and other vapor products are currently primarily consumed in the
31
United States and Western Europe, and it is unclear at this time what effect the consumption of vapor products will have on global
demand for leaf tobacco.
Current Industry Dynamics
Leaf tobacco is sourced directly by product manufacturers, by global leaf suppliers such as ourselves, and by other smaller,
mostly regional or local, leaf suppliers. We estimate that, of the flue-cured and burley tobacco grown outside of China, approximately
one third is purchased directly by manufacturers, slightly over one third is handled by global leaf suppliers, and the remainder is
sourced by the smaller regional or local suppliers. Although we operate in a mature industry, where demand for the end products
is slightly declining, we continually look for ways to grow our business. We believe that there are several trends in the industry
that could provide opportunities for us to increase our market share and to offer additional services to our customers.
Manufacturers naturally seek to mitigate raw materials cost increases, and they are placing increased emphasis on cost
containment as they address declining demand. While this is not a new trend, it continues to offer opportunities to us as we bring
supply chain efficiencies to the leaf markets. We believe that global leaf suppliers add efficiencies to the markets through economies
of scale, as well as through the vital role played in finding buyers for all styles and qualities of leaf tobacco, which achieves overall
cost reductions. To understand our business, it is important to note that tobacco is not a commodity product. Flavor and smoking
characteristics of tobacco vary based on the type of tobacco and the region where the tobacco is grown. In addition, characteristics
of tobacco leaves vary by their position on the stalk of the plant, which means that many different styles and grades of tobacco may
be produced in a single tobacco crop. A particular manufacturer, in seeking tobacco for its proprietary blend, may only want and
have use for certain leaves of a plant. The leaf tobacco supplier plays a vital role in the industry by finding buyers for all of the leaf
grades and styles of tobacco produced in a farmer’s crop. This role helps to eliminate excess tobacco being produced, which improves
leaf utilization.
In addition to leaf utilization, we bring operational efficiencies to the industry, which in turn help reduce costs. These
efficiencies include economical utilization of processing capacity in our facilities, an established and scalable global network of
agronomists and technicians helping maintain a stable, productive, and sustainable farmer base, and agronomic and production
improvements to optimize leaf yields and qualities. In addition, we are able to offer manufacturers a complete range of services
from the field to the delivery of the packed product that benefit from our efficiencies. These services include such things as buying
station optimization, processing to specific customer specifications or needs, storage of green or packed leaf tobacco, and logistical
services. We have seen an increase in the level of supply chain services, which include direct purchasing, that we provide our
customers, notably in the United States, Mexico, Brazil, and the Dominican Republic. We believe these moves acknowledge the
efficiencies and services that global leaf suppliers bring to the entire supply chain.
Several major manufacturers have also indicated to us their interest in reducing sourcing complexity. We believe that these
moves are another way for the industry to increase leaf sourcing efficiency and to reduce costs. We maintain a strong presence in
all of the major tobacco sourcing areas and believe that any growth in these areas would favor global leaf suppliers such as ourselves.
In the future, we expect that increased regulations requiring stringent monitoring and testing of leaf chemistry and compliant sourcing
documentation could place greater emphasis on major sourcing areas.
As we have said for a number of years, the production of compliant leaf for the tobacco industry continues to grow in
importance. To be considered compliant, leaf tobacco must be grown utilizing Good Agricultural Practices. We have long invested
significant resources in the programs and infrastructure needed to work with growers to produce compliant leaf and continue to
enhance our ability to monitor and demonstrate this compliance for customers. Our Good Agricultural Practices programs educate
farmers in such matters as the reduction of non-tobacco related materials, product traceability, environmental sustainability, and
social responsibility. We believe that compliant leaf will continue to be important to our customers and should favor global suppliers
who are able to deliver this product.
We also believe that a key factor in our ability to perform successfully in this industry is our ability to provide customers
with the quality of leaf and the level of service they desire on a global basis at competitive prices, while maintaining a stability of
supply. As the leading global leaf tobacco supplier, we add significant value to the supply chain, providing expertise in dealing with
large numbers of farmers, efficiently selling various qualities of leaf produced in each crop to a broad global customer base, and
delivering products that meet stringent quality and regulatory specifications. We also help stabilize the tobacco markets and influence
crop development at the farm level. Our key objective is to continually adapt our business model to meet our customers' evolving
needs while continuing to provide stability of supply and the quality that distinguishes our products and services. In addition, we
monitor new product developments in the industry to identify areas where we can provide additional value to our customers.
32
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
Interest Rates
We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge
agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order,
which could mitigate a portion of the floating interest rate exposure. We also periodically have large cash balances and may receive
deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our
bank term loans, which were converted to fixed-rate borrowings with interest rate swaps in January 2015, debt carried at variable
interest rates was approximately $60 million at March 31, 2015. Although a hypothetical 1% change in short-term interest rates
would result in a change in annual interest expense of approximately $0.6 million, that amount would be at least partially mitigated
by changes in charges to customers.
In addition, changes in interest rates affect the calculation of our pension plan liabilities. As rates decrease, the liability for
the present value of amounts expected to be paid under the plans increases. Rate changes also affect expense. As of the March 31,
2015 measurement date, a 1% decrease in the discount rate would have increased the projected benefit obligation (“PBO”) for
pensions by $36 million and increased annual pension expense by $3 million. Conversely, a 1% increase in the discount rate would
have reduced the PBO by $30 million and reduced annual pension expense by $3 million.
Currency
The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that
which is related to leaf purchase and production costs, overhead, and income taxes in the source country. We also provide farmer
advances that are directly related to leaf purchases and are denominated in the local currency. Any currency gains or losses on those
advances are usually offset by increases or decreases in the cost of tobacco, which is priced in the local currency. However, the
effect of the offset may not occur until a subsequent quarter or fiscal year. Most of our tobacco operations are accounted for using
the U.S. dollar as the functional currency. Because there are no forward foreign exchange markets in many of our major countries
of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of
sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries. We are
vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency
do not offset each other. We recognized $28.8 million in net remeasurement losses in fiscal year 2015, compared to $14.3 million
in net remeasurement losses in fiscal year 2014, and $10.6 million in net remeasurement gains in fiscal year 2013. We recognized
$17.7 million in net foreign currency transaction gains in fiscal year 2015, compared to net transaction losses of $6.0 million in fiscal
year 2014, and net transaction losses of $1.0 million in fiscal year 2013. In addition to foreign exchange gains and losses, we are
exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the U.S. dollar. We have
entered forward currency exchange contracts to hedge against the effects of currency movements on purchases of tobacco to reduce
the volatility of costs. In addition, we periodically enter into forward contracts to hedge balance sheet exposures. See Note 9 to the
consolidated financial statements in Item 8 for additional information about our hedging activities.
In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency. Examples of
these markets are Hungary, Poland, and the Philippines. In other markets, such as Western Europe, where export sales are primarily
in local currencies, we also use the local currency as the functional currency. In each case, reported earnings are affected by the
translation of the local currency into the U.S. dollar.
Derivatives Policies
Hedging interest rate exposure using swaps and hedging foreign exchange exposure using forward contracts are specifically
contemplated to manage risk in keeping with management's policies. We may use derivative instruments, such as swaps, forwards,
or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce the risks inherent in interest
rate and currency fluctuations. When we use foreign currency derivatives to mitigate our exposure to exchange rate fluctuations,
we may choose not to designate them as hedges for accounting purposes, which may result in the effects of the derivatives being
recognized in our earnings in periods different from the items that created the exposure.
We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading
purposes. Derivatives are transaction-specific so that a specific debt instrument, forecast purchase, contract, or invoice determines
the amount, maturity, and other specifics of the hedge. We routinely review counterparty risk as part of our derivative program.
33
Item 8. Financial Statements and Supplementary Data
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
Fiscal Year Ended March 31,
(in thousands of dollars, except share and per share data)
2015
2014
2013
Sales and other operating revenues ........................................................................................................ $
2,271,801
$
2,542,115
$
2,461,699
Costs and expenses
Cost of goods sold ...............................................................................................................................
1,861,527
2,108,824
1,999,282
Selling, general and administrative expenses......................................................................................
Other income .......................................................................................................................................
Restructuring costs ..............................................................................................................................
250,186
(12,676)
4,890
262,013
(81,619)
6,746
235,295
—
4,113
Operating income ...................................................................................................................................
167,874
246,151
223,009
Equity in pretax earnings of unconsolidated affiliates ........................................................................
Interest income ....................................................................................................................................
Interest expense ...................................................................................................................................
Income before income taxes...................................................................................................................
Income taxes........................................................................................................................................
Net income .............................................................................................................................................
Less: net income attributable to noncontrolling interests in subsidiaries..............................................
Net income attributable to Universal Corporation .................................................................................
7,137
576
17,120
158,467
38,006
120,461
(5,853)
114,608
3,897
949
20,307
230,690
75,535
155,155
(6,146)
149,009
5,635
654
22,013
207,285
66,366
140,919
(8,169)
132,750
Dividends on Universal Corporation convertible perpetual preferred stock..........................................
(14,824)
(14,850)
(14,850)
Cost in excess of carrying value on repurchase of convertible perpetual preferred stock .....................
(36)
—
—
Earnings available to Universal Corporation common shareholders ..................................................... $
99,748
$
134,159
$
117,900
Earnings per share attributable to Universal Corporation common shareholders:
Basic .................................................................................................................................................... $
Diluted ................................................................................................................................................. $
4.33
4.06
$
$
5.77
5.25
$
$
5.05
4.66
Weighted average common shares outstanding:
Basic ....................................................................................................................................................
23,035,920
23,238.978
23,354.793
Diluted .................................................................................................................................................
28,221,264
28,392,033
28,478,058
See accompanying notes.
34
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands of dollars)
Fiscal Year Ended March 31,
2015
2014
2013
Net income ............................................................................................................................................. $
120,461
$
155,155
$
140,919
Other comprehensive income (loss):
Foreign currency translation, net of income taxes ..............................................................................
Foreign currency hedge, net of income taxes .....................................................................................
Interest rate hedge, net of income taxes..............................................................................................
Pension and other postretirement benefit plans, net of income taxes .................................................
Total other comprehensive income (loss), net of income taxes....................................................
Total comprehensive income ........................................................................................................
Less: comprehensive income attributable to noncontrolling interests...................................................
(22,625)
(2,603)
(1,374)
(14,023)
(40,625)
79,836
(5,890)
6,480
1,624
483
32,022
40,609
195,764
(5,547)
(3,370)
87
(364)
8,803
5,156
146,075
(8,504)
Comprehensive income attributable to Universal Corporation ............................................................. $
73,946
$
190,217
$
137,571
See accompanying notes.
35
UNIVERSAL CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands of dollars)
Current assets
ASSETS
March 31,
2015
2014
Cash and cash equivalents.................................................................................................................................................... $
248,783 $
Accounts receivable, net.......................................................................................................................................................
Advances to suppliers, net....................................................................................................................................................
Accounts receivable—unconsolidated affiliates ..................................................................................................................
434,362
114,883
1,907
163,532
468,015
134,621
7,375
Inventories—at lower of cost or market:
Tobacco..............................................................................................................................................................................
636,488
639,812
Other..................................................................................................................................................................................
Prepaid income taxes............................................................................................................................................................
Deferred income taxes..........................................................................................................................................................
62,195
17,811
36,611
67,219
27,866
22,052
Other current assets ..............................................................................................................................................................
81,570
142,755
Total current assets............................................................................................................................................................
1,634,610
1,673,247
Property, plant and equipment
Land......................................................................................................................................................................................
Buildings ..............................................................................................................................................................................
Machinery and equipment ....................................................................................................................................................
16,790
238,372
576,010
831,172
17,275
239,913
562,597
819,785
Less accumulated depreciation..........................................................................................................................................
(525,783)
(523,239)
Other assets
Goodwill and other intangibles ............................................................................................................................................
Investments in unconsolidated affiliates ..............................................................................................................................
Deferred income taxes..........................................................................................................................................................
Other noncurrent assets ........................................................................................................................................................
305,389
296,546
99,146
76,512
6,301
76,515
99,453
95,305
14,562
91,794
258,474
301,114
Total assets......................................................................................................................................................................... $
2,198,473 $
2,270,907
36
UNIVERSAL CORPORATION
CONSOLIDATED BALANCE SHEETS—(Continued)
(in thousands of dollars)
Current liabilities
LIABILITIES AND SHAREHOLDERS’ EQUITY
March 31,
2015
2014
Notes payable and overdrafts............................................................................................................................................... $
59,862
$
Accounts payable and accrued expenses .............................................................................................................................
140,112
Accounts payable—unconsolidated affiliates......................................................................................................................
Customer advances and deposits .........................................................................................................................................
Accrued compensation.........................................................................................................................................................
Income taxes payable...........................................................................................................................................................
Current portion of long-term obligations.............................................................................................................................
3,281
30,183
28,232
9,243
—
Total current liabilities................................................................................................................................................
270,913
62,905
212,422
65
15,869
31,772
15,694
116,250
454,977
Long-term obligations.............................................................................................................................................................
370,000
240,000
Pensions and other postretirement benefits.............................................................................................................................
Other long-term liabilities.......................................................................................................................................................
Deferred income taxes ............................................................................................................................................................
97,048
36,790
26,628
85,081
34,457
45,500
Total liabilities ............................................................................................................................................................
801,379
860,015
Shareholders’ equity
Universal Corporation:
Preferred stock:
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized,
none issued or outstanding ..........................................................................................................................................
—
—
Series B 6.75% Convertible Perpetual Preferred Stock, no par value, 220,000 shares authorized,
218,490 shares issued and outstanding (219,999 at March 31, 2014).........................................................................
211,562
213,023
Common stock, no par value, 100,000,000 shares authorized, 22,593,266 shares issued
and outstanding (23,216,312 at March 31, 2014)...........................................................................................................
206,002
Retained earnings..............................................................................................................................................................
1,020,155
206,446
993,093
Accumulated other comprehensive loss............................................................................................................................
(74,994)
(34,332)
Total Universal Corporation shareholders' equity.......................................................................................................
1,362,725
1,378,230
Noncontrolling interests in subsidiaries..................................................................................................................................
34,369
32,662
Total shareholders' equity ...........................................................................................................................................
1,397,094
1,410,892
Total liabilities and shareholders' equity..................................................................................................................... $
2,198,473 $
2,270,907
See accompanying notes.
37
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands of dollars)
Cash Flows From Operating Activities:
Fiscal Year Ended March 31,
2015
2014
2013
Net income ............................................................................................................................................. $
120,461
$
155,155
$
140,919
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation ........................................................................................................................................
Amortization........................................................................................................................................
Provision for losses on advances and guaranteed loans to suppliers ..................................................
Inventory write-downs ........................................................................................................................
Stock-based compensation expense ....................................................................................................
Foreign currency remeasurement loss (gain), net ...............................................................................
Deferred income taxes.........................................................................................................................
Equity in net income of unconsolidated affiliates, net of dividends ...................................................
Gain on favorable outcome of excise tax case in Brazil .....................................................................
Restructuring costs ..............................................................................................................................
Other, net .............................................................................................................................................
Changes in operating assets and liabilities, net:
Accounts and notes receivable .........................................................................................................
Inventories and other assets..............................................................................................................
Income taxes.....................................................................................................................................
Accounts payable and other accrued liabilities ................................................................................
Customer advances and deposits......................................................................................................
Net cash provided (used) by operating activities ................................................................................
Cash Flows From Investing Activities:
Purchase of property, plant and equipment .........................................................................................
Proceeds from sale of property, plant and equipment .........................................................................
Other, net .............................................................................................................................................
Net cash used by investing activities................................................................................................
Cash Flows From Financing Activities:
Issuance (repayment) of short-term debt, net ......................................................................................
Issuance of long-term obligations .......................................................................................................
Repayment of long-term obligations...................................................................................................
Dividends paid to noncontrolling interests..........................................................................................
Issuance of common stock ..................................................................................................................
Repurchase of convertible perpetual preferred stock ..........................................................................
Repurchase of common stock..............................................................................................................
Dividends paid on convertible perpetual preferred stock....................................................................
Dividends paid on common stock .......................................................................................................
Debt issuance costs and other..............................................................................................................
Net cash used by financing activities ...............................................................................................
Effect of exchange rate changes on cash................................................................................................
Net increase (decrease) in cash and cash equivalents ............................................................................
Cash and cash equivalents at beginning of year.....................................................................................
35,394
1,930
3,734
18,612
6,230
28,836
(13,662)
(1,075)
(12,676)
4,890
(9,272)
49,414
37,751
4,790
(63,257)
14,397
226,497
(58,385)
4,522
(141)
(54,004)
2,618
370,000
(356,250)
(4,183)
187
(1,497)
(31,227)
(14,824)
(47,337)
(3,621)
(86,134)
(1,108)
85,251
163,532
37,257
1,642
6,705
7,654
6,278
14,322
(2,176)
3,420
(81,619)
6,746
2,251
(89,536)
(47,492)
11,391
(27,345)
(8,156)
(3,503)
(45,849)
2,746
1,033
(42,070)
(43,727)
175,000
(211,250)
(1,971)
457
—
(14,145)
(14,850)
(46,721)
(875)
43,408
1,708
1,623
1,523
6,171
(10,579)
11,794
(4,966)
—
4,113
(1,174)
(5,433)
6,578
18,111
11,167
9,503
234,466
(30,783)
3,534
1,004
(26,245)
(18,374)
—
(16,250)
(1,957)
3,949
—
(8,481)
(14,850)
(45,996)
—
(158,082)
(101,959)
(677)
(204,332)
367,864
(97)
106,165
261,699
367,864
Cash and Cash Equivalents at End of Year....................................................................................... $
248,783
$
163,532
$
Supplemental information—cash paid for:
Interest ................................................................................................................................................. $
Income taxes, net of refunds................................................................................................................ $
19,184
46,044
$
$
25,116
65,511
$
$
22,027
35,913
See accompanying notes.
38
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(in thousands of dollars)
Fiscal Year Ended March 31, 2015
Universal Corporation Shareholders
Series B
6.75%
Convertible
Perpetual
Preferred
Stock
Common
Stock
Retained
Earnings
Accumulated
Other
Comprehensive
Income
(Loss)
Non-
controlling
Interests
Total
Shareholders'
Equity
Balance at beginning of year ..........................................................
$
213,023
$ 206,446
$
993,093
$
(34,332) $
32,662
$
1,410,892
Changes in preferred and common stock
Repurchase of Series B 6.75% convertible perpetual
preferred stock .......................................................................
(1,461)
Issuance of common stock ....................................................
Repurchase of common stock................................................
Accrual of stock-based compensation ...................................
Withholding of shares from stock-based compensation for
grantee income taxes ...........................................................
Dividend equivalents on RSUs..............................................
Changes in retained earnings
Net income ............................................................................
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock
($67.50 per share) ..........................................................
Common stock ($2.06 per share) .....................................
Repurchase of Series B 6.75% convertible perpetual
preferred stock .......................................................................
Repurchase of common stock................................................
Dividend equivalents on RSUs..............................................
Other comprehensive income (loss)
Foreign currency translation, net of income taxes ................
Foreign currency hedge, net of income taxes........................
Interest rate hedge, net of income taxes ................................
Pension and other postretirement benefit plans, net of
income taxes........................................................................
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders.....................
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
187
(6,439)
6,230
(1,076)
654
—
—
—
—
—
—
—
114,608
—
—
—
—
—
—
—
—
—
(14,824)
(47,244)
(36)
(24,788)
(654)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
(22,662)
(2,603)
(1,374)
(14,023)
—
—
—
—
—
—
(1,461)
187
(6,439)
6,230
(1,076)
654
5,853
120,461
—
—
—
—
37
—
—
—
(14,824)
(47,244)
(36)
(24,788)
(654)
(22,625)
(2,603)
(1,374)
(14,023)
—
(4,183)
(4,183)
Balance at end of year ....................................................................
$
211,562
$ 206,002
$ 1,020,155
$
(74,994) $
34,369
$
1,397,094
39
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)
(in thousands of dollars)
Fiscal Year Ended March 31, 2014
Universal Corporation Shareholders
Series B
6.75%
Convertible
Perpetual
Preferred
Stock
Common
Stock
Retained
Earnings
Accumulated
Other
Comprehensive
Income
(Loss)
Non-
controlling
Interests
Total
Shareholders'
Equity
Balance at beginning of year ............................................................
$
213,023
$ 202,579
$ 918,509
$
(75,540) $
29,086
$
1,287,657
Changes in preferred and common stock
Issuance of common stock ......................................................
Repurchase of common stock..................................................
Accrual of stock-based compensation .....................................
Withholding of shares from stock-based compensation for
grantee income taxes .............................................................
Dividend equivalents on RSUs................................................
Changes in retained earnings
Net income ..............................................................................
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock
($67.50 per share) ............................................................
Common stock ($2.02 per share) .......................................
Repurchase of common stock..................................................
Dividend equivalents on RSUs................................................
Other comprehensive income (loss)
Foreign currency translation, net of income taxes ..................
Foreign currency hedge, net of income taxes..........................
Interest rate hedge, net of income taxes ..................................
Pension and other postretirement benefit plans, net of
income taxes..........................................................................
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders.......................
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
457
(2,049)
6,278
(1,410)
591
—
—
—
—
—
—
149,009
—
—
—
—
—
—
—
—
—
(14,850)
(46,888)
(12,096)
(591)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
7,079
1,624
483
32,022
—
—
—
—
—
457
(2,049)
6,278
(1,410)
591
6,146
155,155
—
—
—
—
(599)
—
—
—
(14,850)
(46,888)
(12,096)
(591)
6,480
1,624
483
32,022
—
(1,971)
(1,971)
Balance at end of year ......................................................................
$
213,023
$ 206,446
$ 993,093
$
(34,332) $
32,662
$
1,410,892
40
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)
(in thousands of dollars)
Fiscal Year Ended March 31, 2013
Universal Corporation Shareholders
Series B
6.75%
Convertible
Perpetual
Preferred
Stock
Common
Stock
Retained
Earnings
Accumulated
Other
Comprehensive
Income
(Loss)
Non-
controlling
Interests
Total
Shareholders'
Equity
Balance at beginning of year ............................................................
$
213,023
$ 196,135
$ 854,654
$
(80,361) $
22,539
$
1,205,990
Changes in preferred and common stock
Issuance of common stock ......................................................
Repurchase of common stock..................................................
Accrual of stock-based compensation .....................................
Withholding of shares from stock-based compensation for
grantee income taxes .............................................................
Dividend equivalents on RSUs................................................
Changes in retained earnings
Net income ..............................................................................
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock
($67.50 per share) ............................................................
Common stock ($1.98 per share) .......................................
Repurchase of common stock..................................................
Dividend equivalents on RSUs................................................
Other comprehensive income (loss)
Foreign currency translation, net of income taxes ..................
Foreign currency hedge, net of income taxes..........................
Interest rate hedge, net of income taxes ..................................
Pension and other postretirement benefit plans, net of
income taxes..........................................................................
Other changes in noncontrolling interests
Dividends paid to noncontrolling shareholders.......................
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
3,949
(1,432)
6,171
(2,819)
575
—
—
—
—
—
—
132,750
—
—
—
—
—
—
—
—
—
(14,850)
(46,272)
(7,198)
(575)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
3,949
(1,432)
6,171
(2,819)
575
8,169
140,919
—
—
—
—
(14,850)
(46,272)
(7,198)
(575)
(3,705)
335
(3,370)
87
(364)
8,803
—
—
—
87
(364)
8,803
—
(1,957)
(1,957)
Balance at end of year ......................................................................
$
213,023
$ 202,579
$ 918,509
$
(75,540) $
29,086
$
1,287,657
41
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)
Fiscal Year Ended March 31,
2015
2014
2013
Preferred Shares Outstanding:
Series B 6.75% Convertible Perpetual Preferred Stock:
Balance at beginning of year.................................................................................................................
219,999
219,999
219,999
Issuance of convertible perpetual preferred stock ................................................................................
Repurchase of convertible perpetual preferred stock............................................................................
Balance at end of year...........................................................................................................................
—
(1,509)
218,490
—
—
—
—
219,999
219,999
Common Shares Outstanding:
Balance at beginning of year.................................................................................................................
23,216,312
23,343,973
23,257,175
Issuance of common stock ....................................................................................................................
96,947
110,825
Repurchase of common stock ...............................................................................................................
(719,993)
(238,486)
256,230
(169,432)
Balance at end of year...........................................................................................................................
22,593,266
23,216,312
23,343,973
See accompanying notes.
42
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(All dollar amounts are in thousands, except per share amounts or as otherwise noted.)
NOTE 1. NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the
leading global leaf tobacco supplier. The Company conducts business in over 30 countries, primarily in major tobacco-producing
regions of the world.
Consolidation
The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries
in which the Company maintains a controlling financial interest. Control is generally determined based on a voting interest of greater
than 50%, such that Universal controls all significant corporate activities of the subsidiary. All significant intercompany accounts
and transactions are eliminated in consolidation.
The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest
of 20% to 50%. These investments are accounted for under the equity method because Universal exercises significant influence
over those companies, but not control. The Company received dividends totaling $5.2 million in fiscal year 2015, $6.5 million in
fiscal year 2014, and $0.1 million in fiscal year 2013, from companies accounted for under the equity method. Investments where
Universal has a voting interest of less than 20% are not significant and are accounted for under the cost method. Under the cost
method, the Company recognizes earnings upon its receipt of dividends to the extent they represent a distribution of retained earnings.
The Company's 49% ownership interest in Socotab L.L.C. (“Socotab”), a leading processor and leaf merchant of oriental
tobaccos with operations located principally in Europe, is the primary investment accounted for under the equity method. The
investment in Socotab is an important part of the Company's overall product and service arrangements with its major customers. As
discussed further below, the Company reviews the carrying value of its investments in unconsolidated affiliates on a regular basis
and considers whether any factors exist that might indicate an impairment in value that is other than temporary. At March 31, 2015,
the Company determined that no such factors existed with respect to the investment in Socotab. The Company, together with Socotab
management, regularly evaluates the outlook for the business, and an impairment charge could be recorded in a future period if it is
determined that the fair value of the investment is less than the carrying value and the decline in value is not temporary.
In fiscal year 2006, the Company deconsolidated its operations in Zimbabwe under accounting requirements that apply
under certain conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions. Since
that time, the investment has been accounted for using the cost method, as required under the accounting guidance. The investment
in the Zimbabwe operations was zero at March 31, 2015 and 2014. The Company has a net foreign currency translation loss associated
with the Zimbabwe operations of approximately $7.2 million, which remains a component of accumulated other comprehensive loss.
As a regular part of its reporting, the Company reviews the conditions that resulted in the deconsolidation of the Zimbabwe operations
to confirm that such accounting treatment is still appropriate. Dividends from the Zimbabwe operations are recorded in income in
the period received.
The Company holds less than a 100% financial interest in certain consolidated subsidiaries. The net income and shareholders’
equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements.
During fiscal years 2015, 2014, and 2013, there were no changes in the Company’s ownership percentage in any of these subsidiaries.
43
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Investments in Unconsolidated Affiliates
The Company’s equity method investments and its cost method investments, which include its Zimbabwe operations, are
non-marketable securities. Universal reviews such investments for impairment whenever events or changes in circumstances indicate
that the carrying amount of an investment may not be recovered. For example, the Company would review such an investment for
impairment if the investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change
in its business environment, or undergo any other significant change in its normal business. In assessing the recoverability of equity
or cost method investments, the Company follows the applicable accounting guidance in determining the fair value of the investments.
In most cases, this involves the use of discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance).
If the fair value of an equity or cost method investee is determined to be lower than its carrying value, an impairment loss is recognized.
The determination of fair value using discounted cash flow models is normally not based on observable market data from independent
sources and therefore requires significant management judgment with respect to estimates of future operating earnings and the
selection of an appropriate discount rate. The use of different assumptions could increase or decrease estimated future operating
cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to
these investments.
In its consolidated statements of income, the Company reports its proportional share of earnings of unconsolidated affiliates
accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable accounting
guidance. All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of consolidated
income tax expense. For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share of the earnings
through dividends is assumed in determining consolidated income tax expense.
The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported
in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported
in the consolidated statements of cash flows for the fiscal years ended March 31, 2015, 2014, and 2013
Fiscal Year Ended March 31,
2015
2014
2013
Equity in pretax earnings reported in the consolidated statements of income..................... $
7,137
$
3,897
$
Less: Equity in income taxes...............................................................................................
Equity in net income ............................................................................................................
Less: Dividends received on investments (1) ........................................................................
(834)
6,303
(5,228)
(809)
3,088
(6,508)
5,635
(547)
5,088
(122)
Equity in net income, net of dividends, reported in the consolidated statements of cash
flows..................................................................................................................................... $
1,075
$
(3,420) $
4,966
(1)
In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a
return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.
Earnings Per Share
The Company calculates basic earnings per share based on earnings available to common shareholders after payment of
dividends on the Company’s Series B 6.75% Convertible Perpetual Preferred Stock. The calculation uses the weighted average
number of common shares outstanding during each period. Diluted earnings per share is computed in a similar manner using the
weighted average number of common shares and dilutive potential common shares outstanding. Dilutive potential common shares
are outstanding dilutive stock options and stock appreciation rights that are assumed to be exercised, unvested restricted stock units
and performance share awards that are assumed to be fully vested and paid out in shares of common stock, and shares of convertible
perpetual preferred stock that are assumed to be converted when the effect is dilutive. In periods when the effect of the convertible
perpetual preferred stock is dilutive and these shares are assumed to be converted into common stock, dividends paid on the preferred
stock are excluded from the calculation of diluted earnings per share.
Calculations of earnings per share for the fiscal years ended March 31, 2015, 2014, and 2013, are provided in Note 4.
Cash and Cash Equivalents
All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.
44
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Advances to Suppliers
In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed,
fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement
of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances
to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers
to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers
may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of
those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated
balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when
the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers
totaled approximately $156 million at March 31, 2015 and $190 million at March 31, 2014. The related valuation allowances totaled
$35 million at March 31, 2015, and $46 million at March 31, 2014, and were estimated based on the Company’s historical loss
information and crop projections. The allowances were increased by net provisions for estimated uncollectible amounts of
approximately $3.7 million in fiscal year 2015, $5.5 million in fiscal year 2014, and $1.6 million in fiscal year 2013. These provisions
are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is
recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest. Advances on which interest accrual
had been discontinued totaled approximately $15 million at March 31, 2015, and $23 million at March 31, 2014.
Inventories
Tobacco inventories are valued at the lower of cost or market. Raw materials primarily consist of unprocessed leaf tobacco,
which is clearly identified by type and grade at the time of purchase. The Company tracks the costs associated with this tobacco in
the final product lots, and maintains this identification through the time of sale. This method of cost accounting is referred to as the
specific cost or specific identification method. The predominant cost component of the Company’s inventories is the cost of the
unprocessed tobacco. Direct and indirect processing costs related to these raw materials are capitalized and allocated to inventory
in a systematic manner. The Company does not capitalize any interest or sales-related costs in inventory. Freight costs are recorded
in cost of goods sold. Other inventories consist primarily of seed, fertilizer, packing materials, and other supplies, and are valued
principally at the lower of average cost or market.
Recoverable Value-Added Tax Credits
In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”)
on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some
countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction
to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating
subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the
collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally
not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream
sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate.
Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but
the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected
in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in
private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts
that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due
to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The
Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not
expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At March 31, 2015
and 2014, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $60 million
and $66 million, respectively, and the related valuation allowances totaled approximately $23 million and $30 million, respectively.
The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.
Property, Plant and Equipment
Depreciation of plant and equipment is based upon historical cost and the estimated useful lives of the assets. Depreciation
is calculated primarily using the straight-line method. Buildings include tobacco processing and blending facilities, offices, and
warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer equipment.
Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years; transport
equipment - 3 to 10 years; and office and computer equipment - 3 to 10 years. Where applicable and material in amount, the Company
capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready for service.
No interest was capitalized in fiscal years 2015, 2014, or 2013.
45
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Goodwill and Other Intangibles
Goodwill and other intangibles principally consist of the excess of the purchase price of acquired companies over the fair
value of the net assets. Goodwill is carried at the lower of cost or fair value. Accounting Standards Codification Topic 350 (“ASC
350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company
elected to use that approach at March 31, 2015. Those factors did not indicate any potential impairment of the Company's recorded
goodwill. Prior to fiscal year 2015, the Company followed the quantitative approach in ASC 350, which primarily involved the use
of discounted cash flow models (Level 3 of the fair value hierarchy in the accounting guidance). The calculations in these models
were normally not based on observable market data from independent sources and therefore required significant management
judgment with respect to estimates of future operating earnings and the selection of an appropriate discount rate.
Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business
in a specific country or location. Goodwill is allocated to reporting units based on the country or location to which a specific
acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location.
The majority of the Company’s goodwill relates to its reporting unit in Brazil. Significant adverse changes in the operations or
estimated future cash flows for a reporting unit with recorded goodwill could result in an impairment charge. No charges for goodwill
impairment were recorded in fiscal years 2015, 2014, or 2013.
Impairment of Long-Lived Assets
The Company reviews long-lived assets for impairment whenever events, changes in business conditions, or other
circumstances provide an indication that such assets may be impaired. Potential impairment is initially assessed by comparing
management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their carrying value. If the
carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying value of the asset to
its fair value determined in accordance with the accounting guidance. In many cases, this involves the use of discounted cash flow
models that are not based on observable market data from independent sources (Level 3 of the fair value hierarchy under the accounting
guidance). No significant charges for impairment of long-lived assets were recorded during fiscal years 2015, 2014, or 2013.
Income Taxes
The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and
liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed
earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer
advances and value-added tax credits.
Fair Values of Financial Instruments
The fair values of the Company’s long-term obligations, disclosed in Note 7, approximate their carrying amount since the
variable interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March
31, 2015. In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are
available and discounted cash flow models based on current incremental borrowing rates for similar classes of borrowers and
borrowing arrangements. The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable
benchmark rate on outstanding long-term obligations are determined separately and recorded in other long-term liabilities. Except
for interest rate swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets
and liabilities that qualify as financial instruments approximate their carrying amounts.
Derivative Financial Instruments
The Company recognizes all derivatives on the balance sheet at fair value. Interest rate swaps and forward foreign currency
exchange contracts are used from time to time to manage interest rate risk and foreign currency risk. The Company enters into such
contracts only with counterparties of good standing. The credit exposure related to non-performance by the counterparties and the
Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements
or operations of the Company. Additional disclosures related to the Company’s derivatives and hedging activities are provided in
Note 9.
Translation and Remeasurement of Foreign Currencies
The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S.
dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting
period for results of operations. Adjustments resulting from translation of financial statements are reflected as a separate component
of other comprehensive income or loss.
46
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
The financial statements of foreign subsidiaries having the U.S. dollar as the functional currency, with certain transactions
denominated in a local currency, are remeasured into U.S. dollars. The remeasurement of local currency amounts into U.S. dollars
creates remeasurement gains and losses that are included in earnings as a component of selling, general, and administrative expense.
The Company recognized net remeasurement losses of $28.8 million in fiscal year 2015, net remeasurement losses of $14.3 million
in fiscal year 2014, and net remeasurement gains of $10.6 million in fiscal year 2013.
Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate
gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance. These transaction
gains and losses are also included in earnings as a component of selling, general, and administrative expenses. The Company
recognized net foreign currency transaction gains of $17.7 million in fiscal year 2015, net transaction losses of $6.0 million in fiscal
year 2014, and net transaction losses of $1.0 million in fiscal year 2013.
Revenue Recognition
Revenue from the sale of tobacco is recognized when title and risk of loss is transferred to the customer and the earnings
process is complete. Substantially all sales revenue is recorded based on the physical transfer of products to customers. A large
percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products. The Company works
closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco from its
various growing regions, and extensive coordination is maintained on an ongoing basis to determine and satisfy their requirements
for physical shipment of processed tobacco. In most cases, customers request shipment within a relatively short period of time after
the tobacco is processed and packed. The customers also specify, in sales contracts and in shipping documents, the precise terms
for transfer of title and risk of loss for the tobacco. Customer returns and rejections are not significant, and the Company’s sales
history indicates that customer-specific acceptance provisions are consistently met upon transfer of title and risk of loss.
While most of the Company’s revenue consists of tobacco that is purchased from farmers, processed and packed in its
factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers. These arrangements
usually exist in specific markets where the customers contract directly with farmers for leaf production, and they have accounted for
less than 5% of total revenue on an annual basis through the fiscal year ended March 31, 2015. Processing and packing of leaf
tobacco is a short-duration process. Under normal operating conditions, raw tobacco that is placed into the production line exits as
processed and packed tobacco within one hour, and is then transported to customer-designated storage facilities. The revenue for
these services is recognized when processing is completed, and the Company’s operating history indicates that customer requirements
for processed tobacco are consistently met upon completion of processing.
Stock-Based Compensation
Share-based payments, such as grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and
performance share awards, are measured at fair value and reported as expense in the financial statements over the requisite service
period. Additional disclosures related to stock-based compensation are included in Note 13.
Estimates and Assumptions
The preparation of financial statements in conformity with generally accepted accounting principles in the United States
requires management to make estimates and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.
Accounting Pronouncements
Effective April 1, 2013, Universal adopted Financial Accounting Standards Board ("FASB") Accounting Standards Update
2013-02, “Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive
Income” ("ASU 2013-02"). The guidance in ASU 2013-02 requires companies to report the effect of significant reclassifications out
of accumulated other comprehensive income (loss) on the respective line items in net income unless the amounts are not reclassified
in their entirety to net income. For amounts that are not reclassified in their entirety to net income in the same reporting period,
companies are required to cross-reference other disclosures that provide additional detail about those amounts. Since the guidance
requires additional disclosures only, it did not have any impact on the Company's results of operations, cash flows, or financial
position. The required disclosures are provided in Note 16.
In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU
2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting
principles (“U.S. GAAP”). ASU 2014-09 was developed under a joint project with the International Accounting Standards Board
(“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting
Standards. Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are
transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.
The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.
47
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management
judgment and involve more estimates than the current guidance. ASU 2014-09 is effective for annual periods beginning after
December 15, 2016, including all interim periods within the year of adoption. However, the FASB has recently proposed a one-year
deferral of the effective date. Companies are allowed to select between two transition methods: (1) a full retrospective transition
method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method
that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures. Assuming
the proposed one-year deferral of the effective date is issued by the FASB as expected, Universal would expect to adopt ASU 2014-09
effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019. The Company is currently evaluating the
impact that the adoption of ASU 2014-09 will have on its consolidated financial statements and has not made any decision on the
method of adoption.
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year’s presentation.
NOTE 2. RESTRUCTURING COSTS
During the three fiscal years ended March 31, 2015, Universal recorded restructuring costs related to various initiatives
to adjust certain operations and reduce costs. For all three fiscal years, the restructuring costs incurred primarily related to operations
that are part of the Other Regions reportable segment of the Company's flue-cured and burley leaf tobacco operations.
Fiscal Year Ended March 31, 2015
During fiscal year 2015, the Company recorded restructuring costs totaling $4.9 million, primarily related to downsizing
certain functions at its operations in Brazil and a decision to suspend its operations in Argentina effective December 31, 2014. The
decision to discontinue the Argentina operations involved costs for employee termination benefits, as well as costs to exit the
Company's business arrangements with a supplier. The remaining restructuring costs primarily related to other downsizing efforts
at several locations around the Company.
Fiscal Year Ended March 31, 2014
In fiscal year 2014, the Company's operating subsidiary in Brazil closed a factory and centralized all tobacco processing
activities in its primary facility. In connection with this initiative, the Company incurred restructuring costs of approximately $4.0
million, including employee termination benefits, costs to relocate personnel and equipment to the main facility, and lease exit costs
on the building that housed the closed operations. The remaining costs primarily related to voluntary early retirement arrangements
at several locations around the Company.
Fiscal Year Ended March 31, 2013
During fiscal year 2013, the Company recorded restructuring costs totaling $4.1 million, primarily related to workforce
reductions in one of the Company's operations in Africa.
A summary of the restructuring costs incurred during the fiscal years ended March 31, 2015, 2014, and 2013, is as follows:
Employee termination benefits ..........................................................................................
Other restructuring costs ....................................................................................................
Total restructuring costs incurred...................................................................................
$
$
4,354
$
3,743
$
536
3,003
4,890
$
6,746
$
4,113
—
4,113
Fiscal Years Ended March 31,
2015
2014
2013
48
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years
2013 through 2015 is as follows:
Employee
Termination
Benefits
Other Costs
Total
Balance at April 1, 2012........................................................................................................
$
1,271
$
291
$
1,562
Fiscal Year 2013 Activity:
Costs charged to expense...................................................................................................
Payments............................................................................................................................
Balance at March 31, 2013....................................................................................................
Fiscal Year 2014 Activity:
Costs charged to expense...................................................................................................
Payments............................................................................................................................
Balance at March 31, 2014....................................................................................................
Fiscal Year 2015 Activity:
Costs charged to expense...................................................................................................
Payments............................................................................................................................
4,113
(5,002)
382
3,743
(2,099)
2,026
4,354
(5,684)
—
(291)
—
3,003
(2,843)
160
536
(498)
Balance at March 31, 2015....................................................................................................
$
696
$
198
$
4,113
(5,293)
382
6,746
(4,942)
2,186
4,890
(6,182)
894
The majority of the restructuring liability at March 31, 2015 will be paid in the early part of fiscal year 2016. Universal
continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business
changes. The Company may incur additional restructuring costs in future periods as business changes occur and additional cost
savings initiatives are implemented.
49
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 3. EUROPEAN COMMISSION FINES AND OTHER LEGAL AND TAX MATTERS
European Commission Fines in Italy
In 2002, the Company reported that it was aware that the European Commission (the "Commission") was investigating
certain aspects of the leaf tobacco markets in Italy. One of the Company's subsidiaries, Deltafina, S.p.A. ("Deltafina"), buys and
processes tobacco in Italy. The Company reported that it did not believe that the Commission investigation in Italy would result in
penalties being assessed against it or its subsidiaries that would be material to the Company’s earnings. The reason the Company
held this belief was that it had received conditional immunity from the Commission because Deltafina had voluntarily informed the
Commission of the activities that were the basis of the investigation.
On December 28, 2004, the Company received a preliminary indication that the Commission intended to revoke Deltafina’s
immunity for disclosing in April 2002 that it had applied for immunity. Neither the Commission’s Leniency Notice of February 19,
2002, nor Deltafina’s letter of provisional immunity, contains a specific requirement of confidentiality. The potential for such
disclosure was discussed with the Commission in March 2002, and the Commission never told Deltafina that disclosure would affect
Deltafina’s immunity. On November 15, 2005, the Company received notification from the Commission that the Commission had
imposed fines totaling €30 million on Deltafina and the Company jointly for infringing European Union antitrust law in connection
with the purchase and processing of tobacco in the Italian raw tobacco market. In January 2006, the Company and Deltafina each
filed appeals in the General Court of the European Union ("General Court"). Deltafina’s appeal was held on September 28, 2010.
For strategic reasons related to the defense of the Deltafina appeal, Universal withdrew its appeal. On September 9, 2011, the General
Court issued its decision, in which it rejected Deltafina’s application to reinstate immunity. Deltafina appealed the decision of the
General Court to the European Court of Justice, and a hearing was held in November 2012. Effective with the September 9, 2011
General Court decision, the Company recorded a charge for the full amount of the fine (€30 million) plus accumulated interest (€5.9
million). The charge totaled $49.1 million at the exchange rate in effect on the date of the General Court decision. Deltafina previously
provided the Commission a bank guarantee in the amount of the fine plus accumulated interest in order to stay execution during the
appeals process. In January 2013, the guarantee was fully collateralized with a bank deposit. On June 12, 2014, the European Court
of Justice issued its final decision on the matter, in which it rejected Deltafina's application to reinstate immunity. Deltafina and the
Company paid the final amount of the fine and interest, approximately €38.9 million ($53.0 million), before June 30, 2014. Upon
payment, the bank guarantee was terminated and the related deposit was returned. The payment of the fine and interest did not have
a material impact on the Company's or Deltafina's operations.
Other Legal and Tax Matters
In addition to the above-mentioned matter, various subsidiaries of the Company are involved in other litigation and tax
examinations incidental to their business activities, including the assessments disclosed in Note 14 related to inter-state value added
taxes in Brazil. While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the
matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial
position. However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the
effect on the Company’s results of operations for a particular fiscal reporting period could be material.
50
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 4. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
(in thousands, except share and per share data)
Basic Earnings Per Share
Numerator for basic earnings per share
Fiscal Year Ended March 31,
2015
2014
2013
Net income attributable to Universal Corporation ........................................................................... $
114,608
$
149,009
$
132,750
Less: Dividends on convertible perpetual preferred stock ..............................................................
(14,824)
(14,850)
(14,850)
Less: Cost in excess of carrying value on repurchases of convertible perpetual preferred stock ....
(36)
—
—
Earnings available to Universal Corporation common shareholders for
calculation of basic earnings per share .............................................................................................
99,748
134,159
117,900
Denominator for basic earnings per share
Weighted average shares outstanding...............................................................................................
23,035,920
23,238,978
23,354,793
Basic earnings per share ................................................................................................................... $
4.33
$
5.77
$
5.05
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders ............................................... $
99,748
$
134,159
$
117,900
Add: Dividends on convertible perpetual preferred stock (if conversion assumed) .......................
14,824
14,850
14,850
Add: Cost in excess of carrying value on repurchases of convertible perpetual preferred stock....
36
—
—
Earnings available to Universal Corporation common shareholders for
calculation of diluted earnings per share ..........................................................................................
114,608
149,009
132,750
Denominator for diluted earnings per share
Weighted average shares outstanding...............................................................................................
23,035,920
23,238,978
23,354,793
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock............................................................................................
4,843,309
4,821,557
4,796,813
Employee share-based awards .......................................................................................................
342,035
331,498
326,452
Denominator for diluted earnings per share .....................................................................................
28,221,264
28,392,033
28,478,058
Diluted earnings per share................................................................................................................ $
4.06
$
5.25
$
4.66
For the fiscal years ended March 31, 2015, 2014, and 2013, the Company had the following potentially dilutive securities
(stock appreciation rights) outstanding that were not included in the computation of diluted earnings per share because their effect
would have been antidilutive:
Potentially dilutive securities ...............................................................................................
156,200
169,000
Weighted-average exercise price.......................................................................................... $
61.83
$
62.66
$
169,000
62.66
Fiscal Year Ended March 31,
2015
2014
2013
51
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 5. INCOME TAXES
The Company is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can
affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective
income tax rate is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate
changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.
Income Tax Expense
Income taxes for the fiscal years ended March 31, 2015, 2014, and 2013 consisted of the following:
Fiscal Year Ended March 31,
2015
2014
2013
Current
United States ..................................................................................................................... $
4,126
$
1,433
$
(3,465)
State and local ...................................................................................................................
Foreign ..............................................................................................................................
Deferred
United States .....................................................................................................................
State and local ...................................................................................................................
Foreign ..............................................................................................................................
657
46,885
51,668
3,352
159
(17,173)
(13,662)
507
75,770
77,710
1,686
275
(4,136)
(2,175)
Total................................................................................................................................ $
38,006
$
75,535
$
682
57,355
54,572
1,746
279
9,769
11,794
66,366
Foreign taxes include U.S. tax expense on earnings of foreign subsidiaries. The Company has no undistributed earnings
of consolidated foreign subsidiaries that are classified as permanently reinvested.
Consolidated Effective Income Tax Rate
A reconciliation of the statutory U.S. federal rate to the Company’s effective income tax rate is as follows:
Fiscal Year Ended March 31,
2015
2014
2013
Statutory tax rate ...................................................................................................................
35.0%
35.0%
35.0%
State income taxes, net of federal benefit .............................................................................
Dividends received from deconsolidated operations ............................................................
Effect of exchange rate changes on deferred income taxes ..................................................
Tax benefit arising from payment of a portion of the European Commission fine by a
subsidiary ..............................................................................................................................
Other, including changes in liabilities recorded for uncertain tax positions.........................
0.3
(1.3)
(4.9)
(5.0)
(0.1)
0.2
(0.9)
(1.0)
—
(0.6)
0.3
(1.5)
(1.0)
—
(0.8)
Effective income tax rate ......................................................................................................
24.0%
32.7%
32.0%
During the first quarter of fiscal year 2015, the Company recorded a consolidated income tax benefit of $8 million arising
from the ability of its subsidiary, Deltafina S.p.A., to pay a significant portion of the European Commission fine and related interest
charges in Italy that were settled during that quarter following the unsuccessful appeal of the case involving anti-competitive activities
in the Italian tobacco market (see Note 3). Deltafina and Universal Corporation were jointly liable for the amounts imposed by the
European Commission. The Company’s initial accrual of the fine and interest in September 2011 assumed that the entire obligation
would be paid by Universal Corporation due to uncertainty with respect to Deltafina’s financial capacity to bear any significant
portion of the cost upon the eventual settlement and to uncertainty as to when the payment would be made. Deltafina ultimately
was able to assume responsibility for approximately $30 million of the total $53 million obligation for the fine and interest when
those amounts were paid. Although the portion of the fine paid by Deltafina is not deductible for income tax purposes in Italy, it
reduced the subsidiary’s cumulative undistributed earnings and the associated consolidated tax liability, resulting in the $8 million
52
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
benefit in the Company's consolidated income tax provision. This discrete item reduced the effective income tax rate for fiscal year
2015 by 5.0%.
Components of Income Before Income Taxes and Other Items
The U.S. and foreign components of income before income taxes and other items were as follows:
Fiscal Year Ended March 31,
2015
2014
2013
United States ........................................................................................................................ $
27,181 $
9,156 $
(4,161)
Foreign .................................................................................................................................
131,286
221,534
211,446
Total................................................................................................................................... $
158,467 $
230,690 $
207,285
Deferred Income Tax Liabilities and Assets
Significant components of deferred tax liabilities and assets were as follows:
March 31,
2015
2014
Liabilities
Foreign withholding taxes................................................................................................................................. $
34,339 $
Undistributed earnings ......................................................................................................................................
Goodwill ...........................................................................................................................................................
All other ............................................................................................................................................................
14,510
30,851
8,922
Total deferred tax liabilities......................................................................................................................... $
88,622
$
Assets
Employee benefit plans..................................................................................................................................... $
50,977 $
Reserves and accruals .......................................................................................................................................
Deferred income................................................................................................................................................
Currency translation losses of foreign subsidiaries...........................................................................................
Local currency exchange losses of foreign subsidiaries ...................................................................................
All other ............................................................................................................................................................
14,039
5,387
12,167
10,674
9,607
Total deferred tax assets...............................................................................................................................
102,851
Valuation allowance..........................................................................................................................................
(629)
Net deferred tax assets ................................................................................................................................. $
102,222 $
30,147
23,865
30,851
12,471
97,334
40,816
32,248
4,013
—
207
8,612
85,896
(1,252)
84,644
At March 31, 2015, the Company had no material net operating loss carryforwards in either its domestic or foreign operations.
53
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Combined Income Tax Expense (Benefit)
The combined income tax expense (benefit) allocable to continuing operations, other comprehensive income, and direct
adjustments to shareholders' equity was as follows:
Fiscal Year Ended March 31,
2015
2014
2013
Continuing operations........................................................................................................... $
38,006
$
75,535
$
Other comprehensive income ...............................................................................................
(21,900)
22,190
Direct adjustments to shareholders' equity ...........................................................................
(932)
(972)
Total................................................................................................................................ $
15,174 $
96,753 $
66,366
2,600
(1,052)
67,914
Uncertain Tax Positions
A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions for the fiscal years
ended March 31, 2015, 2014 and 2013, is as follows:
Fiscal Year Ended March 31,
2015
2014
2013
Liability for uncertain tax positions, beginning of year ....................................................... $
3,809
$
5,385
$
7,913
Additions:
Related to tax positions for the current year ......................................................................
Related to tax positions for prior years ..............................................................................
Reductions:
Due to settlements with tax jurisdictions ...........................................................................
Due to lapses of statutes of limitations ..............................................................................
Related to tax positions for prior years ..............................................................................
Effect of currency rate movement......................................................................................
272
—
—
(478)
(143)
(566)
194
168
—
(1,776)
—
(162)
Liability for uncertain tax positions, end of year.................................................................. $
2,894
$
3,809
$
191
—
(66)
(2,339)
—
(314)
5,385
Of the total liability for uncertain tax positions at March 31, 2015, approximately $2.2 million could have an effect on the
consolidated effective tax rate if the tax benefits are recognized. The liability for uncertain tax positions includes $0.2 million related
to tax positions for which it is reasonably possible that the amounts could change significantly before March 31, 2016. This amount
reflects a possible decrease in the liability for uncertain tax positions that could result from the completion and resolution of tax
audits and the expiration of open tax years in various tax jurisdictions.
The Company recognizes accrued interest related to uncertain tax positions as interest expense, and it recognizes penalties
as a component of income tax expense. Amounts accrued or reversed for interest and penalties were not material for any of the fiscal
years 2013 through 2015, and liabilities recorded for interest and penalties at March 31, 2015 and 2014 also were not material.
Universal and its subsidiaries file a U.S. federal consolidated income tax return, as well as returns in several U.S. states and
a number of foreign jurisdictions. As of March 31, 2015, the Company's earliest open tax year for U.S. federal income tax purposes
was its fiscal year ended 2012. Open tax years in state and foreign jurisdictions generally range from 3 to 6 years.
54
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 6. CREDIT FACILITIES
Bank Credit Agreements
In December 2014, the Company entered into a new senior unsecured bank credit agreement that replaced its previous short-
term and long-term borrowing facilities, consolidating and extending the maturities of those facilities. The new bank credit agreement
established a $430 million five-year revolving credit facility, along with a $150 million five-year term loan and a $220 million seven-
year term loan. Borrowings under the revolving credit facility bear interest at a variable rate based on either (1) LIBOR plus a margin
that is based on the Company's credit measures or (2) the higher of the federal funds rate plus 0.5%, prime rate, or one-month LIBOR
plus 1.0%, each plus a margin. In addition to interest, the Company pays a facility fee on the revolving credit facility. No amounts
were outstanding under the revolving credit facility at March 31, 2015. The new credit agreement provides for an expansion of the
facility under certain conditions to allow additional borrowings of up to $100 million. Additional information related to the term
loans is provided in Note 7. The credit agreement includes financial covenants that require the Company to maintain a minimum
level of tangible net worth and observe limits on debt levels. The Company was in compliance with those covenants at March 31,
2015.
Short-Term Credit Facilities
The Company maintains short-term uncommitted lines of credit in the United States and in a number of foreign countries.
Foreign borrowings are generally in the form of overdraft facilities at rates competitive in the countries in which the Company
operates. Generally, each foreign line is available only for borrowings related to operations of a specific country. As of March 31,
2015 and 2014, approximately $60 million and $63 million, respectively, were outstanding under these uncommitted lines of credit.
The weighted-average interest rates on short-term borrowings outstanding as of March 31, 2015 and 2014, were approximately 2.7%
and 3.5%, respectively. At March 31, 2015, the Company and its consolidated affiliates had unused uncommitted lines of credit
totaling approximately $328 million.
NOTE 7. LONG-TERM OBLIGATIONS
The Company's long-term obligations at March 31, 2015 and 2014 consisted of the following:
March 31,
2015
2014
Senior bank term loans ...................................................................................................................................... $
370,000 $
175,000
Amortizing senior bank term loan.....................................................................................................................
Medium-term notes ...........................................................................................................................................
—
—
Total outstanding ...........................................................................................................................................
370,000
81,250
100,000
356,250
Less: current portion..........................................................................................................................................
—
(116,250)
Long-term obligations ................................................................................................................................... $
370,000 $
240,000
As discussed in Note 6, the Company entered into a new bank credit agreement in December 2014 that established a $150
million five-year term loan and a $220 million seven-year term loan. Both term loans were fully funded at closing, and the Company
concurrently repaid approximately $250 million aggregate principal amount on term loans outstanding under two previous bank
credit facilities and reduced its revolving credit borrowings by approximately $120 million. The term loans require no amortization
and are prepayable without penalty prior to maturity. Under the credit agreement, both term loans bear interest at variable rates plus
a margin based on the Company's credit measures. However, immediately following closing on the term loans, the Company entered
into receive-floating / pay-fixed interest rate swap agreements that convert the variable benchmark rate on both loans to a fixed rate
over their full terms to maturity. With the swap agreements in place, the effective interest rate on the $150 million five-year loan
and the $220 million seven-year loan were 2.94% and 3.48%, respectively, at March 31, 2015. Those effective rates will change
only if a change in the Company's credit measures results in adjustments to the applicable credit spreads specified in the underlying
loan agreement. The $150 million five-year term loan matures in fiscal year 2020, and the $220 million seven-year term loan matures
in fiscal year 2022.
As noted above, prior to entering into the new bank credit agreement, the Company had an amortizing term loan and a non-
amortizing term loan outstanding under two previous bank credit agreements, as well as $100 million in outstanding medium-term
public notes. The medium-term notes were repaid at maturity in December 2014, and the term loans were repaid upon funding of
the two new term loans, also in December 2014. The Company terminated its $74 million notional amount receive-floating / pay-
fixed interest rate swap agreements on the amortizing term loan upon repayment and paid the $0.6 million fair value of those swaps
to the counterparties. The swap termination cost was recorded in interest expense.
55
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
In November 2014, the Company filed an undenominated universal shelf registration statement with the U.S. Securities
and Exchange Commission to provide for the future issuance of an undefined amount of additional debt or equity securities as
determined by the Company and offered in one or more prospectus supplements prior to issuance.
Disclosures about the fair value of long-term obligations are provided in Note 10.
NOTE 8. LEASES
The Company’s subsidiaries lease various production, storage, distribution, and other facilities, as well as vehicles and
equipment used in their operations. Some of the leases have options to extend the lease term at market rates. These arrangements
are classified as operating leases for accounting purposes. Rent expense on operating leases totaled $15.8 million in fiscal year 2015,
$18.2 million in fiscal year 2014, and $19.3 million in fiscal year 2013. Future minimum payments under non-cancelable operating
leases total $10.8 million in 2016, $7.8 million in 2017, $6.2 million in 2018, $4.3 million in 2019, $3.4 million in 2020, and $8.0
million after 2020.
NOTE 9. DERIVATIVES AND HEDGING ACTIVITIES
Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two
specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering
into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign
currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign
currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local
borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide
additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities
on the consolidated statements of income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash
flows associated with all of these activities are reported in net cash provided by operating activities.
Cash Flow Hedging Strategy for Interest Rate Risk
In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated
and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates
on two outstanding non-amortizing bank term loans that were funded as part of a new bank credit facility in December 2014 (see
Note 7). Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps
is evaluated on a quarterly basis. At March 31, 2015, the total notional amount of the interest rate swaps was $370 million, which
corresponded with the aggregate outstanding balance of the term loans.
Previously, the Company had receive-floating/pay-fixed interest rate swap agreements that were designated and qualified
as cash flow hedges on an amortizing bank term loan that was repaid concurrent with closing on the new bank credit facility. Those
swap agreements, which had an aggregate notional amount of approximately $74 million reflecting the principal balance outstanding
on the loan, were terminated upon repayment of the debt. The fair value of the swap agreements, approximately $0.6 million, was
paid to the counterparties upon termination and charged to expense.
Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related
Processing Costs
The majority of the tobacco production in most countries outside the United States where Universal operates is sold in
export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such
as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S.
dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco.
From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that
coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability
of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This
hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional
amount of forward contracts entered for these purposes during fiscal years 2015, 2014, and 2013 was as follows:
(in millions)
Fiscal Year Ended March 31,
2015
2014
2013
Tobacco purchases ...............................................................................................................
$
105.6
$
126.1
$
Processing costs ...................................................................................................................
22.9
26.8
Total..................................................................................................................................
$
128.5
$
152.9
$
158.9
34.3
193.2
56
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
All contracts related to tobacco purchases were designated and qualify as hedges of the future cash flows associated with
the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any
early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive
income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts
related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in
earnings on a mark-to-market basis.
For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at March 31, 2015, the
Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2016. At March 31,
2015, all hedged forecast purchases of tobacco not yet completed remained probable of occurring within the originally designated
time period and, as a result, no hedges had been discontinued. Purchases of the 2015 crop are expected to be completed by August
2015, and all forward contracts to hedge those purchases will mature and be settled by that time.
Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of
Foreign Subsidiaries
Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of
their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These
subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency.
Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers
and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and
liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that
the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets
or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most
common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the
local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated
on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure
to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future
dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses
on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting
period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for
the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are
generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and
new contracts are entered as necessary throughout the year to replace previous contracts as they mature. The Company is currently
using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil. The total notional amounts of
contracts outstanding at March 31, 2015 and 2014, were approximately $80.4 million and $65.9 million, respectively. To further
mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing
during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s
net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities and thus
hedging a portion of the overall position.
Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating
requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting
purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional
currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period
of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not
designated as hedges for accounting purposes.
57
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Effect of Derivative Financial Instruments on the Consolidated Statements of Income
The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements
of income for the fiscal years ended March 31, 2015, 2014, and 2013.
Fiscal Year Ended March 31,
2015
2014
2013
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss............................................
Gain (loss) reclassified from accumulated other comprehensive loss into earnings .............
$
$
(4,044) $
(142) $
(1,470)
(1,929) $
(886) $
(910)
Location of gain (loss) reclassified from accumulated other comprehensive loss into
earnings ................................................................................................................................
Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings.........................................................................................
$
— $
— $
—
Location of gain (loss) recognized in earnings ......................................................................
Selling, general and administrative expenses
Hedged Item
Description of hedged item.......................................................................................................
Floating rate interest payments on term loans
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss............................................
Gain (loss) reclassified from accumulated other comprehensive
loss into earnings....................................................................................................................
$
$
1,410
3,099
$
$
(1,635) $
(8,709)
(3,844) $
(8,741)
Location of gain (loss) reclassified from accumulated other
comprehensive loss into earnings ..........................................................................................
Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings.........................................................................................
$
257
$
(1,839) $
(1,325)
Location of gain (loss) recognized in earnings ......................................................................
Selling, general and administrative expenses
Hedged Item
Description of hedged item......................................................................................................
Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges -
Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings.........................................................................................
$
13,178
$
(6,609) $
(3,115)
Location of gain (loss) recognized in earnings ......................................................................
Selling, general and administrative expenses
For the interest rate swap agreements designated as cash flow hedges, the effective portion of the gain or loss on the derivative
is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative
expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net
hedge loss of approximately $0.3 million remained in accumulated other comprehensive loss at March 31, 2015. That balance reflects
net losses on contracts related to the 2015 crop. No hedged purchases of 2015 crop tobaccos had been completed and no hedge gain
or loss had been reclassified to earnings at March 31, 2015. The majority of the balance in the accumulated other comprehensive
loss will be recognized in earnings as a component of cost of goods sold in fiscal year 2016 as the 2015 Brazilian crop tobacco is
sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change
in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins
on the sale of the tobacco will not be significantly affected.
58
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Effect of Derivative Financial Instruments on the Consolidated Balance Sheets
The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets
at March 31, 2015 and 2014:
Derivatives Designated as Hedging
Instruments
Interest rate swap agreements
Forward foreign currency exchange contracts
Total
Derivatives Not Designated as Hedging
Instruments
Forward foreign currency exchange contracts
Total
Derivatives in a Fair Value
Asset Position
Derivatives in a Fair Value
Liability Position
Balance
Sheet
Location
Fair Value as of March 31,
2015
2014
Other
non-current
assets
Other
current
assets
Other
current
assets
$
— $
—
106
$
106
$
1,731
1,731
$
$
5,148
5,148
$
$
343
343
Balance
Sheet
Location
Other
long-term
liabilities
Accounts
payable and
accrued
expenses
Accounts
payable and
accrued
expenses
Fair Value as of March 31,
2015
2014
$
3,050
$
936
396
$
3,446
$
13
949
$
$
183
183
$
$
3,960
3,960
Substantially all of the Company's forward foreign exchange contracts are subject to master netting arrangements, whereby
the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a
gross basis in the consolidated balance sheets.
NOTE 10. FAIR VALUE MEASUREMENTS
Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting
guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with
deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank
loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the
determination of fair value for goodwill and long-lived assets when indicators of potential impairment are present.
Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value
is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based
on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about
the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within
the fair value hierarchy.
Level
1
2
3
Description
quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the
reporting date;
quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities
in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
unobservable inputs for the asset or liability.
In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value.
Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be
reported at fair value under current accounting guidance.
59
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
At March 31, 2015 and 2014, the Company had certain financial assets and financial liabilities that were required to be
measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified
based on how their values were determined under the fair value hierarchy:
March 31, 2015
Level 1
Level 2
Level 3
Total
Assets
Money market funds .....................................................................................
$
— $
86,552
$
— $
Trading securities associated with deferred compensation plans .................
Forward foreign currency exchange contracts ..............................................
20,692
—
—
5,254
—
—
86,552
20,692
5,254
Total financial assets measured and reported at fair value.........................
$
20,692
$
91,806
$
— $
112,498
Liabilities
Guarantees of bank loans to tobacco growers...............................................
$
— $
— $
1,695
$
Interest rate swap agreements .......................................................................
Forward foreign currency exchange contracts ..............................................
—
—
3,050
579
—
—
Total financial liabilities measured and reported at fair value ...................
$
— $
3,629
$
1,695
$
1,695
3,050
579
5,324
March 31, 2014
Level 1
Level 2
Level 3
Total
Assets
Money market funds.......................................................................................
$
— $
1,527
$
— $
Trading securities associated with deferred compensation plans...................
Forward foreign currency exchange contracts ...............................................
19,754
—
—
2,074
—
—
1,527
19,754
2,074
Total financial assets measured and reported at fair value........................
$
19,754
$
3,601
$
— $
23,355
Liabilities
Guarantees of bank loans to tobacco growers ................................................
$
— $
— $
2,270
$
Interest rate swap agreements.........................................................................
Forward foreign currency exchange contracts ...............................................
—
—
936
3,973
—
—
Total financial liabilities measured and reported at fair value ..................
$
— $
4,909
$
2,270
$
2,270
936
3,973
7,179
Money market funds
The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets,
is based on net asset value, which is computed based on amortized cost (Level 2). The fair values of these investments approximate
cost due to the short-term maturities and the high credit quality of the issuers of the underlying securities.
Trading securities associated with deferred compensation plans
Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations.
These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds
underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.
Interest rate swap agreements
The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model
matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required
in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.
60
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Forward foreign currency exchange contracts
The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted
cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant
judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2
of the fair value hierarchy.
Guarantees of bank loans to tobacco growers
The Company guarantees bank loans to tobacco growers in Brazil for crop financing and has previously guaranteed loans
to those growers for construction of curing barns and other tobacco producing assets, as well as loans to growers in Malawi for crop
financing. In the event that the farmers default on their payments to the banks, the Company would be required to perform under
the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records
the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined
using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with
the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and
includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.”
Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of
guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases
in the risk-adjusted interest rate could result in a significantly higher or lower fair value measurement. The guarantees of bank loans
to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.
A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level
3) for the fiscal years ended March 31, 2015 and 2014 is provided below.
Balance at beginning of year ..............................................................................................................................
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of
prior crop year loans from the portfolio) ............................................................................................................
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop
year loans)...........................................................................................................................................................
Change in discount rate and estimated collection period ...................................................................................
Currency remeasurement ....................................................................................................................................
Fiscal Year Ended March 31,
2015
2014
$
2,270
$
4,235
(2,392)
(7,463)
2,320
130
(654)
5,566
130
(198)
Balance at end of year.........................................................................................................................................
$
1,674
$
2,270
During the year ended March 31, 2014, additional loss provisions related to guaranteed loans in Malawi were recorded, and
payments were made to third-party banks under those guarantees.
Long-term Obligations
The fair value of the Company’s long-term obligations, including the current portion, was approximately $370 million at
March 31, 2015, and $360 million at March 31, 2014. The Company estimates the fair value of its long-term obligations using Level
2 inputs which are based upon quoted market prices for the same or similar obligations or on calculations that are based on the current
interest rates available to the Company for debt of similar terms and maturities.
61
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 11. PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Defined Benefit Plans
Description of Plans
The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and
other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service.
Plan assets consist primarily of equity and fixed income investments. The Company also sponsors defined benefit plans that provide
postretirement health and life insurance benefits for eligible U.S. employees who have attained specific age and service levels,
although postretirement life insurance benefits were discontinued for active employees during fiscal year 2015. The health benefits
are funded by the Company as the costs of those benefits are incurred. The plan design includes cost-sharing features such as
deductibles and coinsurance. The life insurance benefits are funded with deposits to a reserve account held by an insurance company.
The Company has the right to amend or discontinue its pension and other postretirement benefit plans at any time.
In the following disclosures, the term “accumulated benefit obligation” (“ABO”) represents the actuarial present value of
estimated future benefit payments earned by participants in the Company's defined benefit pension plans as of the balance sheet
date without regard to the estimated effect of future compensation increases on those benefits. The term does not apply to other
postretirement benefits. “Projected benefit obligation” refers to the projected benefit obligation (“PBO”) for pension benefits and
the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits. These amounts represent the actuarial
present value of estimated future benefit payments earned by participants in the benefit plans as of the balance sheet date. For
pension benefits, the projected benefit obligation includes the estimated effect of future compensation increases on those benefits.
Actuarial Assumptions
Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the
Company's primary defined benefit plans were as follows:
Pension Benefits
Other Postretirement Benefits
2015
2014
2013
2015
2014
2013
Discount rates:
Benefit cost for plan year...........................
Benefit obligation at end of plan year........
4.50%
3.80%
4.20%
4.50%
Expected long-term return on plan assets:
Benefit cost for plan year...........................
7.75%
8.00%
Benefit obligation at end of plan year........
7.25%
7.75%
Salary scale:
Benefit cost for plan year...........................
Benefit obligation at end of plan year........
4.50%
4.50%
5.00%
4.50%
Healthcare cost trend rate .............................
N/A
N/A
4.60%
4.20%
8.00%
8.00%
5.00%
5.00%
N/A
4.10%
3.70%
3.90%
4.30%
4.30%
4.30%
3.00%
4.30%
4.50%
4.50%
5.00%
4.50%
7.20%
7.40%
4.40%
3.90%
4.30%
4.30%
5.00%
5.00%
7.60%
Changes in the discount rates in the above table reflect prevailing market interest rates at the end of each fiscal year when
the benefit obligations are actuarially measured. The reduction in the expected long-term return on plan assets assumption from
fiscal year 2013 to fiscal year 2015 is primarily due to changes in the underlying plan assets. These changes reflect a move toward
a liability-driven investment strategy in the Company's ERISA-regulated U.S. defined benefit pension plan due to the high percentage
of retired and inactive participants in the plan and the high funded status of the plan. The healthcare cost trend rate used by the
Company is based on a study of medical cost inflation rates that is reviewed annually for continued applicability. The revised trend
assumption of 7.20% in 2015 declines gradually to 4.50% in 2028.
62
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Benefit Obligations, Plan Assets, and Funded Status
The following table reflects the changes in benefit obligations and plan assets in 2015 and 2014, as well as the funded
status of the plans at March 31, 2015 and 2014:
Pension
Benefits
March 31,
Other Postretirement
Benefits
March 31,
2015
2014
2015
2014
Actuarial present value of benefit obligation:
Accumulated benefit obligation ..................................................................... $
287,133 $
258,240
Projected benefit obligation............................................................................
288,908
259,928
$
40,863
$
41,846
Change in projected benefit obligation:
Projected benefit obligation, beginning of year ............................................. $
259,928
$
299,161
$
41,846
$
48,970
Service cost.....................................................................................................
Interest cost.....................................................................................................
Effect of discount rate change ........................................................................
Plan amendment .............................................................................................
5,099
11,215
30,744
—
Foreign currency exchange rate changes........................................................
(6,033)
Curtailment.....................................................................................................
Settlements .....................................................................................................
—
—
Other...............................................................................................................
2,879
5,190
12,223
(8,316)
(22,145)
22
—
(2,136)
(2,586)
347
1,699
2,669
—
(444)
(1,465)
—
(788)
Benefit payments............................................................................................
(14,924)
(21,485)
(3,001)
527
2,106
(2,483)
—
—
—
—
(4,282)
(2,992)
Projected benefit obligation, end of year........................................................ $
288,908
$
259,928
$
40,863
$
41,846
Change in plan assets:
Plan assets at fair value, beginning of year .................................................... $
213,282
$
205,942
$
2,535
$
2,932
Actual return on plan assets............................................................................
Employer contributions ..................................................................................
Settlements .....................................................................................................
Foreign currency exchange rate changes........................................................
Benefit payments............................................................................................
23,486
8,063
—
(5,354)
(14,924)
15,758
17,866
(2,136)
(2,663)
73
2,508
—
—
97
2,498
—
—
(21,485)
(3,001)
(2,992)
Plan assets at fair value, end of year .............................................................. $
224,553
$
213,282
$
2,115
$
2,535
Funded status:
Funded status of the plans, end of year .......................................................... $
(64,355) $
(46,646) $
(38,748) $
(39,311)
The curtailment for other postretirement benefits in fiscal year 2015 was attributable to the discontinuation of postretirement
life insurance benefits for active U.S. employees. During fiscal year 2014, the Company amended its ERISA-regulated and non-
regulated pension plans in the U.S. to change the benefit formula applied to service periods beginning January 1, 2014, to modify
early retirement factors, and to cover on a prospective basis certain employees who did not previously participate in the plans. Due
to the significance of the amendments on the benefit obligation for the plans, the Company remeasured the plan's assets and liabilities
during the quarter using actuarial assumptions that were updated as of the valuation date. The updated actuarial assumptions included
an increase in the discount rate used to calculate the benefit liability, reflecting a general rise in the market interest rates since March
31, 2013. The remeasurement resulted in a prior service benefit of approximately $22 million. During fiscal year 2014, the Company
also offered terminated participants in its ERISA-regulated U.S. defined benefit pension plan who had not yet begun receiving
monthly retirement payments the opportunity to receive a lump-sum distribution of their vested benefit. Benefit payments for fiscal
year 2014 in the above table include approximately $7.0 million paid to participants who accepted that offer.
The Company funds its non-regulated U.S. pension plan, one of its foreign pension plans, and its U.S. postretirement
medical plan on a pay-as-you-go basis as the benefit payments are incurred. Those plans account for approximately 60% of the
63
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
$64.4 million unfunded pension obligation and approximately 95% of the $38.7 million unfunded postretirement benefit obligation
shown on the funded status line in the above table at March 31, 2015.
The funded status of the Company’s plans at the end of fiscal years 2015 and 2014 was reported in the consolidated balance
sheets as follows:
Pension
Benefits
March 31,
Other Postretirement
Benefits
March 31,
2015
2014
2015
2014
Non-current asset (included in other noncurrent assets)................................... $
1,900
$
2,476
$
— $
—
Current liability (included in accounts payable and accrued expenses) ...........
(5,458)
(764)
Non-current liability (reported as pensions and other postretirement benefits)
(60,797)
(48,358)
(2,497)
(36,251)
(2,587)
(36,724)
Amounts recognized in the consolidated balance sheets .................................. $
(64,355) $
(46,646) $
(38,748) $
(39,311)
Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal
years ended March 31, 2015 and 2014, is as follows:
Pension
Benefits
March 31,
Other Postretirement
Benefits
March 31,
2015
2014
2015
2014
For plans with a projected benefit obligation in excess of plan assets:
Aggregate projected benefit obligation (PBO)............................................... $
283,070
$
254,117
$
40,863
$
41,846
Aggregate fair value of plan assets.................................................................
216,815
204,995
2,115
2,535
For plans with an accumulated benefit obligation in excess of plan
assets:
Aggregate accumulated benefit obligation (ABO).........................................
Aggregate fair value of plan assets.................................................................
281,354
216,815
243,496
195,627
N/A
N/A
N/A
N/A
Net Periodic Benefit Cost
The components of the Company’s net periodic benefit cost were as follows:
Pension Benefits
Other Postretirement Benefits
Fiscal Year Ended March 31,
Fiscal Year Ended March 31,
2015
2014
2013
2015
2014
2013
Components of net periodic benefit cost:
Service cost................................................ $
5,099
$
5,190
$
4,650
$
347
$
527
$
Interest cost................................................
11,215
12,223
13,001
Expected return on plan assets ..................
(15,493)
(14,218)
(14,632)
Curtailment gain ........................................
Settlement cost...........................................
—
—
Net amortization and deferral....................
6,169
—
1,094
6,779
—
3,304
10,299
1,699
(102)
(1,465)
—
(671)
2,106
(119)
—
—
(5)
467
2,303
(124)
—
—
(8)
Net periodic benefit cost............................ $
6,990
$
11,068
$
16,622
$
(192) $
2,509
$
2,638
A one-percentage-point increase in the assumed healthcare cost trend rate would increase the March 31, 2015 accumulated
postretirement benefit obligation by approximately $1.3 million, while a one-percentage-point decrease would reduce the benefit
obligation by approximately $1.2 million. The aggregate service and interest cost components of the net periodic postretirement
benefit expense for fiscal year 2016 would not change by a significant amount as a result of a one-percentage-point increase or
decrease in the assumed healthcare cost trend rate.
64
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Amounts Included in Accumulated Other Comprehensive Loss
Reclassification adjustments represent amounts included in accumulated other comprehensive loss at the beginning of the
year that were recognized in net periodic benefit cost during the year. The amounts recognized in other comprehensive income or
loss for fiscal years 2015 and 2014 and the amounts included in accumulated other comprehensive loss at the end of those fiscal
years are shown below. All amounts shown are before allocated income taxes.
Pension
Benefits
March 31,
Other Postretirement
Benefits
March 31,
2015
2014
2015
2014
Change in net actuarial loss (gain):
Net actuarial loss (gain), beginning of year ................................................... $
70,488
$
93,357
$
(9,952) $
Losses (gains) arising during the year............................................................
23,353
Reclassification adjustments during the year .................................................
(12,297)
Net actuarial loss (gain), end of year..............................................................
81,544
Change in prior service cost (benefit):
Prior service cost (benefit), beginning of year ...............................................
(22,998)
Prior service cost (benefit) arising during the year ........................................
Reclassification adjustments during the year .................................................
(675)
6,043
(12,834)
(10,035)
70,488
(2,617)
(22,145)
1,764
Prior service cost (benefit), end of year .........................................................
(17,630)
(22,998)
2,879
671
(3,918)
(6,039)
5
(6,402)
(9,952)
—
—
—
—
226
—
(226)
—
Total amounts in accumulated other comprehensive loss
at end of year, before income taxes ................................................................ $
63,914
$
47,490
$
(6,402) $
(9,952)
Amounts in the above table reflect the Company and its consolidated subsidiaries. The accumulated other comprehensive
loss reported in the consolidated balance sheets also includes pension and other postretirement benefit adjustments related to
ownership interests in unconsolidated affiliates. As noted above, the prior service benefit arising during fiscal year 2014 related to
an amendment to the Company's U.S. pension plans to change the benefit formula applied to service periods beginning January 1,
2014 and to modify early retirement benefit factors.
The Company expects to recognize approximately $8.4 million of the March 31, 2015 net actuarial loss and $3.4 million
of the March 31, 2015 prior service benefit in net periodic benefit cost during fiscal year 2016.
Allocation of Pension Plan Assets
The Company has established, and periodically adjusts, target asset allocations for its investments in its U.S. ERISA-
regulated defined benefit pension plan, which represents 91% of consolidated plan assets and 80% of consolidated PBO at March 31,
2015, to balance the needs of liquidity, total return, and risk control. The assets are required to be diversified across asset classes
and investment styles to achieve that balance. During the year, the asset allocation is reviewed for adherence to the target policy
and rebalanced to the targeted weights. The Company reviews the expected long-term returns of the asset allocation each year to
help determine whether changes are needed. The return is evaluated on a weighted-average basis in relation to inflation. As noted
above and reflected in the table below, the Company has changed some of the underlying assets in the plan to move toward a
liability-driven investment strategy, resulting in a reduction of the expected long-term return on assets. The assumed long-term
rate of return used to calculate annual benefit expense is based on the asset allocation and expected market returns for the respective
asset classes.
65
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
The weighted–average target pension asset allocation and target ranges at the March 31, 2015 measurement date and the
actual asset allocations at the March 31, 2015 and 2014 measurement dates by major asset category were as follows:
Major Asset Category
Target
Allocation
Actual Allocation
March 31,
Range
2015
2014
Equity securities......................................................................................
Fixed income securities (1) ......................................................................
Alternative investments ..........................................................................
26.0% 16% - 36%
69.0% 59% - 79%
5.0% 0% - 10%
25.3%
69.1%
5.6%
48.3%
41.3%
10.4%
Total...................................................................................................
100.0%
100.0%
100.0%
(1)
Actual amounts include high yield securities and cash balances held for the payment of benefits.
Universal makes regular contributions to its pension and other postretirement benefit plans. As previously noted, for
postretirement health benefits, contributions reflect funding of those benefits as they are incurred. With plan contributions and an
increase in asset values during fiscal years 2014 and 2015, the Company believes that it is in full compliance with all funding
requirements of the Pension Protection Act of 2006. The Company expects to make contributions of approximately $12.0 million
to its defined benefit pension plans in fiscal year 2016, including $5.4 million to its ERISA-regulated U.S. plan and $6.6 million
to its non-ERISA regulated and other plans.
Estimated future benefit payments to be made from the Company’s plans are as follows:
Fiscal Year
Pension
Benefits
Other
Postretirement
Benefits
2016 .................................................................................................................................................................... $
19,297
$
2017 ....................................................................................................................................................................
2018 ....................................................................................................................................................................
2019 ....................................................................................................................................................................
2020 ....................................................................................................................................................................
2021 - 2025.........................................................................................................................................................
21,040
16,957
19,853
16,875
88,195
2,925
2,944
2,880
2,921
2,904
13,789
Fair Values of Pension Plan Assets
Assets held by the Company's defined benefit pension plans primarily consist of equity securities, fixed income securities,
and alternative investments. Equity securities are primarily invested in actively-traded mutual funds with underlying common stock
investments in U.S. and foreign companies ranging in size from small to large corporations. Fixed income securities are also held
primarily through actively-traded mutual funds with the underlying investments in both U.S. and foreign securities. The
methodologies for determining the fair values of the plan assets are outlined below. Where the values are based on quoted prices
for the securities in an active market, they are classified as Level 1 of the fair value hierarchy. Where secondary pricing sources
are used, they are classified as Level 2 of the hierarchy. Pricing models that use significant unobservable inputs are classified as
Level 3.
• Equity securities: Investments in equity securities through actively-traded mutual funds are valued based on the net
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally
recognized securities exchanges. These securities are classified as Level 1
•
Fixed income securities: Fixed income investments that are held through mutual funds are valued based on the net
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally
recognized securities exchanges. These securities are classified as Level 1. Other fixed income investments are valued
at an estimated price that a dealer would pay for a similar security on the valuation date using observable market inputs
and are classified as Level 2. These market inputs may include yield curves for similarly rated securities. Small
amounts of cash are held in common collective trusts. Fixed income securities also include insurance assets, which
are valued based on an actuarial calculation. Those securities are classified as Level 3.
66
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
• Alternative investments: Real estate assets are valued using valuation models that incorporate income and market
approaches, including external appraisals, to derive fair values. The hedge fund allocation is a fund of hedge funds
and is valued by the manager based on the net asset value of each fund. These models use significant unobservable
inputs and are classified as Level 3 within the fair value hierarchy.
Fair values of the assets of the Company’s pension plans as of March 31, 2015 and 2014, classified based on how their
values were determined under the fair value hierarchy are as follows:
March 31, 2015
Level 1
Level 2
Level 3
Total
Equity securities ......................................................................................... $
Fixed income securities (1) ..........................................................................
Alternative investments..............................................................................
51,300
$
— $
— $
51,300
141,655
—
7,738
—
12,424
11,436
161,817
11,436
Total investments .................................................................................. $
192,955
$
7,738
$
23,860
$
224,553
March 31, 2014
Level 1
Level 2
Level 3
Total
Equity securities.......................................................................................... $
Fixed income securities (1) ...........................................................................
Alternative investments ..............................................................................
93,229
$
— $
— $
93,229
80,567
—
8,287
—
11,266
19,933
100,120
19,933
Total investments................................................................................... $
173,796
$
8,287
$
31,199
$
213,282
(1)
Includes high yield securities and cash and cash equivalent balances.
Other Benefit Plans
Universal and several subsidiaries offer employer defined contribution savings plans. Amounts charged to expense for
these plans were approximately $1.8 million for fiscal year 2015, $1.6 million for fiscal year 2014, and $1.5 million for fiscal year
2013.
NOTE 12. COMMON AND PREFERRED STOCK
Common Stock
At March 31, 2015, the Company’s shareholders had authorized 100,000,000 shares of its common stock, and 22,593,266
shares were issued and outstanding. Holders of the common stock are entitled to one vote for each share held on all matters requiring
a vote. Holders of the common stock are also entitled to receive dividends when, as, and if declared by the Company’s Board of
Directors. The Board of Directors customarily declares and pays regular quarterly dividends on the outstanding common shares;
however, such dividends are at the Board’s full discretion, and there is no obligation to continue them. If dividends on the Company’s
Series B 6.75% Convertible Perpetual Preferred Stock (the “Preferred Stock” or “Preferred Shares”) are not declared and paid for
any dividend period, then the Company may not pay dividends on the common stock or repurchase common shares until the dividends
on the Preferred Stock have been paid for a period of four consecutive quarters.
Preferred Stock
The Company is also authorized to issue up to 5,000,000 shares of preferred stock, 500,000 shares of which have been
reserved for Series A Junior Participating Preferred Stock and 220,000 shares of which have been reserved for Series B 6.75%
Convertible Perpetual Preferred Stock. No Series A Junior Participating Preferred Stock has been issued. In 2006, 220,000 shares
of Series B 6.75% Convertible Perpetual Preferred Stock (the “Preferred Stock” or “Preferred Shares”) were issued under this
authorization. At March 31, 2015, 218,490 shares were issued and outstanding. The Preferred Stock has a liquidation preference
of $1,000 per share. Holders of the Preferred Shares are entitled to receive quarterly dividends at the rate of 6.75% per annum on
the liquidation preference when, as, and if declared by the Company’s Board of Directors. Dividends are not cumulative in the event
the Board of Directors does not declare a dividend for one or more quarterly periods. Under the terms of the Preferred Stock, the
Board of Directors is prohibited from declaring regular dividends on the Preferred Shares in any period in which the Company fails
to meet specified levels of shareholders’ equity and net income; however, in that situation, the Board of Directors may instead declare
such dividends payable in shares of the Company’s common stock or from net proceeds of common stock issued during the ninety-
day period prior to the dividend declaration. The Preferred Shares have no voting rights, except in the event the Company fails to
67
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
pay dividends for four consecutive or non-consecutive quarterly dividend periods or fails to pay the redemption price on any date
that the Preferred Shares are called for redemption, in which case the holders of Preferred Shares will be entitled to elect two additional
directors to the Company’s Board to serve until dividends on the Preferred Stock have been fully paid for four consecutive quarters.
The Preferred Shares are convertible at any time, at the option of the holder, into shares of the Company’s common stock
at a conversion rate that is adjusted each time the Company pays a dividend on its common stock that exceeds $0.43 per share. The
conversion rate at March 31, 2015, was 22.1183 shares of common stock per preferred share, which represents a conversion price
of approximately $45.21 per common share. Upon conversion, the Company may, at its option, satisfy all or part of the conversion
value in cash.
Through March 15, 2018, the Company may, at its option, cause the Preferred Shares to be automatically converted into
shares of common stock that are issuable at the prevailing conversion rate, only if the closing price of the common stock during a
specified period exceeds 135% of the then prevailing conversion price. With this conversion, the Company may, at its option, satisfy
all or part of the conversion value in cash in lieu of delivering shares. On or after March 15, 2018, the Company may, at its option,
redeem all or part of the outstanding Preferred Shares for cash at the $1,000 per share liquidation preference.
Share Repurchase Programs
Universal’s Board of Directors has authorized programs to repurchase outstanding shares of the Company’s capital stock
(common and preferred stock). Under these programs, the Company has made and may continue to make share repurchases from
time to time in the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. Programs
have been in place continuously throughout fiscal years 2013 through 2015. The current program, which replaced an expiring
program, was authorized and became effective on November 5, 2013. It authorizes the purchase of up to $100 million of the
Company's outstanding common and/or preferred stock and expires on the earlier of November 15, 2015, or when the funds authorized
for the program have been exhausted. At March 31, 2015, $67.3 million remained available for share repurchases under the current
program.
Share repurchases under the programs for the fiscal years ended March 31, 2015, 2014, and 2013 were as follows:
Fiscal Year Ended March 31,
2015
2014
2013
Common Stock
Number of shares repurchased...............................................................................................
719,993
238,486
169,432
Cost of shares repurchased (in thousands of dollars)............................................................. $
Weighted-average cost per share............................................................................................ $
Series B 6.75% Convertible Perpetual Preferred Stock
Number of shares repurchased...............................................................................................
Cost of shares repurchased (in thousands of dollars)............................................................. $
31,227
43.37
1,509
1,497
Weighted-average cost per share............................................................................................ $
992.27
NOTE 13. EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION
$
$
$
$
14,145
59.31
$
$
8,631
50.94
—
— $
— $
—
—
—
Executive Stock Plans
The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the
Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share
awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. Currently, grants
are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, and the 2007 Stock Incentive Plan. Together,
these plans are referred to in this disclosure as the “Plans.” Up to 2 million shares of the Company’s common stock may be issued
under each of the Plans; however, direct awards of common stock, restricted stock, or RSUs are limited to 500,000 shares under the
2002 Executive Stock Plan and 1,350,000 shares under the 2007 Stock Incentive Plan.
The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting
of the Executive Compensation, Nominating, and Corporate Governance Committee of the Board of Directors (the “Compensation
Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. Since fiscal year
2006, grants have been limited to restricted stock, RSUs, PSAs, and stock-settled SARs. In fiscal years 2014 and 2015, the
Compensation Committee has awarded only grants of RSUs and PSAs. Outside directors automatically receive restricted stock units
following each annual meeting of shareholders.
68
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Non-qualified stock options and SARs granted under the Plans have an exercise price equal to the market price of a share
of common stock on the date of grant. No stock options are currently outstanding under the Plans. SARs granted under the Plans
vest in equal one-third tranches one, two, and three years after the grant date and expire 10 years after the grant date, except that
SARs granted after fiscal year 2007 expire on the earlier of 3 years after the grantee’s retirement date or 10 years after the grant date.
RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock. Under the terms
of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date
as the original RSU grant. The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting date,
and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are
dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range
from zero to 150% of the stated award. RSUs awarded to outside directors vest 3 years after the grant date, and restricted stock vests
upon the individual’s retirement from service as a director.
Stock Options and SARs
The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2013
through 2015:
Weighted-
Average
Exercise
Price
Weighted-
Average
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
Shares
Fiscal Year Ended March 31, 2013:
Outstanding at beginning of year...............................................................
855,850
$
Exercised....................................................................................................
(407,758)
Cancelled/expired ......................................................................................
Outstanding at end of year .........................................................................
(29,615)
418,477
Fiscal Year Ended March 31, 2014:
Exercised....................................................................................................
(161,137)
Outstanding at end of year .........................................................................
257,340
Fiscal Year Ended March 31, 2015:
Exercised....................................................................................................
Cancelled/expired ......................................................................................
(63,539)
(24,200)
Outstanding at end of year .........................................................................
169,601
$
46.01
41.21
54.83
50.07
42.48
54.83
38.50
62.66
59.82
2.07
$
144
Fiscal Year Ended March 31,
2015
2014
2013
Total intrinsic value of stock options and SARs exercised .................................................... $
Total fair value of SARs vested.............................................................................................. $
1,091
375
$
$
2,816
769
$
$
4,249
1,460
All of the grants outstanding at the end of fiscal year 2015 in the above tables represent SARs, all of which were exercisable
at the end of the year. Intrinsic value and aggregate intrinsic value in the tables above are based on the difference between the market
price of the underlying shares at the exercise date or balance sheet date, as applicable, and the exercise prices of the stock options
and SARs. The closing market prices used to determine the aggregate intrinsic value at the end of each fiscal year were as follows:
$47.16 at March 31, 2015, $55.89 at March 31, 2014, and $56.04 at March 31, 2013.
69
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
RSUs, Restricted Stock, and PSAs
The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2013 through 2015:
RSUs
Restricted Stock
PSAs
Weighted-
Average
Grant Date
Fair Value
Weighted-
Average
Grant Date
Fair Value
Weighted-
Average
Grant Date
Fair Value
Shares
Shares
Shares
Fiscal Year Ended March 31, 2013:
Unvested at beginning of year ..................
291,279
$
Granted......................................................
Vested........................................................
Forfeited....................................................
87,780
(86,925)
—
Unvested at end of year.............................
292,134
Fiscal Year Ended March 31, 2014:
Granted......................................................
Vested........................................................
Forfeited....................................................
70,092
(69,046)
—
Unvested at end of year.............................
293,180
Fiscal Year Ended March 31, 2015:
Granted......................................................
94,539
Vested........................................................
(123,322)
Forfeited....................................................
—
Unvested at end of year.............................
264,397
$
43.72
44.06
52.42
—
41.23
57.79
44.89
—
44.33
51.86
42.02
—
48.10
67,400
$
—
(7,550)
—
59,850
—
(11,750)
—
48,100
—
—
—
41.91
—
43.74
—
41.68
—
39.02
—
42.33
—
—
—
142,466
$
92,425
(94,725)
(5,149)
135,017
52,400
(32,464)
(5,566)
149,387
57,580
(50,092)
(3,400)
48,100
$
42.33
153,475
$
31.45
35.25
29.67
36.15
35.12
53.56
33.95
37.45
41.76
46.41
31.95
53.56
45.58
Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base
grant under the performance provisions of PSAs. Shares forfeited or canceled include any reductions from the base PSA grant under
those same performance provisions. The fair values of RSUs, restricted stock, and PSAs are based on the market price of the common
stock on the grant date.
Stock-Based Compensation Expense
Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1)
the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are
already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant.
For the fiscal years ended March 31, 2015, 2014, and 2013, total stock-based compensation expense and the related income tax
benefit recognized were as follows:
Fiscal Year Ended March 31,
2015
2014
2013
Total stock-based compensation expense ............................................................................... $
Income tax benefit recorded on stock-based compensation expense ..................................... $
6,230
2,181
$
$
6,278
2,197
$
$
6,171
2,160
At March 31, 2015, the Company had $5.3 million of unrecognized compensation expense related to stock-based awards,
which will be recognized over a weighted-average period of approximately 1.3 years. Cash proceeds from the exercise of stock
options were $3.9 million for the fiscal year ended March 31, 2013, and were not material for the fiscal years ended March 31, 2014
or 2015.
70
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 14. COMMITMENTS AND OTHER MATTERS
Commitments
The Company enters into contracts to purchase tobacco from farmers in a number of the countries in which it operates.
Contracts in most countries cover one annual growing season, but current contracts with some farmers in Brazil and the United States
cover more than one year. Primarily with the farmer contracts in Brazil, Malawi, Mozambique, Zambia, the Philippines, Guatemala,
and Mexico, the Company provides seasonal financing to support the farmers’ production of their crops or guarantees their financing
from third-party banks. At March 31, 2015, the Company had contracts to purchase approximately $555 million of tobacco to be
delivered during the coming fiscal year and $336 million of tobacco to be delivered in subsequent years. These amounts are estimates
since actual quantities purchased will depend on crop yields, and prices will depend on the quality of the tobacco delivered and other
market factors. Tobacco purchase obligations have been partially funded by advances to farmers and other suppliers, which totaled
approximately $115 million, net of allowances, at March 31, 2015. The Company withholds payments due to farmers on delivery
of the tobacco to satisfy repayment of the financing it provided to the farmers. As noted above and discussed in more detail below,
the Company also has arrangements to guarantee bank loans to farmers in Brazil, and payments are also withheld on delivery of
tobacco to satisfy repayment of those loans. In addition to its contractual obligations to purchase tobacco, the Company had
commitments related to agricultural materials, approved capital expenditures, and various other requirements that approximated $66
million at March 31, 2015.
Guarantees and Other Contingent Liabilities
Guarantees of Bank Loans and Other Contingent Liabilities
Guarantees of bank loans to growers for crop financing and construction of curing barns or other tobacco producing assets
have long been industry practice in Brazil and support the farmers’ production of tobacco there. During fiscal year 2013, similar
arrangements were established in Malawi in connection with a shift from auction market sourcing to direct procurement in that
country, but those arrangements were not continued for subsequent crops. At March 31, 2015, the Company’s total exposure under
guarantees issued by its operating subsidiary for banking facilities of farmers in Brazil was approximately $15 million ($17 million
face amount including unpaid accrued interest, less $2 million recorded for the fair value of the guarantees). All of these guarantees
expire within one year. As noted above, the subsidiary withholds payments due to the farmers on delivery of tobacco and forwards
those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover their
obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case,
the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s
subsidiary could be required to make at March 31, 2015, was the face amount, $17 million including unpaid accrued interest ($22
million as of March 31, 2014). The fair value of the guarantees was a liability of approximately $2 million at March 31, 2015 ($2
million at March 31, 2014). In addition to these guarantees, the Company has other contingent liabilities totaling approximately $2
million at March 31, 2015.
Value-Added Tax Assessments in Brazil
As discussed in Note 1, the Company's local operating subsidiaries pay significant amounts of value-added tax ("VAT") in
connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between
states. The Company's operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are
transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional
VAT plus interest and penalties from the tax authorities for the States of Santa Catarina and Parana based on audits of the subsidiary's
VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest,
and penalties for periods from 2006 through 2009 totaling approximately $15 million based on the exchange rate for the Brazilian
currency at March 31, 2015. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and
penalties for periods from 2009 through 2014 totaling approximately $17 million based on the exchange rate at March 31, 2015.
Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in
determining all or significant portions of these assessments and that various defenses support the subsidiary's positions.
With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims.
As of March 31, 2015, a portion of the subsidiary's arguments had been accepted, and the outstanding assessments had been reduced
to approximately $12 million (at the March 31, 2015 exchange rate). The subsidiary is continuing to contest the full remaining
amount of the assessment. While the range of reasonably possible loss is zero up to the full $12 million remaining assessment, based
on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been
recorded at March 31, 2015.
With respect to the Parana assessment, management of the subsidiary and outside counsel have undertaken the steps required
to contest the full amount of the claim. A significant portion of the Parana assessment is based on positions taken by the tax authorities
that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition,
71
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
under the law, the subsidiary's tax filings for certain periods covered in the assessment were no longer open to any challenge by the
tax authorities. On that basis, the range of reasonably possible loss is considered to be zero up to a maximum of $14 million, rather
than the full amount of the assessment. Based on the strength of the subsidiary's defenses, no loss within that range is considered
probable at this time and no liability has been recorded at March 31, 2015.
In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is
not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest,
or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.
Major Customers
A material part of the Company’s business is dependent upon a few customers. The Company's five largest customers are
Philip Morris International, Inc., Imperial Tobacco Group, PLC, British American Tobacco, PLC, China Tobacco International, Inc.,
and Japan Tobacco, Inc. In the aggregate, these customers have accounted for more than 60% of consolidated revenue for each of
the past three fiscal years. For the fiscal years ended March 31, 2015, 2014, and 2013, revenue from Philip Morris International,
Inc. was approximately $580 million, $590 million, and $550 million, respectively. For the same periods, Imperial Tobacco Group,
PLC accounted for revenue of approximately $280 million, $340 million, and $330 million, respectively. These customers primarily
do business with various affiliates in the Company’s flue-cured and burley leaf tobacco operations. The loss of, or substantial
reduction in business from, any of these customers could have a material adverse effect on the Company.
Accounts Receivable
The Company’s operating subsidiaries perform credit evaluations of customers’ financial condition prior to the extension
of credit. Generally, accounts receivable are unsecured and are due within 30 days. When collection terms are extended for longer
periods, interest and carrying costs are usually recovered. Credit losses are provided for in the financial statements, and historically
such amounts have not been material. The allowance for doubtful accounts was approximately $5 million and $7 million at March 31,
2015 and 2014, respectively. At March 31, 2015 and 2014, net accounts receivable by reportable operating segment were as follows:
March 31,
2015
2014
Flue-Cured and Burley Leaf Tobacco Operations:
North America................................................................................................................................................. $
38,046
$
64,195
Other Regions .................................................................................................................................................
Subtotal .......................................................................................................................................................
Other Tobacco Operations ..................................................................................................................................
350,122
388,168
46,194
362,146
426,341
41,674
Consolidated accounts receivable, net ................................................................................................................ $
434,362
$
468,015
Favorable Outcome of IPI Tax Credit Case in Brazil
During the quarter ended June 30, 2013, a longstanding lawsuit related to IPI tax credits filed by the Company's operating
subsidiary in Brazil was concluded in the subsidiary's favor with a decision by the Brazilian Superior Court of Justice on the final
appeal filed by the Brazilian federal government. Although additional appeals by the government were expected in the case, the
time period to file those appeals expired before the end of the quarter, and the decision and overall outcome of the case were confirmed.
IPI tax credits were established under Brazilian tax laws to allow recovery of a portion of the excise taxes paid on
manufactured products when those products are sold in export markets. In prior years, the subsidiary paid excise taxes on the
component cost of unprocessed tobacco purchased from growers, as well as the cost of electricity, packing materials, and other inputs
used in its manufacturing process. Under the law, the subsidiary believed it was entitled to use IPI tax credits to recover excise taxes
on the processed tobacco it exported. However, specific regulations issued by the Brazilian tax authorities did not permit the subsidiary
to claim those credits. The suit filed by the subsidiary challenged the denial of the tax credits based on the law. Several decisions
in lower courts were decided in the subsidiary's favor for a portion of the tax credits claimed in the suit, but those decisions were
appealed on various grounds by both the government and the subsidiary. The expiration of the appeal period ended the matter in the
courts.
The final court decision entitled the subsidiary to approximately $104 million of IPI tax credits (based on the exchange rate
at the date of the decision), which can be used to offset future payments of other Brazilian federal taxes for a period of up to five
years. That amount includes the tax credits generated over the period granted by the courts, as well as interest calculated from the
date those credits should have been available to the subsidiary. As noted, the ability to use the tax credits to offset other Brazilian
federal tax payments expires five years after the subsidiary's right to claim the credits was confirmed. Utilization of the credits is
also subject to audit by the tax authorities. Based on estimates of the tax credits that were probable of being realized at the time the
72
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
case was decided, the subsidiary recorded an allowance, reducing the net book value of the credits to approximately $90 million.
After deducting related legal fees and Brazilian social contribution taxes assessed on the interest portion of the total IPI tax credits
received, the subsidiary recorded a net gain of $81.6 million ($53.1 million after tax, or $1.87 per diluted share) during the quarter
ended June 30, 2013, as a result of the favorable outcome of the case. That gain is reported in Other Income for the fiscal year ended
March 31, 2014 in the consolidated statement of income. The subsidiary began using the credits to offset tax payments during the
quarter ended December 31, 2013. At March 31, 2015, the remaining unused tax credits totaled approximately $30 million at the
current exchange rate. Actual realization of the tax credits to date, as well as updated tax payment projections prepared during the
quarter ended March 31, 2015, indicate that all remaining IPI tax credits will be fully utilized prior to expiration. On that basis, the
subsidiary reversed the full remaining valuation allowance on the credits of $12.7 million (based on the current exchange rate) during
the quarter. Consistent with the reporting of the original gain in fiscal year 2014, the reversal of the valuation allowance is reported
in Other Income for the fiscal year ended March 31, 2015 in the consolidated statement of income.
NOTE 15. OPERATING SEGMENTS
Universal’s operations involve selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for
sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating
subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates,
the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured,
burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in
the manufacture of cigars, pipe tobacco, and smokeless tobacco products. A substantial portion of the Company’s revenues are
derived from sales to a limited number of large, multinational cigarette manufacturers.
The principal approach used by management to evaluate the Company’s performance is by geographic region, although the
dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. Oriental tobacco
operations consist principally of a 49% interest in an affiliate, and the performance of those operations is evaluated based on the
Company’s equity in the pretax earnings of that affiliate. Under this structure, the Company has the following primary operating
segments: North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services. North America,
South America, Africa, Europe, and Asia are primarily involved in flue-cured and/or burley leaf tobacco operations for supply to
cigarette manufacturers. The Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe
tobacco, and smokeless tobacco products, and the Oriental business supplies oriental tobacco to cigarette manufacturers. From time
to time, the segments may trade in tobaccos that differ from their main varieties, but those activities are not significant to their overall
results. Special Services includes the Company's laboratory services business, which provides physical and chemical product testing
and smoke testing for customers, as well as its liquid nicotine joint venture and its food and vegetable ingredients business.
The five regional operating segments serving the Company’s cigarette manufacturer customer base share similar
characteristics in the nature of their products and services, production processes, class of customer, product distribution methods,
and regulatory environment. Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe,
and Asia – are aggregated into a single reporting segment, “Other Regions”, because they also have similar economic characteristics.
North America is reported as an individual operating segment because its economic characteristics differ from the other regions,
generally because its operations require lower working capital investments for crop financing and inventory. The Dark Air-Cured,
Oriental and Special Services segments, which have dissimilar characteristics in some of the categories mentioned above, are reported
together as “Other Tobacco Operations” because each is below the measurement threshold for separate reporting.
Universal incurs overhead expenses related to senior management, finance, legal, and other functions that are centralized
at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These
overhead expenses are allocated to the various operating segments, generally on the basis of tobacco volumes planned to be purchased
and/or processed. Management believes this method of allocation is representative of the value of the related services provided to
the operating segments. The Company evaluates the performance of its segments based on operating income after allocated overhead
expenses, plus equity in the pretax earnings of unconsolidated affiliates.
73
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Reportable segment data as of, or for, the fiscal years ended March 31, 2015, 2014, and 2013, is as follows:
Sales and Other Operating Revenues
Operating Income
Fiscal Year Ended March 31,
Fiscal Year Ended March 31,
2015
2014
2013
2015
2014
2013
Flue-Cured and Burley Leaf Tobacco Operations:
North America.................................................... $
305,028
Other Regions (1) ...............................................1,739,781
$
348,627
$
334,676
$
31,060
$
23,217
$
19,740
1,932,228
1,871,880
Subtotal..........................................................
Other Tobacco Operations (2) .................................
2,044,809
2,280,855
2,206,556
226,992
261,260
255,143
Segment total..........................................................
2,271,801
2,542,115
2,461,699
Deduct: Equity in pretax earnings of
unconsolidated affiliates
(3) .................
Restructuring costs (4) ..............................
Add: Other income (5) ........................................
125,839
156,899
10,326
167,225
(7,137)
(4,890)
12,676
133,447
156,664
18,511
175,175
(3,897)
(6,746)
81,619
192,556
212,296
20,461
232,757
(5,635)
(4,113)
—
Consolidated total................................................... $
2,271,801
$
2,542,115
$
2,461,699
$
167,874
$
246,151
$
223,009
Segment Assets
March 31,
Goodwill
March 31,
2015
2014
2013
2015
2014
2013
Flue-Cured and Burley Leaf Tobacco Operations:
North America.................................................... $
289,792
Other Regions (1) ...............................................1,611,083
Subtotal..........................................................
Other Tobacco Operations (2) .................................
1,900,875
1,954,682
1,978,366
297,598
316,225
327,789
$
277,028
$
295,785
$
— $
— $
1,677,654
1,682,581
97,372
97,372
1,713
97,367
97,367
1,713
—
96,667
96,667
1,713
Segment and consolidated totals ............................ $
2,198,473
$
2,270,907
$
2,306,155
$
99,085
$
99,080
$
98,380
Depreciation and Amortization
Capital Expenditures
Fiscal Year Ended March 31,
Fiscal Year Ended March 31,
2015
2014
2013
2015
2014
2013
Flue-Cured and Burley Leaf Tobacco Operations:
North America.................................................... $
Other Regions (1) ...............................................
Subtotal..........................................................
Other Tobacco Operations
(2) ................................
4,284
$
6,018
$
11,017
$
5,814
$
2,676
$
28,827
33,111
4,213
29,044
35,062
3,837
30,118
41,135
3,981
39,303
45,117
13,268
37,584
40,260
5,589
2,459
24,886
27,345
3,438
Segment and consolidated totals ............................ $
37,324
$
38,899
$
45,116
$
58,385
$
45,849
$
30,783
(1)
(2)
(3)
(4)
(5)
Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.
Includes Dark Air-Cured, Oriental, and Special Services, as well as inter-company eliminations. Sales and other operating revenues, goodwill, depreciation
and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and
its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate. The investment in the unconsolidated affiliate is included
in segment assets and was approximately $74.9 million, $93.3 million, and $91.8 million, at March 31, 2015, 2014, and 2013, respectively.
Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below
consolidated operating income and excluded from that total in the consolidated statements of income.
Restructuring costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income
(see Note 2).
Other income represents the reversal of a valuation allowance on the remaining unused balance of IPI excise tax credits in Brazil in fiscal year 2015 and the
gain on the favorable outcome of the IPI tax credit case in fiscal year 2014 (see Note 14).
74
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Geographic data as of, or for, the fiscal years ended March 31, 2015, 2014, and 2013, is presented below. Sales and other
operating revenues are attributed to individual countries based on the final destination of the shipment. Long-lived assets generally
consist of net property, plant, and equipment, goodwill, and other intangibles.
Geographic Data
Sales and Other Operating Revenues
Fiscal Year Ended March 31,
2015
2014
2013
United States............................................................................................................................................. $
290,950
$
304,527
$
324,285
Belgium ....................................................................................................................................................
China ........................................................................................................................................................
Germany ...................................................................................................................................................
Russia .......................................................................................................................................................
Poland.......................................................................................................................................................
Netherlands...............................................................................................................................................
226,562
174,872
170,338
126,652
114,765
113,297
218,550
210,956
173,872
123,114
106,443
208,031
203,539
229,112
128,144
130,906
126,826
174,481
All other countries ....................................................................................................................................
1,054,365
1,196,622
1,144,406
Consolidated total..................................................................................................................................... $
2,271,801
$
2,542,115
$
2,461,699
Long-Lived Assets
March 31,
2015
2014
2013
United States............................................................................................................................................. $
70,929
$
61,347
$
64,235
Brazil ........................................................................................................................................................
Mozambique.............................................................................................................................................
All other countries ....................................................................................................................................
135,980
55,733
141,893
135,359
49,543
149,750
137,133
48,016
137,132
Consolidated total..................................................................................................................................... $
404,535
$
395,999
$
386,516
75
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 16. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following table summarizes the changes in the balances for each component of accumulated other comprehensive
income (loss) attributable to the Company for the fiscal years ended March 31, 2015, 2014, and 2013:
(in thousands of dollars)
Foreign currency translation:
Fiscal Year Ended March 31,
2015
2014
2013
Balance at beginning of year ..........................................................................................................
$
(8,476) $ (15,555) $
(11,850)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $12,181,
$(3,489), and $1,815) ...................................................................................................................
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests ....
Other comprehensive income (loss) attributable to Universal Corporation, net of income
taxes..............................................................................................................................................
(22,625)
(37)
6,480
599
(3,370)
(335)
(22,662)
7,079
(3,705)
Balance at end of year.....................................................................................................................
$ (31,138) $
(8,476) $
(15,555)
Foreign currency hedge:
Balance at beginning of year ..........................................................................................................
$
769
$
(855) $
(942)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $2,304, $(312), and
$3,234) .........................................................................................................................................
Reclassification of net loss to earnings (net of tax benefit of $(903), $(563), and $(3,281)) (1)..
Other comprehensive income (loss) attributable to Universal Corporation, net of income
taxes..............................................................................................................................................
(4,280)
1,677
580
1,044
(6,006)
6,093
(2,603)
1,624
87
Balance at end of year.....................................................................................................................
$
(1,834) $
769
$
(855)
Interest rate hedge:
Balance at beginning of year ..........................................................................................................
$
(608) $
(1,091) $
(727)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax benefit of $1,416, $49, and $515).............
Reclassification of net loss to earnings (net of tax benefit of $(675), $(310), and $(319)) (2).....
Other comprehensive income (loss) attributable to Universal Corporation, net of income
taxes..............................................................................................................................................
(2,628)
1,254
(1,374)
(93)
576
483
(955)
591
(364)
Balance at end of year.....................................................................................................................
$
(1,982) $
(608) $
(1,091)
Pension and other postretirement benefit plans:
Balance at beginning of year ..........................................................................................................
$ (26,017) $ (58,039) $
(66,842)
Other comprehensive income (loss) attributable to Universal Corporation:
Gains (losses) arising during the year (net of tax (expense) benefit of $9,719, $(6,449), and
$96)(3) .............................................................................................................................
Prior service credit arising during the year (net of tax expense of $7,751) (3) ..........................
Amortization included in earnings (net of tax benefit of $(2,163), $(3,042), and $(4,841)) (4) ..
Other comprehensive income (loss) attributable to Universal Corporation, net of income
taxes..............................................................................................................................................
(18,049)
—
4,026
11,977
14,394
5,651
(187)
—
8,990
(14,023)
32,022
8,803
Balance at end of year.....................................................................................................................
$ (40,040) $ (26,017) $
(58,039)
Total accumulated other comprehensive income (loss) at end of year..............................................
$ (74,994) $ (34,332) $
(75,540)
76
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(1) Gain (loss) on foreign currency cash flow hedges is reclassified from accumulated other comprehensive income (loss) to cost of goods sold
when the related tobacco is sold to customers. See Note 9 for additional information.
(2) Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when
the related interest payments are made on the debt or upon any termination of the interest rate swap agreements prior to their scheduled
maturity dates. See Note 9 for additional information.
(3) These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans. Those remeasurements
are made on an annual basis at the end of the fiscal year. In addition, the assets and liabilities of the Company's U.S.-based pension plans
were also remeasured on an interim basis during the second quarter of fiscal year 2014 to reflect the effect of plan amendments adopted
during the period. See Note 11 for additional information.
(4) This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 11
for additional information.
77
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 17. UNAUDITED QUARTERLY FINANCIAL DATA
Unaudited quarterly financial data for the fiscal years ended March 31, 2015 and 2014 is provided in the table below. Due
to the seasonal nature of the Company's business, management believes it is generally more meaningful to focus on cumulative rather
than quarterly results.
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Fiscal Year Ended March 31, 2015
Operating Results:
Sales and other operating revenues ...................................................................... $
271,472
$
464,116
$
758,054
$
778,159
Gross profit...........................................................................................................
55,540
Net income ...........................................................................................................
Net income attributable to Universal Corporation ...............................................
525
717
85,071
15,484
15,025
147,572
58,077
53,039
122,091
46,375
45,827
Earnings (loss) available to Universal Corporation common shareholders after
dividends on convertible perpetual preferred stock .............................................
Earnings (loss) per share attributable to Universal Corporation common
shareholders:
Basic.................................................................................................................
Diluted..............................................................................................................
Cash Dividends Declared:
Per share of convertible perpetual preferred stock ...............................................
Per share of common stock ..................................................................................
Market Price Range of Common Stock:
High ......................................................................................................................
Low.......................................................................................................................
(2,995)
11,312
49,309
42,122
(0.13)
(0.13)
16.88
0.51
56.82
52.16
0.49
0.48
16.87
0.51
56.35
44.39
2.13
1.87
16.88
0.52
45.63
38.53
1.86
1.64
16.87
0.52
48.10
39.27
Fiscal Year Ended March 31, 2014
Operating Results:
Sales and other operating revenues ...................................................................... $
433,528
$
650,869
$
767,802
$
689,916
Gross profit...........................................................................................................
Net income ...........................................................................................................
Net income attributable to Universal Corporation ...............................................
Earnings available to Universal Corporation common shareholders after
dividends on convertible perpetual preferred stock .............................................
Earnings per share attributable to Universal Corporation common
shareholders:
Basic.................................................................................................................
Diluted..............................................................................................................
Cash Dividends Declared:
Per share of convertible perpetual preferred stock ...............................................
Per share of common stock ..................................................................................
Market Price Range of Common Stock:
High ......................................................................................................................
Low.......................................................................................................................
71,468
53,913
58,309
119,312
29,830
25,444
139,307
44,203
38,585
103,204
27,209
26,671
54,597
21,731
34,873
22,958
2.34
2.05
16.88
0.50
61.46
54.45
0.94
0.90
16.87
0.50
63.36
48.43
1.50
1.36
16.88
0.51
54.60
50.06
0.99
0.94
16.87
0.51
58.99
49.84
78
UNIVERSAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Note: Earnings per share amounts for each fiscal year may not equal the total of the four quarterly amounts due to differences in
weighted-average outstanding shares for the respective periods and to the fact that the Company’s convertible perpetual
preferred stock may be antidilutive for some periods.
Significant items included in the quarterly results were as follows:
Fiscal Year Ended March 31, 2015
•
•
First Quarter – an income tax benefit of $8.0 million resulting from the ability of the Company's subsidiary, Deltafina S.p.A, to
pay a significant portion of the European Commission fine and related interest charges settled during the quarter following the
unsuccessful appeal of the case related to tobacco buying practices in Italy (see Note 3). The tax benefit reduced the diluted
loss per share after dividends on the Company's convertible perpetual preferred stock by $0.34.
Second Quarter – restructuring costs of approximately $3.4 million, primarily related to workforce reductions in the Company's
operations in Brazil, as well as the suspension of operations in Argentina. The restructuring costs reduced net income attributable
to Universal Corporation by $2.2 million and diluted earnings per share by $0.09.
• Third Quarter – additional restructuring costs of approximately $1.1 million, primarily related to additional workforce reductions
in Brazil, as well the suspension of operations in Argentina. The restructuring costs reduced net income attributable to Universal
Corporation by $0.7 million and diluted earnings per share by $0.03.
•
Fourth Quarter – a gain of $12.7 million from the reversal of a valuation allowance on the remaining unused balance of IPI
excise tax credits in Brazil. The gain increased net income attributable to Universal Corporation by $8.2 million and diluted
earnings per share by $0.30. The Company also recorded additional restructuring costs of approximately $0.4 million, which
reduced net income attributable to Universal Corporation by approximately $0.3 million and diluted earnings per share by $0.01.
Fiscal Year Ended March 31, 2014
•
•
First Quarter – a gain of $81.6 million resulting from the favorable outcome of litigation by the Company’s operating subsidiary
in Brazil related to previous years’ excise tax credits. The gain increased net income attributable to Universal Corporation by
$53.1 million. Excluding the effect of the gain on net income attributable to Universal Corporation, the Company's outstanding
convertible perpetual preferred stock would have been antidilutive to earnings per share for the quarter. As a result, the gain
increased diluted earnings per share for the quarter by $1.96. For the full fiscal year, the preferred stock was dilutive to earnings
per share with or without the gain, and the effect on diluted earnings per share was only $1.87.
Second Quarter – restructuring costs of approximately $1.3 million, primarily related to the closure of a tobacco processing
facility in Brazil and consolidation of those operations into the Company's primary facility there. The restructuring costs reduced
net income attributable to Universal Corporation by $0.9 million and diluted earnings per share by $0.03.
• Third Quarter – additional restructuring costs of approximately $3.4 million, primarily related to the facility closure in Brazil.
The restructuring costs reduced net income attributable to Universal Corporation by $2.2 million and diluted earnings per share
by $0.08.
•
Fourth Quarter – restructuring costs of approximately $2.0 million, representing additional costs associated with the facility
closure in Brazil and costs related to voluntary early retirement arrangements at several locations. The restructuring costs reduced
net income attributable to Universal Corporation by $1.3 million and diluted earnings per share by $0.04.
79
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm
The Board of Directors and Shareholders of
Universal Corporation
We have audited the accompanying consolidated balance sheets of Universal Corporation as of March 31, 2015 and 2014, and the
related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the
three years in the period ended March 31, 2015. Our audits also included the financial statement schedule listed in the Index at Item
15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express
an opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position
of Universal Corporation at March 31, 2015 and 2014, and the consolidated results of its operations and its cash flows for each of
the three years in the period ended March 31, 2015, in conformity with U.S. generally accepted accounting principles. Also, in our
opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole,
presents fairly in all material respects the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Universal
Corporation’s internal control over financial reporting as of March 31, 2015, based on criteria established in Internal Control—
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and
our report dated May 22, 2015 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Richmond, Virginia
May 22, 2015
80
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm,
on Internal Control Over Financial Reporting
The Board of Directors and Shareholders of
Universal Corporation
We have audited Universal Corporation’s internal control over financial reporting as of March 31, 2015, based on criteria established
in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission
(2013 framework) (the COSO criteria). Universal Corporation’s management is responsible for maintaining effective internal control
over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the
accompanying Management’s Report on Internal Control over Financial Reporting in Item 9A. Our responsibility is to express an
opinion on the company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over
financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over
financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness
of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.
We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets
of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being
made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a
material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Universal Corporation maintained, in all material respects, effective internal control over financial reporting as of
March 31, 2015, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Universal Corporation as of March 31, 2015 and 2014, and the related consolidated statements of
income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the three years in the period ended
March 31, 2015 and our report dated May 22, 2015 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Richmond, Virginia
May 22, 2015
81
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
For the three years ended March 31, 2015, there were no changes in independent auditors, nor were there any disagreements
between the Company and its independent auditors on any matter of accounting principles, practices, or financial disclosures.
Item 9A. Controls and Procedures
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be
disclosed in reports filed by the Company under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC rules and forms and that such information is accumulated and communicated to the Company’s
management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding
required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer evaluated, with the participation of the
Company’s management, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule
13a-15(e)), as of the end of the period covered by this Annual Report. Based on this evaluation, the Company’s management, including
its Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were
effective.
Management’s Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining effective internal control over financial
reporting as defined in Rule 13a-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed
to provide reasonable assurance to management and the Board of Directors regarding the preparation and fair presentation of the
consolidated financial statements. Due to inherent limitations, internal control over financial reporting may not prevent or detect all
errors or misstatements in the financial statements, and even control procedures that are determined to be effective can provide only
reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions.
As required by Exchange Act Rule 13a-15(c), the Company’s Chief Executive Officer and Chief Financial Officer, with
the participation of other members of management, assessed the effectiveness of the Company’s internal control over financial
reporting as of March 31, 2015. The evaluation was based on the criteria set forth in “Internal Control – Integrated Framework”
issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (“the COSO criteria”). Based
on this assessment, the Company’s management concluded that the Company’s internal control over financial reporting was effective
as of March 31, 2015.
The Company’s independent registered public accounting firm, Ernst & Young LLP, has audited the Company’s internal
control over financial reporting as of March 31, 2015. Their report on this audit appears on page 81 of this Annual Report.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last
fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial
reporting.
Item 9B. Other Information
None.
82
Item 10. Directors, Executive Officers, and Corporate Governance
PART III
Except as to the matters set forth below, information required by this Item is incorporated herein by reference to the Company’s
2015 Proxy Statement.
The following are executive officers of the Company as of May 22, 2015:
Name and Age
G. C. Freeman, III (51) Chairman, President and
Chief Executive Officer
Position
A. L. Hentschke (45)
Senior Vice President and
Chief Operating Officer
D. C. Moore (59)
Senior Vice President and
Chief Financial Officer
T. G. Broome (61)
Executive Vice President and
Sales Director, Universal
Leaf Tobacco Company, Inc.
P. D. Wigner (46)
Vice President, General
Counsel and Secretary
J. A. Huffman (53)
Senior Vice President,
Information and Planning,
Universal Leaf Tobacco
Company, Inc.
Business Experience During Past Five Years
Mr. Freeman was elected Chairman of the Board in August 2008, Chief
Executive Officer effective April 2008, President in December 2006,
and Vice President in November 2005. Mr. Freeman served as General
Counsel and Secretary from February 2001 until November 2005 and
has been employed with the Company since 1997.
Mr. Hentschke was elected Senior Vice President and Chief Operating
Officer in April 2015. From January 2013 to April 2015, he served as
Executive Vice President of Universal Leaf. Tobacco Company,
Incorporated ("Universal Leaf"). From November 2009 to January
2013, Mr. Hentschke served as President and Chief Executive Officer
of Universal Leaf Tabacos, Limitada, the Company's operating
subsidiary in Brazil. He has been employed with the Company and its
affiliates since 1991.
Mr. Moore was elected Senior Vice President and Chief Financial
Officer effective September 2008. Mr. Moore served as Vice President
and Chief Administrative Officer from April 2006 until September
2008, as Senior Vice President of Universal Leaf from September 2005
until April 2006, and as Managing Director of Universal Leaf
International SA from April 2002 until September 2005. He has been
employed with the Company since 1978.
Mr. Broome was elected Executive Vice President and Sales Director,
Universal Leaf, in October 2012. From April 2011 through October
2012, Mr. Broome served as Executive Vice President. From September
1998 through March 2011, Mr. Broome served as Senior Vice President-
Sales. He has been employed with the Company since 1994.
Mr. Wigner was elected Vice President in August 2007, and General
Counsel and Secretary in November 2005 and also served as Chief
Compliance Officer from November 2007 until September 2012. Mr.
Wigner served as Senior Counsel of Universal Leaf from November
2004 until November 2005. He has been employed with the Company
since 2003.
Mr. Huffman was elected Senior Vice President, Information and
Planning, Universal Leaf, in August 2007. From September 2003 to
August 2007, Mr. Huffman served as Senior Vice President. From
September 2002 to September 2003, Mr. Huffman served as Vice
President and Controller. He has been employed with the Company
since 1996.
C. C. Formacek (55)
R. M. Peebles (57)
Vice President and Treasurer Ms. Formacek was elected Vice President and Treasurer effective April
2012. Ms. Formacek served as Treasurer of Universal Leaf from April
2011 through March 2012. She joined the Company in September 2009
and served as Assistant Treasurer of Universal Leaf from that time
through March 2011.
Vice President and Controller Mr. Peebles was elected Vice President and Controller in April 2011.
Mr. Peebles joined the Company in September 2003 and served as
Controller from that time through March 2011.
There are no family relationships between any of the above officers.
83
The Company has a Code of Conduct that includes the NYSE requirements for a “Code of Business Conduct and Ethics”
and the SEC requirements for a “Code of Ethics for Senior Financial Officers.” The Code of Conduct is applicable to all officers,
employees, and outside directors of the Company, including the principal executive officer, principal financial officer, and principal
accounting officer. A copy of the Code of Conduct is available through the “Corporate Governance-Overview” section of the
Company’s website at www.universalcorp.com. If the Company amends a provision of the Code of Conduct, or grants a waiver
from any such provision to a director or executive officer, the Company will disclose such amendments and the details of such
waivers on the Company’s website www.universalcorp.com to the extent required by the SEC or the NYSE.
The information required by Items 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is contained under the captions “Corporate
Governance and Committees—Committees of the Board—Compensation Committee,” “Corporate Governance and Committees—
Committees of the Board—Audit Committee” of the Company’s 2015 Proxy Statement and such information is incorporated by
reference herein.
Item 11. Executive Compensation
Refer to the captions “Executive Compensation” and “Directors’ Compensation” in the Company’s 2015 Proxy Statement,
which information is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Refer to the caption “Equity Compensation Information” in the Company’s 2015 Proxy Statement, which information is
incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Refer to the caption “Certain Transactions” in the Company’s 2015 Proxy Statement, which information is incorporated
herein by reference. The information required by Item 407(a) of Regulation S-K is contained under the caption “Corporate Governance
and Committees—Director Independence” of the Company’s 2015 Proxy Statement and such information is incorporated by reference
herein.
Item 14. Principal Accounting Fees and Services
Refer to the captions “Audit Information – Fees of Independent Auditors” and “Audit Information – Pre-Approval Policies
and Procedures” in the Company’s 2015 Proxy Statement, which information is incorporated herein by reference.
84
Item 15. Exhibits, Financial Statement Schedules
(a)
The following are filed as part of this Annual Report:
1. Financial Statements.
PART IV
Consolidated Statements of Income for the Fiscal Years Ended March 31, 2015, 2014, and 2013
Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 31, 2015, 2014, and 2013
Consolidated Balance Sheets at March 31, 2015 and 2014
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2015, 2014, and 2013
Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Years Ended March 31, 2015, 2014,
and 2013
Notes to Consolidated Financial Statements for the Fiscal Years Ended March 31, 2015, 2014, and 2013
Report of Ernst & Young LLP, Independent Registered Accounting Firm
Report of Ernst & Young LLP, Independent Registered Accounting Firm, on Internal Control Over Financial
Reporting
2. Financial Statement Schedules.
Schedule II – Valuation and Qualifying Accounts
3. Exhibits. The exhibits are listed in the Exhibit Index immediately following the signature pages to this Annual Report.
(b)
Exhibits
The response to this portion of Item 15 is submitted as a separate section to this Annual Report.
(c)
Financial Statement Schedules
Schedule II – Valuation and Qualifying Accounts appears on the following page of this Annual Report. All other
schedules are not required under the related instructions or are not applicable and therefore have been omitted.
85
Schedule II - Valuation and Qualifying Accounts
Universal Corporation
Fiscal Years Ended March 31, 2015, 2014, and 2013
Description
(in thousands of dollars)
Fiscal Year Ended March 31, 2013:
Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................
$
Balance at
Beginning
of Period
Net
Additions
(Reversals)
Charged
to Expense
Additions
Charged
to Other
Accounts
Deductions (1)
Balance
at End
of Period
8,307
$
1,788
$
— $
(2,127) $
7,968
Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................
74,382
1,623
Allowance for recoverable taxes (deducted from other
current assets and other noncurrent assets) ........................
24,719
4,005
—
—
(21,612)
54,393
(2,680)
26,044
Fiscal Year Ended March 31, 2014:
Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................
$
7,968
$
419
$
— $
(1,851) $
6,536
Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................
54,393
5,461
Allowance for recoverable taxes (deducted from other
current assets and other noncurrent assets) ........................
26,044
5,607
—
—
(13,776)
46,078
(2,147)
29,504
Fiscal Year Ended March 31, 2015:
Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................
$
6,536
$
1,341
$
— $
(2,395) $
5,482
Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................
46,078
3,734
Allowance for recoverable taxes (deducted from other
current assets and other noncurrent assets) ........................
29,504
1,855
—
—
(15,139)
34,673
(8,141)
23,218
(1)
Includes direct write-offs of assets and currency remeasurement.
86
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
May 22, 2015
UNIVERSAL CORPORATION
By:
/s/ GEORGE C. FREEMAN, III
George C. Freeman, III
Chairman, President, and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the
following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature
/s/ GEORGE C. FREEMAN, III
George C. Freeman, III
Title
Chairman, President, Chief Executive Officer, and Director
(Principal Executive Officer)
/s/ DAVID C. MOORE
David C. Moore
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
/s/ ROBERT M. PEEBLES
Robert M. Peebles
Vice President and Controller
(Principal Accounting Officer)
/s/ JOHN B. ADAMS, JR.
John B. Adams, Jr.
/s/ DIANA F. CANTOR
Diana F. Cantor
/s/ CHESTER A. CROCKER
Chester A. Crocker
/s/ CHARLES H. FOSTER, JR.
Charles H. Foster, Jr.
/s/ LENNART R. FREEMAN
Lennart R. Freeman
/s/ THOMAS H. JOHNSON
Thomas H. Johnson
/s/ EDDIE N. MOORE, JR.
Eddie N. Moore, Jr.
/s/ ROBERT C. SLEDD
Robert C. Sledd
Director
Director
Director
Director
Director
Director
Director
Director
87
Date
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
May 22, 2015
EXHIBIT INDEX
3.1 Amended and Restated Articles of Incorporation, effective August 9, 2011 (incorporated herein by reference to the
Registrant’s Current Report on Form 8-K Registration Statement filed August 9, 2011, File No. 001-00652).
3.2 Amended and Restated Bylaws (as of August 3, 2010) (incorporated herein by reference to the Registrant’s Current
Report on Form 8-K dated August 3, 2010, File No. 001-00652).
4.1
Indenture between the Registrant and Chemical Bank, as trustee (incorporated herein by reference to the Registrant’s
Current Report on Form 8-K dated February 25, 1991, File No. 001-00652).
4.2 Specimen Common Stock Certificate (incorporated herein by reference to the Registrant’s Amendment No. 1 to
Registrant’s Form 8-A Registration Statement, dated May 7, 1999, File No. 001-00652).
10.1 Form of Universal Leaf Tobacco Company, Incorporated Executive Life Insurance Agreement (incorporated herein by
reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.2 Universal Leaf Tobacco Company, Incorporated Deferred Income Plan (incorporated herein by reference to the
Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.3 Universal Leaf Tobacco Company, Incorporated Benefit Replacement Plan (incorporated herein by reference to the
Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.4 Universal Leaf Tobacco Company, Incorporated 1994 Benefit Replacement Plan (incorporated herein by reference to
the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.5 Universal Leaf Tobacco Company, Incorporated 1996 Benefit Restoration Plan (incorporated herein by reference to
the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1996, File No. 001-00652).
10.6 Universal Leaf Tobacco Company, Incorporated 1994 Deferred Income Plan, amended and restated as of July 1, 1998
(incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September
30, 1998, File No. 001-00652).
10.7 Universal Corporation Outside Directors’ Deferred Income Plan, restated as of October 1, 1998 (incorporated herein
by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No.
001-00652).
10.8 Revised Form of Universal Corporation Non-Employee Director Restricted Stock Agreement (incorporated herein by
reference to the Registrant’s Current Report on Form 8-K dated June 9, 2010, File No. 001-00652).
10.9 Form Change of Control Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-
K filed November 10, 2008, File No. 001-00652).
10.10 Universal Corporation Director’s Charitable Award Program (incorporated herein by reference to the Registrant’s
Annual Report on Form 10-K for the fiscal year ended June 30, 1998, File No. 001-00652).
10.11 Universal Corporation 1997 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.12 Universal Corporation 2002 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.13 Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Current Report
on Form 8-K filed November 10, 2008, File No. 001-00652).
10.14 Form of Stock Appreciation Rights Agreement (incorporated herein by reference to the Registrant’s Current Report on
Form 8-K filed June 1, 2006, File No. 001-00652).
88
10.15 Form Stock Appreciation Rights Agreement (incorporated herein by reference to the Registrant’s Current Report on
Form 8-K filed June 3, 2008, File No. 001-00652).
10.16 Universal Corporation 2007 Amended and Restated Stock Incentive Plan effective August 7, 2012 (incorporated herein
by reference to Exhibit A to the Registrant’s definitive proxy statement filed June 28, 2012, File No. 001-00652).
10.17 Universal Corporation Executive Officer Annual Incentive Plan, as amended (incorporated herein by reference to the
Registrant's definitive proxy statement filed June 25, 2014, File No. 001-00652).
10.18 Form of Universal Corporation 2010 Restricted Stock Units Agreement with Schedule of Awards to named executive
officers (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended
March 31, 2010, File No. 001-00652).
10.19 Form of Universal Corporation Stock Appreciation Rights Agreement for executive officers (incorporated herein by
reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.20 Universal Leaf Tobacco Company, Incorporated Deferred Income Plan III, amended and restated as of December 31,
2008 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March
31, 2010, File No. 001-00652).
10.21 Universal Corporation Outside Directors' Deferred Income Plan III, amended and restated as of December 31, 2008,
and amended as of February 1, 2010 (incorporated herein by reference to the Registrant's Annual Report on Form 10-
K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.22 Form of Universal Corporation 2011 Restricted Stock Units Agreement (incorporated herein by reference to the
Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.23 Form of Universal Corporation Stock Appreciation Rights Agreement for executive officers (incorporated herein by
reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.24 Form of Universal Corporation Performance Share Award Agreement (incorporated herein by reference to the
Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.25 Credit Agreement dated December 30, 2014 among the Company, JPMorgan Chase Bank, N.A., as Administrative
Agent, SunTrust Bank and AgFirst Farm Credit Bank, as Co-Syndication Agents and Keybank National Association
and Capital One, National Association, as Co-Documentation Agents (incorporated herein by reference to the
Registrant’s Current Report on Form 8-K dated December 30, 2014 (December 23, 2014), File No. 001-00652).
12 Ratio of Earnings to Fixed Charges and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
21 Subsidiaries of the Registrant.*
23 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.*
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1 Statement of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*
32.2 Statement of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*
101
Interactive Data File (Annual Report on Form 10-K, for the fiscal year ended March 31, 2015, furnished in XBRL
(eXtensible Business Reporting Language)).*
89
Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements
of Income for each of the three years ended March 31, 2015, 2014 and 2013, (ii) the Consolidated Statements of
Comprehensive Income for each of the three years ended March 31, 2014, 2013 and 2012, (iii) the Consolidated Balance
Sheets at March 31, 2015 and 2014, (iv) the Consolidated Statement of Cash Flows for each of the three years ended
March 31, 2015, 2014 and 2013, (v) the Consolidated Statement of Shareholders’ Equity for each of the three years
ended March 31, 2015, 2014 and 2013, (vi) the Notes to Consolidated Financial Statements, (vii) Schedule II - Valuation
and Qualifying Accounts.
_________
* Filed herewith.
90
SHAREHOLDER INFORMATION
ANNUAL MEETING
The Annual Meeting of Shareholders will be held at
SEC FORM 10-K
Shareholders may obtain additional copies of the
the offices of the Company, 9201 Forest Hill Avenue,
Company’s annual report to the Securities and
Richmond, Virginia, on Tuesday, August 4, 2015. A
Exchange Commission on its website or by writing to
proxy statement and request for proxies are included
the Treasurer of the Company.
in this mailing to shareholders.
INDEPENDENT AUDITORS
Ernst & Young LLP
The Edgeworth Building
Suite 201, 2100 East Cary Street
Richmond, Virginia 23223
INVESTOR RELATIONS
Contact:
Candace C. Formacek
Vice President and Treasurer
Jennifer S. Rowe
STOCK LISTED
New York Stock Exchange
STOCK SYMBOL
UVV
DIVIDEND REINVESTMENT PLAN
The Company offers to its common shareholders an
automatic dividend reinvestment and cash payment
plan to purchase additional shares. The Company
bears all brokerage and service fees. Booklets
describing the plan in detail are available upon
Assistant Vice President, Capital Markets
request.
(804) 359-9311
Information Requests:
(804) 254-3789 or investor@universalleaf.com
TRANSFER AGENT AND REGISTRAR AND DIVIDEND
REINVESTMENT PLAN AGENT
Wells Fargo Bank, N.A.
DIVIDEND PAYMENTS
Dividend declarations are subject to approval by
Shareowner Services
P.O. Box 64854
the Company’s Board of Directors. Dividends on
St. Paul, Minnesota 55164-0854
the Company’s common stock have traditionally
(800) 468-9716
been paid quarterly in February, May, August, and
or
November to shareholders of record on the second
Monday of the previous month.
Universal Corporation
Shareholder Services
(804) 359-9311
P.O. Box 25099
Richmond, VA 23260
www.universalcorp.com